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ABSTRACT 
 The major goal of my study is to understand how the nervous system regulates 
lung function and disease pathophysiology. Asthma, which is a chronic allergic disease in 
the lung, has been associated with deregulated airway innervation.  The two cell types in 
the lung that are innervated are airway smooth muscle cells and pulmonary 
neuroendocrine cells (PNECs).  Given that asthma often starts in early childhood, prior 
research established a neonatal mouse model of allergen exposure to facilitate functional 
studies of nerves in the development of asthma.  Our previous findings showed that 
allergen exposure to developing, postnatal lungs upregulated levels of neurotrophin 4 
(NT4), and caused airway hyperinnervation associated with persistent mucus 
overproduction.  In this work, I describe a novel role of the pulmonary neuroendocrine 
system in promoting mucus overproduction in early life through deregulated GABAergic 
signaling.   
PNECs are the only innervated epithelial cells and express a variety of 
neuropeptides and bioactive amines.  However, how neural innervation affects PNEC 
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secretion and function in disease is not known.  Here, I demonstrated that PNECs were 
the only source of gamma-Aminobutyric acid (GABA) in airways and that GABA 
hypersecretion from PNECs was required for mucus overproduction following early life 
allergen exposure.  Further, mice lacking NT4 were protected from allergen-induced 
PNEC hyperinnervation, GABA hypersecretion, and thus mucus overproduction, all 
which could be rescued with addition of GABA. These findings link PNECs and 
allergen-induced mucus overproduction through NT4-dependent innervation.  Notably, 
like mice, infant nonhuman primates exhibit PNEC hyperinnervation following early life 
exposure to ozone and allergens. In addition, I demonstrate that GABA acts in concert 
with interleukin-13 to induce the proliferation of mucus-producing goblet cells in human 
airway epithelium cell cultures.  Lastly, building upon our previous observations that 
mast cells contributed to the elevated NT4 levels after allergen exposure, I initiated a 
research project that investigates the function of a discrete, resident mast cell in: NT4 
expression, PNEC innervation, and mucus overproduction. 
Together, my findings address a novel fundamental role of the neuroendocrine 
system biology in animal models of asthma. Targeting the nerve–PNEC axis may be a 
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 MAIN INTRODUCTION 
 
The primary function of the lung is gas exchange.1  However, this fundamental 
function is compromised greatly in disease.  In the lung, a complex neural network exists 
to regulate coughing, breathing, and mucus secretion.2  The respiratory tract, which 
includes the trachea and lung, is innervated by a rich variety of nerves, whose primary 
targets are airway smooth muscle (ASM) and pulmonary neuroendocrine cells (PNECs) 
in the airway epithelium.2 The developing lung is highly vulnerable to exposures 
including environmental pollutants, pathogens, and allergens.3-5  Indeed, deregulated lung 
innervation has been implicated in the pathophysiology of lung diseases including 
asthma.6  Understanding the relationship between these early life changes and the 
nervous system is a major goal of this work.  We have shown that after early life 
exposure to allergens in mice, a neurotrophic factor, so called neurotrophin 4, was 
elevated, promoting ASM hyperinnervation, which directly influenced airway 
hyperreactivity (AHR).7  This event was highly specific to early life, as adult mice did 
not develop these phenotypes following allergen exposures.  Further, we investigated the 
cell source that contributed to the elevated NT4 levels and found activated mast cells as a 
de novo source of NT4.8  
Another symptom commonly seen in asthmatic patients is mucus overproduction.9  
Besides the typical type 2 inflammation markers and transcription factors that drive 




identified in lung epithelium which was essential for mucus overproduction.10  The 
precise source and mechanisms of GABA secretion remain unclear.         
Neurotrophins are also found to be upregulated in young asthmatic patients and 
genome wide association studies (GWAS) have identified several single nucleotide 
polymorphisms in neurotrophin genes and receptors.  However, the role of neurotrophins 
in mucus overproduction in early life exposures is unclear.  This work will address 
effects of neurotrophin 4 and GABAergic signaling on mucus overproduction using early 
life allergen exposure mouse models and ex vivo cultures.   
Lung innervation 
The lung and trachea arise from the anterior foregut endoderm.  Along with 
complicated and precisely timed signaling, lung specification in mice, begins around 
embryonic day 9 (E9) with the expression of transcription factor Nkx2.1.11  Over the 
course of lung development (E9.5-E16.5) the trachea separates from the esophagus and 
the single lung bud bifurcates into two buds and distal and proximal patterning begins.  
During the canalicular (E16.5-E17.5) and saccular stages (E18.5-postnatal (P) day 5) 
airway branches narrow and begin to form primitive epithelial sacs which will develop 
into alveoli postnatally (P0-P14).   
 During the complex processes of lung branching morphogenesis and 
alveolarization, the neuronal network forms concurrently.  In a normal postnatal lung in 
mice, innervation peaks at P14 and stabilizes around P21.7 The lungs are innervated by a 
rich combination of intrinsic and extrinsic neurons.2  Intrinsic neurons’ cell bodies reside 




neuron cell bodies.  Extrinsic neurons, however reside outside the lung within the jugular, 
nodose/petrosal ganglia and brain stem and supply the parasympathetic efferents and 
sensory afferents.  Axons from extrinsic nerves travel along the vagus nerve to innervate 
ASM and PNECs in the lung epithelium.  Around E10.5, during trachea and esophagus 
separation, neural crest cells from the neural tube cluster to form intrinsic ganglia in the 
trachea and upper bronchi.2,12  In order to extend into distal parts of the lung, extrinsic 
nerves require trophic nerve growth factors, neurotrophins (NTs).  Both ASM and PNECs 
are extensively innervated and depend on NTs for proper innervation. 
Asthma 
We and others have shown that deregulated innervation during development 
contributes to AHR and mucus overproduction.7,8,13,14  Asthma is a chronic inflammatory 
disease of the airway. The clinical features of asthma include bronchial smooth muscle 
thickening, reversible airway hyperreactivity, aberrant matrix deposition, and mucus 
overproduction, all of which significantly reduce airflow into the lung.15  Asthma’s 
worldwide impact is staggering as more than 300 million people are affected by asthma 
and thus it places a significant global health and economic burden.  Asthma is typically 
classified as a type 2 inflammation response where patients typically have high levels of 
type 2 cytokines including interleukin-13 (IL-13).16 Patients with high type 2 responses 
are also accompanied by high numbers of eosinophils, mast cells, neutrophils, 
immunoglobulin E levels, and macrophages.15  However, asthma complexity is reflected 




pathophysiology. There are many risk factors for the development of asthma and a few of 
those will be discussed below. 
Early life exposures significantly alter the lung and immune development 
program.17  Risk factors for asthma include exposure to environmental pathogens, 
allergens, pollutants, and genetic predispositions.  Children infected with respiratory 
syncytial virus (RSV) and rhinovirus, predispose the developing lung to the onset of 
wheeze and asthma.3,4,18,19  In addition, early life pollutants and cigarette smoke exposure 
are associated with reduced lung function in children with asthma.20-22   
It is technically challenging to study the young lung as samples are limited, and 
thus, mechanisms linking early life events to long-term abnormalities in lung structure 
and function remain poorly understood.  Additionally, typical asthmatic treatments in 
young children raise concerns, as long term effects of inhaled corticosteroid (ICS) 
treatments may have side effects.23  Regardless, a few studies have shown that ICS 
treatments or oral corticoid treatments do not reduce intermittent acute symptoms in 
children.24,25  Unfortunately, current treatment strategies only aim to alleviate the 
symptoms rather than eradicating pathogenic changes and as such, have no beneficial 
effect on the progression of asthma.  As a result, up to 55% of asthmatic patients still 
experience poorly controlled symptoms.26-28  Thus, it is necessary to uncover new 
mechanisms underlying childhood asthma as novel treatments are an urgent need.  Due to 
technical difficulties in obtaining samples from young patients and a need to understand 
asthma pathophysiology, mouse models and non-human primate models have provided 




Mucus overproduction in asthma 
The normal pseudostratified epithelium of the lung exists in harmony with 
secretory club cells, ciliated cells, PNECs, and mucus producing goblet cells.  Normal 
airway mucus plays a critical immune function by trapping and clearing inhaled 
pathogens and particles in coordination with beating ciliated cells, in a process called 
mucociliary clearance.  While protective in the lung, excessive mucus or impaired 
clearance contributes to many common lung diseases.  In asthmatic humans, 
exacerbations are consistently associated with mucus overproduction and changes in 
mucus composition.29,30  Exacerbations are usually amplified through severe airflow 
obstruction caused by bronchoconstriction and mucous plugging.31,32  Thus, mucus 
overproduction is a significant patient burden and can contribute to mortality.   
Goblet cells: content and location 
Mucus is composed mainly of water, salts, lipids, and mucins.33,34  Mucins are 
very large (>1000kDa) heavily glycosylated proteins and are mainly carbohydrate based.  
There are more than 20 mucin and mucin like genes identified in the mammalian genome 
and they generally can be categorized into anchored membrane mucins or secreted 
mucins.35  Here, I will focus on the secreted mucins.  In asthma, secreted mucus is 
typically stiff and forms a consistent gel over the airway.9  This structure is related to the 
sulfhydryl groups near their termini that allows crosslinking and leads to an overall 
highly negatively charged molecule.33,34                                     
 Goblet cells have many small granules in their cytoplasm that occupy more than 




alcian blue staining, which detects carbohydrate rich mucins.  Additionally, more specific 
quantification can be used, such as qRT-PCR or immunohistochemistry for mucin 
glycoproteins, such as MUC5AC.   
 Two mucins that are highly expressed in the human airway are MUC5AC and 
MUC5B.  In healthy humans, MUC5AC is predominantly produced by goblet cells in the 
proximal airways, whereas MUC5B is produced by the submucosal glands and secretory 
cells.9,36  Under baseline conditions, in small human airways (<2mm), and all pulmonary 
murine airways, there are few or no goblet cells.  However, under allergic conditions, the 
airway epithelium composition changes and there is an increased number of goblet cells 
and mucus secretion.32,37,38  In the airways of normal mice, almost no baseline Muc5ac is 
produced.  On the other hand, Muc5b produced by secretory club cells is required for 
proper mucociliary clearance and bacterial defense, as mice deficient in Muc5b die from 
lung inflammation.  This suggests that Muc5b is important for maintaining proper 
mucociliary clearance and is not necessarily involved in mucus overproduction as levels 
typically remain stable during inflammation.39,40  Contrary to MUC5B, MUC5AC is 
consistently upregulated in asthmatic patients.9,41  In mouse models of asthma, Muc5ac is 
the major mucin induced.13,37,42  Further, Muc5ac was shown to be required for mucus 
plugging and triggering AHR.43  Mechanisms underlying mucus hypersecretion and 
mucus overproduction are incompletely understood.  
Mechanisms of mucus secretion and regulation 
Increased mucus production in humans has been linked to an increased number of 




compared to 5% in healthy individuals.44  This number also was highly correlated to the 
amount of mucus plugging the airway.  Further, moderate asthmatic patients had higher 
mucin secretion compared to mild asthmatic patients.45  These studies suggest that mucus 
overproduction is related to increases in goblet cell numbers and can be associated with 
asthma disease severity.  
In mice, the normal epithelium consists of 40% ciliated cells and 60% secretory 
cells, with little to no goblet cells.  After allergen exposure, goblet cell numbers 
dramatically increase.38  This change is accompanied by a 75% decrease of secretory club 
cells and 25% reduction of ciliated cells.38  Notably, increases in goblet cell numbers 
were not attributed to proliferation as proliferation markers remained constant when the 
highest numbers of goblet cells were observed after challenge.37,38  These data suggested 
that unlike human, mucus overproduction may be driven through transdifferentiation, 
where secretory club cells differentiate to mucus producing goblet cells.37  This transition 
is documented in electron microscopy images where traditional club cells (smooth 
endoplasmic reticulum, apical cell projection and electron dense vesicles) transform into 
goblet cells packed with mucus vesicles.38  Newly transitioned goblet cells retain 
molecular and functional properties of club cells, and they continue to coexpress club cell 
secretory protein (CCSP) and MUC5AC.37  Additionally, lineage tracing of CC10 
expressing club cells during allergen challenge, also maintain expression of  goblet cell 
marker, MUC5AC.46  Lineage tracing analysis of FOXJ1+ ciliated cells during allergen 




 While the cell of origin for mucus overproduction is different between mouse and 
human, mechanisms of mucus overproduction are conserved.  Mechanistically IL-13 is 
shown to promote mucus overproduction in mouse models of asthma.13,16,48-50  Goblet 
cells in mouse models of asthma arise after allergen challenges and are mediated by Th2 
cytokines, IL-4 and IL-13, which activate downstream signaling, STAT6 
phosphorylation, and gene expression.49,51  Transdifferentiation of goblet cells in murine 
airways requires transcription factor, SAM pointed domain containing ETS transcription 
factor (SPDEF), for mucin synthesis and secretion, and for proteins that regulate mucin 
folding, packaging, and processing.46,52  Additionally, SPDEF and Forkhead box protein 
A3 (FOXA3) have been identified as transcription factors exclusively expressed in 
airway goblet cells, cause AHR, and both are increased after allergen exposure.13,46,53,54  
Notably, in human airways, SPDEF and FOXA3 are highly expressed in asthmatic, 
COPD, and CF samples compared to non-diseased human lungs.  
A previous study identified an aberrant GABAergic system essential for mucus 
overproduction in a mouse model of asthma and human bronchial epithelial cell lines.10  
Gamma amino-butyric acid (GABA) is a single amino acid neurotransmitter and the 
major inhibitory neurotransmitter in the brain.  GABA is converted from glutamate by 
glutamate decarboxylase 67 (Gad67) and Gad65, encoded by Gad1 and Gad2 genes, 
respectively.55  Then, GABA is transported and packaged into secretory vesicles by 
Slc32a1.56   However, the mechanisms of GABA production and intracellular signaling in 




airways, the mechanisms of GABA secretion, and its promotion of mucus overproduction 





Neurotrophins in Asthma 
As mentioned above, deregulation of nerves, NTs, and neurotransmitters in the 
lung are critical for the development of asthma pathology.  Here, I will highlight studies 
of early phases of asthma that collectively reveal a profound impact of elevated NT levels 
following initial detrimental insults on long-term airway dysfunction.  This chapter will 
stimulate further insight into the complex interactions between NTs, nerves, immune 
cells, and airway structural cells during a critical time window of development and 
disease susceptibility.    
Neurotrophins (NTs) were initially discovered as essential trophic factors for the 
survival and axon outgrowth of neurons during the development of the central and 
peripheral nervous systems 57.  Since then, many studies have implicated nerves and NTs 
in the pathophysiology of asthma and other allergic diseases.  The family of NTs consists 
of nerve growth factor (NGF), brain-derived neurotrophic factor (BNDF), neurotrophin 3 
(NT3), and neurotrophin 4 (NT4).  All four NTs are expressed as precursors that undergo 
N-terminal cleavage of pro-domains to generate the mature proteins.  The pro-domain of 
NTs affects protein folding and the interaction with the receptor.  NTs bind to their 
respective high-affinity tropomyosin receptor kinase (Trk) receptors with relatively high 
fidelity: TrkA for NGF, TrkB for BDNF and NT4, and TrkC for NT3 58 (Figure 1.1).  In 
addition, all 4 NTs bind to a low-affinity p75 neurotrophin receptor (p75NTR) 59,60. 









Figure 1.1: NTs and their receptors.  
NTs bind to respective high-affinity Trk receptors with relative specificity that triggers 
the activation of the PI3K/Akt and Ras/MAPK pathways and in turn, induces cell 
survival, proliferation, and differentiation. All 4 NTs also bind to a low-affinity p75NTR 





and PI3K/Akt signaling pathways upon NT binding. Trks play essential roles in the 
survival, proliferation, and differentiation of the nervous system. In contrast, p75NTR 
belongs to a family of transmembrane molecules that include receptors for the tumor  
necrosis factor family. NT signaling through p75NTR induces cell apoptosis through the 
intracellular JNK pathway58. The biological roles of p75NTR remain elusive. As 
p75NTR can interact with the Trk receptors and modulate the high-affinity binding of 
NTs to the Trk receptors, the function of p75NTR may be context-dependent.  Elevated 
levels of NTs have been found to be associated with asthma. Airway epithelium, smooth 
muscle cells, and immune cells are the likely source of elevated levels of NTs.  Notably, 
in addition to Trk-expressing nerves, non-neuronal cell types in the lung have also been 
reported to express the Trk receptors.  For example, TrkA was found in macrophages, 
basophils, mast cells, eosinophils, and memory B cells61.  TrkB has also been reported in 
primary human airway smooth muscle cells in culture62.  Therefore, NTs may contribute 
to asthma pathophysiology through two modes of action.  The direct mode is mediated by 
NT signaling in Trk-expressing cells (Figure 1.2).   
Alternatively, NTs indirectly modulate allergic inflammation and airway 
dysfunction through the role of NTs in airway innervation and nerve-derived 
neurotransmitters, such as acetylcholine.  Building upon this, NTs are also expressed by 
ASM and PNECs, and serve as target-derived trophic factors to orchestrate the process of 
innervation.  Genome wide association studies (GWAS) have detected genetic variants  
associated with asthma.  In experimental models and clinical studies, increased NT 









Figure 1.2: The expression of NTs and the Trk receptors in the lung.  
 
Airway epithelium, airway smooth muscle cells and immune cells express NTs, including 
NGF, BDNF and NT4. Nerves innervating the airway smooth muscle and pulmonary 
neuroendocrine cells (PNECs) express p75NTR and TrkA/B receptors.  In addition, a 
variety of immune cells including macrophages, T cells, B cells, eosinophils, and mast 
cells express the TrkA receptor, which promotes their survival, cytokine secretion, 
degranulation, and phagocytosis.  TrkB expression is reported in primary human airway 





action and contribute to the susceptibility and severity of asthma. The respective sections 
in the body of this review provide details regarding the source of NTs, and the cell types 
that express the Trk receptors.  This review will summarize recent findings of NTs in 
asthma with a special emphasis on the role of NTs in airway development and early 
phases of the disease in children. 
Nerve growth factor (NGF) and its receptor TrkA 
NGF was identified as a trophic factor necessary for survival and differentiation 
of developing sympathetic and sensory neurons63.  However, whether NGF is required for 
airway innervation is unknown.  Due to early postnatal lethality of mice deficient in NGF 
and its high-affinity receptor TrkA, functional studies of NGF and TrkA in allergic 
inflammation resort to in vitro culture models, overexpression of NGF in the airway 
epithelium, and loss-of-function approaches utilizing neutralizing antibodies and siRNA 
against NGF in vivo.   TrkA and NGF are expressed in many cell types thus potentiating 
their roles in regulating many aspects of asthma (Figure 1.2).  Multiple reports have 
shown TrkA expression in B cells, activated T cells, macrophages, and granulocytes 61.  
In addition, NGF expression was found in airway epithelium, B cells, T cells, eosinophils 
and mast cells 64-69.  NGF treatment of eosinophils in culture triggered the activation of 
the TrkA receptor and promoted IL-4 secretion 68,70.  NGF also promoted chemotaxis, 
mast cell degranulation, and enhanced neutrophil and macrophage phagocytosis 71,72.  
Furthermore, NGF promoted cell survival of multiple immune cells, such as eosinophils, 
mast cells, neutrophils, B cells, and monocytes, likely by inhibiting apoptosis through the 




colleagues reported an age dependent decline of NGF, P75NTR, and TrkA expression 75.  
In their study, RSV infection upregulated the level of NGF to a greater extent in 
weanlings compared to adult rats.   
Previous studies in rodent models provide evidence for the interaction between 
NGF and allergic inflammation.  For example, exposure to sidestream tobacco smoke in 
early life caused an increase in NGF expression in concurrence with high levels of NGF 
in BALF 76.  Notably, this phenotype was only apparent in mice that were exposed to 
tobacco smoke as pups, while the same exposure had no effect on NGF levels in 
weanlings.  Infection by respiratory syncytial virus (RSV) or allergen exposure also 
doubled the levels of NGF in lungs of rodent models 75.  In addition, NGF overexpression 
in airway epithelium driven by the CC10 promoter caused airway hyperinnervation by 
sensory nerves, increased bronchoconstriction to capsaicin stimulation, and worsened 
allergic inflammation following allergen exposure 77,78.  In contrast, mice treated with a 
neutralizing NGF antibody during allergen exposure showed a reduction in the number of 
eosinophils, levels of type 2 cytokines, and airway bronchoconstriction 77.  Consistently, 
in vivo inhibition of NGF via siRNA administration diminished bronchoconstriction, 
airway innervation density, and immune cell infiltration following allergen exposure 79.   
The effect of NGF in these rodent models of asthma was at least in part mediated by 
neurotransmitters, such as serotonin and substance P 77,78,80-82.   
Clinical studies have reported that increased levels of NGF are associated with 
asthma.  Asthmatic patients have significantly elevated NGF levels in the serum 




elevated levels of NGF in cell fractions of the BALF compared to uninfected children 5.  
More recently, genome wide association studies (GWAS) identified that NGF serum 
levels were affected by NGF rs6330 and TrkA rs6334 variants in asthmatics 84.  
However, whether NGF levels have any impact on the age of onset, severity, and 
treatment outcomes of asthmatic patients remains to be investigated. 
BDNF and the TrkB receptor 
BDNF is required for airway innervation during embryogenesis 12. In the mouse 
embryonic lung, BDNF is expressed by ASM progenitors as early as E12.5 and serves as 
a target-derived trophic factor for the innervating nerves that express TrkB. Mice 
deficient in BDNF had significant defects in branching axons and 50% reduction in ASM 
innervation density compared to WT controls 85.  BDNF expression has also been 
described in airway epithelium and immune cells, such as T cells, macrophages and mast 
cells, while TrkB expression has been detected on CD45+ lymphocytes, mast cells, 
alveolar type II cells, eosinophils 13,61,86.  Notably, while others showed TrkB receptor in 
cultured human ASM cells 62, TrkB lineage tracing in mice found no evidence of TrkB 
expression in ASM cells.  The discrepancy may be caused by differences between species 
or by culture conditions 13.  In the mouse model of allergic inflammation, BDNF levels 
were elevated in BALF and in activated macrophages 61.  Unfortunately, BDNF-/- and 
TrkB-/- mice fail to thrive postnatally with severe defects in central and peripheral nervous 
systems. The early mortality of these mutant mice limits functional studies in vivo aiming 
to understand the role of BDNF and TrkB in allergic inflammation in the airway.  




variants and 3 protein isoforms: pre-BDNF, pro-BDNF, and mature BDNF 87,88. While  
mature BDNF can support cell survival through TrkB signaling, the physiological 
function of pro-BDNF remains to be identified 89,90.  In addition to the complexity of 
BDNF transcripts and post-transcriptional modifications, in vitro studies have uncovered 
additional regulatory mechanisms of BDNF expression and function in ASM.  ASM cells 
in culture express a variety of TRPC channels, which modulate calcium levels in 
response to airway inflammation.  TNFα treatment in primary ASM cells enhanced 
BDNF release in a TRPC3 dependent mechanism 91. In human ASM, BDNF secretion 
could be triggered through a hypoxic-cAMP dependent mechanism 92.  Furthermore, 
treatment of human airway epithelial cells with IL-13 increased BDNF Vlb splice variant 
93.  These findings suggest that type 2 cytokines may regulate BDNF levels in asthma.  
Patients with moderate and severe asthma had higher serum levels of BDNF 
compared to mild asthmatic children 84,94.  In asthmatic adults provoked with allergen, 
BDNF levels were elevated significantly in the BALF 94.  In addition, Watanabe et. al 
correlated asthma severity to elevated BDNF levels, where severe asthmatics had higher 
levels of mature BDNF isoforms compared to healthy controls 93. Furthermore, a 
previous study identified that the Val66Met polymorphism in the BDNF gene was 
protective against asthma in children 95. The Val66Met BDNF variant causes reduced 
secretion of BDNF from neurons 96.  In contrast, another BDNF SNP (rs7124442) was 
found to be associated with disease severity in children measured by increased exhaled 





Neurotrophin 3 (NT3) and the TrkC receptor 
There are few studies of NT3 in the lung. Mice deficient in NT3 have a 50% 
reduction in sympathetic innervation 98,99.  However, whether NT3 plays a role in 
sympathetic innervation of the lung is unknown.  In a mouse model of allergic asthma, 
NT3 treatment caused a switch of non-cholinergic innervation to cholinergic innervation 
100.  Clinical reports show that NT3 levels were higher in BALF and serum from 
asthmatic patients compared to nonasthmatics 101. 
NT4 and the TrkB receptor 
NT4 binds to the same high affinity TrkB receptor as BDNF. NT4 levels in mouse 
lungs peaked at postnatal day 14.  In contrast, the BDNF levels were higher in the fetal 
lung than postnatal lungs.7  In addition, compared to BDNF-/- and TrkB-/- mice that die 
early postnatally, NT4-/- mice mature into adulthood, breed normally, and exhibit no 
obvious behavior defects.  These findings indicate that BDNF and NT4 play distinct roles 
that may be explained at least in part by the difference in temporal expression. NT4 was 
expressed by ASM, PNECs, and mast cells in postnatal lungs of mouse, nonhuman 
primates, and humans 7,8,13 (Figure 1.3).  NT4 is required for the innervation of the lung, 
as NT4-/- mice have significantly less nerve density in ASM and selective reduction of 
PNEC innervation by purinergic nerves7,13.   
NT4 from mast cells has no effect on NT4-dependent innervation during normal 
postnatal development.  However, early life allergen exposure increases the number of 
mast cells, triggers mast cell degranulation to release NT4, which thereby elevates the 











Figure 1.3: A model of deregulated NT function following early life allergen 
exposure.   
 
(A) During postnatal development, ASM and PNECs express NT4, while the innervating 
nerves express TrkB thereby establishing a functional connection. (B) In a neonatal 
mouse model of allergic inflammation, the levels of NTs are increased.  Under this 
condition, NTs may directly signal in the recruited Trk receptor-expressing immune cells 
to regulate the survival, cytokine secretion, degranulation, and enhanced phagocytosis.  
Specifically, NT4 produced by mast cells mediates airway hyperinnervation following 
early life allergen exposure and indirectly induces airway hyperreactivity and mucus 





following allergen exposure in mice was associated with persistent airway hyperreactivity 
and mucus overproduction into adulthood without additional allergen challenges.7  In 
contrast, allergen exposure in adult mice had no effect on NT levels and elicited short-
term airway dysfunction.  These findings emphasize early life as a critical time window 
for the susceptibility to asthma.  Notably, NT4-/- mice were protected from early life 
allergen-induced airway hyperinnervation, hypercontractility, and mucus overproduction, 
while having no change in airway inflammation 7,14.  Lineage tracing of TrkB in mice 
showed highly selective TrkB expression in nerves (Figure 1.3).  Therefore, elevated 
NT4 levels following early life allergen exposure likely acts through an indirect mode of 
action by causing airway dysfunction through aberrant neural innervation.8  Functional 
rescue assays in NT4-/- mice identified that the hypercontractile phenotype of ASM is 
caused by cholinergic hyperinnervation, while deregulated neural control of GABA 
secretion from PNECs is involved in mucus overproduction following early life allergen 
exposure.13,14  Through immunofluorescence microscopy and genetic labeling, we and 
others identified PNECs as the sole source of GABA in the airway (discussed in chapter 
3).13,102  Indeed, elevated NT4 levels promoted aberrant GABA secretion through 
increased PNEC innervation, to induce mucus overproduction. 
Consistent with the findings in the rodent model of early life allergen exposure, 
children with asthma have elevated serum levels of NT4 101.  In all, these studies 
highlight the highly conserved mechanism of neuroplasticity in the lung and how insults 






There is a paucity of literature on the low affinity NT receptor p75NTR.  In the 
lung, p75NTR was expressed in large bundles of nerve fibers along the airway 103.  These 
nerve fibers are detected as early as embryonic day 11 and extend into the trachea and 
lung 104.  P75NTR expression has also been detected on human basophils and B cells 
73,105.  Characterization of p75NTR knockout mice has identified a reduction in sensory 
innervation but no change in sympathetic innervation in the lung 103.  Mice deficient in 
p75NTR were protected against capsaicin induced AHR and ozone-induced neutrophilia, 
which might be attributed to reduced substance P levels from sensory nerves, compared 
to controls 103,106.  Given that p75NTR can form heterodimers with Trk receptors, 
p75NTR may regulate inflammation via direct binding to NTs or indirectly by affecting 
Trk signaling 60,107.   
In conclusion, NTs contribute to asthma pathophysiology through direct and 
indirect interactions with immune cells, ASM cells, airway epithelium, and nerves 
(Figure 1.1).  While NTs and Trk receptors have been shown to be expressed by a variety 
of immune cells, the expression and precise roles in airway physiology and diseases 
warrant further investigation.  
The lung continues to grow after birth and during postnatal development, the 
structural cells in the lung, nervous system, and the immune system, undergo dramatic 
changes in configuration and functional maturation.  Compared to mature lungs, exposure 
to a variety of environmental insults preferentially affects NT levels and airway 




mechanisms may be particularly relevant to the early phase of asthma in children.    In a 
nonhuman primate model of asthma, exposure to ozone and house dust mite allergen in 
infancy causes hyperinnervation of airway epithelium 108.  Therefore, it is possible that 
elevated NT levels following detrimental exposures in childhood may disrupt airway 
innervation and the communication with immune cells and airway epithelium, which in 
turn causes prolonged airway dysfunction and increased disease susceptibility.   
To study the mechanistic link between NTs and early life asthma 
pathophysiology, we developed an early mouse model of asthma to study the effects of 
neural regulation on mucus overproduction.  We hypothesize that neurotrophin 4 levels 
are coupled to the innervation and regulation of PNEC function, and ultimately mucus 
overproduction.  In turn, hyperinnervation of PNECs controls the aberrant secretion of 
GABA, whereby GABA triggers transdifferentiation of club cells to mucus producing 
goblet cells.  We believe that genetic and pharmacological disruptions of neurotrophin 4 
signaling in the early life allergen exposure model, will lead to reduced PNEC 
innervation and GABA secretion, resulting in the reduction of mucus overproduction.   
Deleting Gad1 and Slc32a1 in the lung epithelium, will yield insight into this hypothesis, 
as well as how GABA from PNECs relates to mucus overproduction.  Results from these 
experiments will generate novel pathways targeting the nerve-PNEC axis to provide new 
treatment strategies for mucus overproduction.   
This work is divided into several chapters to address the role of neural regulation 
in asthma pathophysiology.  Chapter 2 will give an overview of PNEC development and 




highlights our novel findings of neural regulation of PNEC function, and links neural 
regulation to aberrant GABA secretion, to induce mucus overproduction in an early life 
mouse model of asthma.  Chapter 4 covers how GABA coordinates with IL-13 to 
promote mucus overproduction in a well established human bronchial epithelial cell air 
liquid interface (ALI) culture system.  Finally, chapter 5 introduces ongoing work in 
understanding the role of connective tissue mast cells (CTMCs) during lung development 
and in allergic lung disease.  Based on our previous studies8, recruited mast cells elevate 





CHAPTER TWO  
PNEC FUNCTION IN LUNG DEVELOPMENT AND DISEASE 
Summary 
Pulmonary neuroendocrine cells (PNECs) are a rare, dynamic, and complex lung 
cell population.  Because of their early specification in lung development they are 
implicated in promoting normal lung function and lung disease.  Compared to other 
neuroendocrine organs, such as the gut, pancreas, pituitary gland, and the reproductive 
system, how pulmonary neuroendocrine cells (PNECs) become innervated and whether 
nerves regulate PNEC secretion and function in airway physiology and diseases are 
discussed here and in further detail in chapter 3.  
This chapter will highlight what is known about PNECs: their development, their 
complex innervation, their function in the developing lung, and their function in disease.  
I also will introduce ongoing work in nonhuman primates that suggests aberrant 








PNECs are the first specialized airway epithelial cells.109  However, the precise 
mechanisms of PNEC differentiation are incompletely understood. They are the only 
innervated airway epithelial cells and exist as single PNECs or in clusters named 
neuroepithelial bodies (NEBs) and contain dense vesicles filled with bioactive 
neuropeptides and amines.109  
The achaete-scute family of bHLH transcription factors in Drosophila and 
vertebrates play a critical developmental role in neuronal specification and 
differentiation.110  Proneural gene, Achaete-scute-homolog-1 (Ascl1), is critical for 
neuronal cell commitment.  In humans, Ascl1 is termed hASH1 and Mash1 in mice.  
Outside the neuronal system, achaete-scute homologue 1, ASH1, is expressed in human 
and mouse pulmonary neuroendocrine cells.111  Human ASH1 is also frequently 
expressed in lung cancers with neuroendocrine features.109   
Similar to neural progenitor cells in development, Mash1 is required for PNEC 
differentiation. In fact, mice deficient in Mash1 completely lack PNECs with no apparent 
defects in other lung cell populations.111  Presence of other neuroendocrine cells in the 
pancreas and gut remain in the Mash1 knockout suggesting a distinct role of MASH1 in 
the specification of PNECs.111  However, mutant mice do die 12 hours after birth due to 
severe defects in the central nervous system and hypoventilation.  To test whether 
MASH1 is sufficient to induce PNEC differentiation, hASH1 was constitutively 




differentiation in club cells.112   Together, these studies suggest that Mash1 is specifically 
required but not sufficient for PNEC differentiation.  
Notch Signaling 
Notch components are present early in lung development and signaling is 
extensively activated at the lung bud tips. 113-115  Notch signaling components include 
four Notch receptors and 5 ligands.  Briefly, γ-secretase enzymatically cleaves notch 
intracellular domain, which then binds to transcriptional effector Rbpjk, and this leads to 
downstream activation of Notch target genes, Hes and Hey. 
Notch signaling affects progenitor cell fate specification and differentiation. Hes1 
deficient mouse airways have small reductions in club cell populations and are 
overpopulated with neuroendocrine cells and hyperplastic PNEC clusters by E18.109,116  
In addition, Hes1 deficient mice have increased levels of Mash1, suggesting Hes1 is an 
active repressor of Mash1.   
Further, global Notch signaling deficiency further potentiated this phenotype.  
Pofut1 (protein O-fucosyltransferase 1) and Rbpjk deficient airways contain abundant 
ciliated cells and neuroendocrine cells and are completely devoid of secretory club 
cells.113  Pofut1 modifications are crucial for efficient Notch ligand binding and Notch 
mediated signaling.  Collectively, these studies suggest Notch signaling is required for 






In humans, PNEC precursors are detected as early as 8 weeks gestation in the 
pseudoglandular period.109  At about 10 weeks of gestation, single and clustered PNECs 
are detected.  PNECs are a rare and stable population that constitute only 0.41% of the 
human lung epithelium and proliferate relatively slowly as compared to the lung 
epithelium.117  Cell specific markers of human PNECs include: serotonin (5-HT), ASH1, 
neuron specific enolase, synaptophysin, chromogranin A, and gastrin releasing peptide 
(bombesin, GRP).  In humans and non-human primates, bombesin is the major 
neuropeptide produced.118,119  Because of the difficulty in obtaining human tissue to study 
neuroendocrine cell biology, most of the work described below, are in primate and mouse 
models.   
In the mouse lung, single PNECs are detected as early as E13.5 with clusters 
forming by E15.5.120  Consistent with human studies, PNECs proliferate relatively slowly 
compared to the surrounding lung mesenchyme.121   Markers of murine PNECs include: 
calcitonin gene related peptide (CGRP), protein gene product 9.5 (PGP9.5), MASH1, and 
Glutamate Decarboxylase 1 (GAD1).13,102  CGRP is the major neuropeptide produced by 
murine PNECs.  Of importance, while PNECs do express common neural markers and 
neuropeptides, such as MASH1 and CGRP, they are not neural cells.  In our studies, we 
show that PNECs do not express a pan neuronal marker, beta tubulin III (TuJ1).  To 
determine the epithelial origin of PNECs, another group used a Sonic HedgehogCre 
(ShhCre) knockin mouse line to lineage label airway epithelial progenitors.121  As 




contrast, lineage labeling of neural crest cells through a Wnt1-Cre mouse line showed no 
lineage labelling in PNECs at E18.5.121   Based on our studies and lineage tracing 
analysis, PNECs in the mouse arise from the Shh lineage and not from neural crest 
lineages.  
PNEC clustering 
Lineage labeling of PNECs through Ascl1CreER, a transcription factor that 
specifically labels the PNEC lineage, indicates diverse singular PNEC and PNEC clusters 
throughout the airways.  PNEC clusters are almost completely restricted to airway branch 
points and are highly organized in diametrically opposed positions.121-123  Singular 
PNECs are typically found in the trachea and distal airways, whereas clustered PNECs 
are typically found in the proximal airways.124  By E15.5, PGP9.5 and CGRP are 
expressed in solitary and clustered PNECs.121     
In Drosophila, neuroendocrine clusters arise from a single Ascl1 progenitor.  To 
study this phenomenon in mice PNECs, investigators crossed a ShhCre mouse with a 
“rainbow” Cre-reporter that randomly and permanently labels each progenitor with one 
of three fluorescent proteins.121  When analyzed at E18, PNEC clusters are multicolored 
indicating that PNEC clusters arose from multiple progenitors as opposed to one.121  
Labeled PNEC progenitors, in fact form clusters through dynamic cell migration coined, 
“slithering.”  PNECs are able to downregulate adhesion and polarity proteins and 
upregulate epithelial mesenchymal transition proteins to crawl over and between cells to 
reach cluster sites, but yet remain intimately associated with the basement membrane.121  




identified in driving proper PNEC clustering.  Robo deficiency in PNECs completely lack 
clusters, but still maintain solitary PNECs.120   
PNEC innervation 
As early as E15.5, PGP9.5+ innervating nerves begin to appear within the PNEC 
clusters.121  As we observe in the mouse, there are three types of PNEC innervation: no 
innervation, innervation at the base of the PNEC cluster, and penetrating innervation.13  
As the only airway epithelial cells that are innervated, PNECs form complex contacts 
with afferent and efferent nerves.2,122,125,126  PNECs are innervated by a mixture of 
sensory and cholinergic nerves.125,127  The nodose ganglion provides a major source of 
sensory afferent innervation for PNECs, whereas the brainstem and intrinsic ganglia 
provide the cholinergic efferents.125,128  The majority of these neurons also express 
purinergic P2X3 receptors which respond to ATP released by epithelial cells during 
inflammatory conditions.128  Further, PNEC purinergic innervation requires NT4/TrkB 
signaling as PNEC innervation by P2X2 and P2X3 axons is reduced in NT4−/−  mice.129   
PNEC markers, PGP9.5 and CGRP, also mark PNEC innervating nerves.  In addition, 
afferent intraepithelial nerves express vesicular glutamate transporters (VGLUTs) and 
nitrergic+ neurons whose action is mediated by nitric oxide.125  In rats, it is estimated that 
~50% of PNECs receive purinergic innervation, 56% CGRP-containing nerves, and 9–
10% nitric oxide synthase+ fibers.130  Also, while Robo/Slit mutants have deregulated 
PNEC clustering, PNECs still maintain their innervation, suggesting that PNEC 
innervation is not dependent on cluster formation or on Robo signaling in PNECs.120   As 




interactions are incompletely understood. Together, these studies highlight the diverse 
nerve populations in PNECs and may potentially highlight future functions in normal and 
diseased airways.   
PNEC functions 
As oxygen sensors 
The ability to sense oxygen levels internally and externally is crucial for an 
organism to maintain and respond to increased demand or pressure changes.122,131,132   
Based on the analogy with carotid bodies, PNECs can detect and respond to variable 
changes in oxygen (O2) and carbon dioxide (CO2), via the principal O2 sensor, NADPH 
oxidase.133  The carotid bodies (clusters of neuroendocrine cells) are located near the 
branching carotid artery and have the ability to sense changes in O2, CO2 and pH.133  
However, at birth, carotid bodies are believed to be functionally immature, which then 
may allow PNECs to function as chemoreceptors early in development.  As 
chemoreceptor function is highly dependent on innervation, both carotid bodies and 
PNECs are innervated. Thus, they may serve as auxiliary chemoreceptors in early 
development and may play critical roles in immature lung responses.122,133,134     
Further, patch clamp electrophysiology studies confirmed PNECs could be 
excited and bore voltage-activated Ca2+, Na+, and K+ channels.135  Under hypoxic 
conditions, inhibition of O2-sensitive K+ channels depolarizes the membrane, causes 
influx of Ca2+ and triggers release of 5-HT.122,136  5-HT can then bind to 5-HT receptors 
on 5-HT-expressing nerves or PNECs, providing a potential autocrine positive feedback 




In addition to oxygen sensing, PNECs can act as mechanotransducers.  During 
lung development, lung fluid and breathing movements play an important role in lung 
growth and development.  PNEC cultures subjected to stretch, release more 5-HT 
compared to control.  Further, its release is not affected by a Ca2+ channel inhibitor, but is 
blocked by mechanosensitive inhibitors.138   
Together, these studies suggest a critical role of PNECs as oxygen sensors and 
mechanotransducers during fetal lung development.  Finally, studies on NEB 
microenvironment and their secreted products might provide clues on lung diseases such 
as neuroendocrine derived cancers. 
In disease 
Excess number, altered clustering, and altered PNEC innervation, have all been 
linked in lung disease pathogenesis.  PNECs have long been implicated as the cell of 
origin in human small cell lung cancer (SCLC), the most deadly form of lung cancer and 
highly metastatic.139  This is supported by clinical studies demonstrating characteristic 
neuroendocrine origins in human SCLC.139   
In mouse models of SCLC, PNECs are the initiating tumor cells.140,141  Lineage 
labeling of PNECs through CGRPCreER/+ in a mouse model of SCLC, effectively 
demonstrates that the developing tumors had PNEC origins with actively proliferating 
PNECs.141  In addition to cancer, some pediatric patients present with neuroendocrine 
hyperplasia of infancy (NEHI).142  NEHI patients typically present with symptoms within 
the first year, which include chronic tachypnea, cough, intermittent wheeze, and 




including inhaled corticosteroids or bronchodilators.142  PNEC hyperplasia is described in 
a number of pulmonary disorders such as bronchopulmonary dysplasia (BPD) and sudden 
infant death syndrome.142-144  However, compared to other lung diseases, Young et. al 
argue that NEHI patients have a unique PNEC prominence and distribution.  But the 
signals that cause PNEC prominence in NEHI are unknown.  Since NEHI PNECs do not 
proliferate,142 it is speculated that NEHI might be familial145 or part of a broader lung 
disease spectrum.146  
Congenital diaphragmatic hernia (CDH) is a birth defect associated with ROBO 
gene mutations and manifests itself in significant lung dysfunction, including heightened 
immune response and pulmonary hypertension.120,147  In a genetic mouse model of CDH, 
PNECs fail to properly cluster and is followed by increased neuropeptide release 
(CGRP), immune cells, and lung remodeling, because of failure of proper PNEC 
clustering.120  
In summary, these studies highlight the biology of pulmonary neuroendocrine 
cells and their potential roles in lung disease pathogenesis. While identified as major 
participants in lung disease, further research is required to better understand mechanisms 





CHAPTER THREE  
EARLY LIFE ALLERGEN-INDUCED MUCUS OVERPRODUCTION 
REQUIRES AUGMENTED NEURAL STIMULATION OF PULMONARY 
NEUROENDOCRINE CELL SECRETION 
Disclaimer: This chapter is adapted from Barrios J., Patel K.R., Aven L., Achey R., 
Minns M.S., Lee Y., Trinkaus-Randall V.E., and Ai X. (2017).  Early life allergen-
induced mucus overproduction requires augmented neural stimulation of pulmonary 
neuroendocrine cell secretion.  FASEB Journal 31, doi: 10.1096/fj.201700115R.  
 
Abstract 
Pulmonary neuroendocrine cells (PNECs) are the only innervated airway 
epithelial cells. To what extent neural innervation regulates PNEC secretion and function 
is completely unknown. Here, we discover that neurotrophin 4 (NT4) orchestrates PNEC 
innervation and secretion of γ-aminobutyric acid (GABA) to induce mucus 
overproduction following allergen exposure in early life. We showed that NT4 served as 
a PNEC-derived neurotrophic factor for PNEC innervation during postnatal development. 
PNECs were found to be the only cellular source of GABA that was essential for 
allergen-induced mucus overproduction by our genetic studies. Allergen exposure in 
early life aberrantly increased sensory neuron receptor expression and the density of 
PNEC-innervating nerves associated with augmented GABA secretion. Genetic 
disruption of NT4 prevented allergen-induced changes in PNEC innervation, GABA 




allergic inflammation. In addition, GABA installation restored mucus overproduction in 
NT4-/- mice in the presence of allergen exposure. These findings reveal an essential role 
of NT4 in mucus overproduction through neural regulation of PNEC secretion of GABA 
in a mouse model of allergic inflammation. Targeting the nerve-PNEC axis may be a 







Mucus overproduction is a salient symptom of patients suffering from chronic 
airway diseases, such as asthma. Excessive mucus blocks airway flow and is a major 
contributor to morbidity and mortality in asthmatics. The production of excessive mucus 
in asthmatics involves an increase in the number of mucus-producing goblet cells.45 
However, unlike human airways, mouse airways have few goblet cells under normal 
conditions. Allergen exposure in mice triggers trans-differentiation of club cells into 
goblet cells.37,47 While the cellular origin of goblet cells in lungs differs between humans 
and mice, mechanisms underlying mucus overproduction are evolutionally conserved. 
Master transcriptional factors, such as SPDEF and STAT6, as well as key cytokines, such 
as IL-13, are critical inducers of mucus overproduction in both human asthmatics and 
mouse models of allergic inflammation.46,53,148  In addition, an airway GABAergic 
system was found to be aberrantly activated to induce mucus overproduction in adult 
mouse models and human airway epithelium cell lines.10,149  These previous studies of 
GABA signaling exclusively relied on pharmaceutical approaches.10,149  As a result, the 
precise functional source of GABA in airways and mechanisms of GABA secretion 
remain unclear. 
Asthma often progresses from wheezing in early childhood into a chronic 
disease.150,151  Risk factors for asthma include exposure to allergens, respiratory viruses, 
ozone, and pollutants in infancy and early childhood. As the lung continues to grow after 
birth, early life exposure to environmental insults may disrupt the developmental process 




clinical data indicate that commonly used treatment strategies for asthma, such as early 
life introduction of inhaled corticosteroid that temporally dampens inflammation, have 
little beneficial impact on disease progression.152  These findings raise the possibility that 
the pathogenesis of persistent asthma may involve developmental factors.  
Changes in neural innervation may be a developmental factor that connects early 
episodes of exposure to prolonged airway dysfunction.  For example, respiratory 
syncytial viral infection in neonatal guinea pigs altered sensory neuropeptide expression 
in airways.153  Exposure to ozone, cigarette smoke, or house dust mite allergen also 
increased airway innervation in neonatal rodents and infant rhesus monkeys.76,108,154,155  
In a previous study, we showed that allergen exposure in early life aberrantly increased 
the level of airway innervation.7  Compared to adult mouse models, allergen exposure 
during the first 3 weeks after birth induced similar but modest eosinophilic 
inflammation.7  In contrast, allergen exposure in adult mice has no effect on innervation.7  
However, the neonatal mouse model exhibited persistent airway hyper-reactivity (AHR) 
that was functionally linked to airway smooth muscle (ASM) hyperinnervation.7  
Mechanistically, we showed that NT4 was expressed by developing ASM, while nerves 
selectively expressed the specific NT4 receptor, tropomyosin receptor kinase B TrkB, 
thereby establishing innervation during postnatal development.7  Early life allergen 
exposure in mice activated mast cells as a de novo source of NT4, which in turn 
aberrantly increased ASM innervation.8 Genetic disruption of NT4 and TrkB signaling 
prevented allergen-induced increases in airway innervation and diminished AHR without 




in animal models of neonatal exposure, the levels of neurotrophins were positively 
associated with respiratory viral infection in infants and with severity of asthma in 
children.5,101  These findings highlight unique changes in airway innervation following 
early life exposures and emphasize the disease relevance of the animal models of 
childhood asthma. 
In addition to ASM, the other innervated cell type in airways is pulmonary 
neuroendocrine cells (PNECs).  PNECs exist as solitary cells or in clusters called 
neuroendocrine bodies (NEBs). PNECs express a variety of bioactive amines and 
neuropeptides, such as calcitonin gene related peptide (CGRP), and are innervated by a 
neurocircuitry that consists of sensory afferents mostly from the nodose ganglion and 
vagal efferents.109,122,156 PNECs are sensors for oxygen and inflammation during the 
transition to air breathing and are mechanotransducers in adult lungs via secretion of 
bioactive mediators.120,122 Compared to other neuroendocrine organs, such as gut, 
pancreas, pituitary gland, and the reproductive system where endocrine secretion is 
regulated by neural activities to accommodate for fundamental bodily functions, how 
PNECs become innervated and whether nerves regulate PNEC secretion and function in 
airway physiology and diseases are unknown.    
In this study, we investigated the mechanism of PNEC innervation during 
postnatal development and assessed the role of the nerve-PNEC axis in the neonatal 
mouse model of allergic inflammation.  We identified NT4 as an essential factor for 
PNEC innervation and PNECs as the only cellular source of GABA in airways. Notably, 




that are encoded by Gad1 and Gad2 genes, respectively. In addition, a specific vesicular 
GABA transporter, Slc32A1, is responsible for packaging GABA into secretory vesicles 
before secretion.56 To identify the functional relationship between NT4 and PNEC-
derived GABA, our study used genetic approaches to disrupt NT4 and GABA 
biosynthesis. These assays, in combination with GABA rescue in NT4-/- mice, revealed a 
critical role of NT4-dependent neural regulation of PNEC secretion of GABA in mucus 
overproduction after early life allergen exposure. 
 
The introduction has lots of materials discussed in previous chapters.  Please 





Materials and Methods  
Mice 
C57BL6, NT4-/- (002497), ShhCre/+ (005622), TrkBCreERT2/+ (027214), Slc32a1f/f (012897), 
RosatmRed/tmRed (007955) were purchased from The Jackson Laboratories (Bar Harbor, 
ME, USA). Mice were in C57BL/6 genetic background except Slc32a1flox/flox mice that 
were in a mixed C57/129 background. All mouse experiments were approved by the 
Institutional Animal Care and Use Committee at Harvard Medical School.  
OVA exposure in neonatal mice  
For ovalbumin (OVA) exposure, mice were sensitized at P5 and P10 followed by daily 
challenges of 3% OVA between P18 and P20 (16). Controls were challenged with PBS. 
For the GABA rescue assay, GABA (10µg/g body weight; Cat. #A2129, Sigma-Aldrich) 
was given intra-tracheally between P14 and P20 in NT4-/- mice. For the rescue assay with 
methacholine (Mch), NT4-/- mice were nebulized for 10 minutes daily between P15 and 
P20 with Mch (30mg/mL; Cat. #A2251, Sigma-Aldrich). Mice were sacrificed at P21 for 
bodily fluid and tissue collection. Serum levels of OVA-specific IgE and GABA were 
measured with ELISA kit from BioProducts (Cat. #M036005) and Rocky Mountain 
Diagnostics (Cat. #NC0436948), respectively. Left lobes were prepared for lung slices. 
Right cranial lobes were prepared for histology. Right middle lobes were harvested for 
RNA preparation.  Right caudal lobes were prepared for protein extraction.   
Bronchoalveolar lavage (BAL) counts 
Mouse lungs were flushed with 0.5mL cold PBS before BAL fluid was collected. Cells 




Cytospin (ThermoScientific). The slides stained with Hema3 Stain. 200 cells were 
counted to determine relative abundance of different immune cell types. 
TrkB lineage tracing TrkBCreERT2/+ mice were crossed with a Rosa(tmRed) reporter line. 
TrkBCreERT2/+;Rosa(tmRed) mice received 6 tamoxifen injections (0.2mg per injection) 
between P5-P7 and P15-17. Lungs were harvested at P21 followed by processing for 
cryopreservation and sectioning.   
Lung slice preparation and culture 
The lung was infused with 1.5% low-melting agarose (Cat. #16520, Invitrogen). After 
cooling on ice for 15 min, the lobe was sliced at 150µm in thickness with a VF-300 
microtome (Precisionary Instruments, Inc.). Lung slices were recovered overnight in 
DMEM/F12 media (1:1; Life Technologies) before treatment with GABA (10mg/mL), 
CGRP (10µM), substance P (SP, 10µM), dopamine (10µM), and Mch (10µM).  After 2 
days, slices were collected for gene expression assays.   
Histology and immunohistochemistry 
Lungs were fixed in 4% paraformaldehyde/PBS. Paraffin sections (5µm) of right cranial 
lobes were collected for Periodic acid–Schiff (PAS) staining of mucus (Cat. #395B, 
Sigma-Aldrich) and for antibody staining. For staining of nodose ganglion neurons, 
frozen sections of dissected nodose ganglions were used. For double staining of PNECs 
and nerves, lung slices were used. Primary antibodies include: mouse anti-NT4 (1:200; 
Cat. #SC-365444, Santa Cruz Technology), rabbit anti-Uchl1 (1:100, Cat. #PA5-29012, 
ThermaFisher Scientific), guinea pig anti-P2X3 (1:100, Cat. #AB5896, Millipore), mouse 




rabbit anti-CGRP (1:1000; Sigma-Aldrich, Cat. #C8198), goat anti-Foxa3 (1:50; Cat. #sc-
5361, Santa Cruz Biotechnologies), goat anti-Scgb1a1 (CC10) (1:1000, Cat. #sc-9772, 
Santa Cruz Biotechnology), mouse anti-Gad67 (1:500; Cat. #MAB5406, Millipore), 
mouse anti-Foxj1 (1:300, Cat. #14-9965-82, eBioscience). All secondary antibodies were 
purchased from Life Technologies. Nuclei were stained using Hoescht dye (1:1000).  
Fluorescent staining  was imaged using Leica DFC480.  For double stained lung slices, 
slices were imaged by confocal microscopy (Carl Zeiss, LSM 710). Compressed z-stack 
images were quantified to determine the PNEC innervation density by normalizing the 
TuJ1 immune-reactive area quantified using NIH Image J to the number of cells within 
the cluster.  
Quantitative Real Time PCR (qRT-PCR) 
RNA was extracted from lung samples with an RNeasy kit (QIAGEN) followed by 
reverse transcription using Supercript III Reverse Transcriptase (Invitrogen). TaqMan 
primers were purchased from Applied Biosystems. The relative gene expression was 
measured by normalizing to 18S rRNA using ΔΔCt (cycle threshold difference). 
Lung epithelial cell sorting 
Lungs were digested with 0.1% collagenase A (Roche Diagnostics), 2.4 units/mL dispase 
(Roche Diagnostics), and 6 units/mL DNase I (Qiagen). Single cell suspensions were 
stained with rat anti-mouse CD45 and rat anti-mouse CD31 (BD Pharmingen) and rat 
anti-mouse CD326 (eBioscience). Cell isolation was performed using FACSAria III (BD 
Biosciences). Isotype antibodies were used as controls.  The CD31-CD45-CD326+ 




Primary nodose ganglion neuron culture and Ca2+ imaging 
Nodose ganglions were dissected from P18 mice, followed by enzymatic dissociation 
using 2.4U/ml dispase (Roche).  A total of 1000 cells were plated in each glass-bottomed 
dish (0.5 mm in diameter) precoated with poly-lysine. Cells were cultured in neurobasal 
medium supplemented with B-27 (Thermo Fisher Scientific). Recombinant human NT4 
(N1780; Sigma-Aldrich) was added at a concentration of 100 ng/ml, while control 
cultures had bovine serum albumin (BSA). After 3 d, cells were washed with neurobasal 
media before cells were loaded with 5 mMFluo-3 AM fluorescent dye (Thermo Fisher 
Scientific) for 20 min at 37°C and 5% CO2. Images were collected every 100 ms on a 
Zeiss LSM 880 confocal microscope. Approximately 50 frames were captured to 
establish baseline fluorescence (F0). Cells were stimulated with ATP (100 mM; Sigma-
Aldrich), and images were continuously captured. Analysis was performed by Fiji 
(https://fiji.sc/)/ImageJ software. Relative fluorescence was calculated by normalizing 
Fluo-3 AM fluorescence after ATP stimulation to the baseline fluorescence (Ft/F0)157. To 
block the P2X3 receptor, cultures were treated for 20 min before imaging and during the 
course of imaging with a selective inhibitor, A-317491 (1 mM, A2979; Sigma-
Aldrich).158  After imaging, primary nodose ganglion neuron cultures were fixed, 
followed by P2X3 staining. 
Statistical Analysis 
Data were presented as mean ± SEM from at least 3 independent experiments.  Statistical 




ANOVA of variance with appropriate post hoc tests using GraphPad Prism 5 (GraphPad 






NT4 was required for mucus overproduction following early life allergen exposure in 
mice. 
We utilized the disease-mimicking, early life exposure model to study the 
mechanism of mucus overproduction. Repetitive exposure to allergens such as ovalbumin 
(OVA) (Figure 3.1A), house dust mite, and cockroach allergen within the first 3 wk after 
birth caused mucus overproduction in wild type mice (WT) (Figure 3.1B-E; Figure 
S3.1A-E).  In contrast, NT4-/- mice were resistant to mucus overproduction following 
similar exposures without any defects in allergic inflammation (Figure 3.1B-E and 
S3.1A-E).7  In support of this finding, blockade of the NT4 receptor TrkB signaling in 
TrkBF616A/TrkBF616A mice by 1NMPP1 during OVA exposure also reduced mucus 
overproduction (Figure S3.1F and G).7  TrkBF616A/TrkBF616A mice harbor a point 
mutation rendering the receptor sensitive to 1NMPP1 inhibition.159   Given that TrkB was 
selectively expressed by nerves in airways,7 these findings indicate that NT4-dependent 
airway innervation is required for allergen-induced mucus overproduction in early life.  
To elucidate the role of NT4 in allergen-induced mucus overproduction, we tested 
several neurotransmitters in Muc5ac gene expression using NT4-/- lung slices as an ex 
vivo system.  After 2d in culture, lung slices from WT and NT4-/- at P21 with and without 
OVA exposure maintained differential Muc5ac mRNA expression as in vivo (Figure 
3.1E-G). Therefore, lung slice cultures maintained relevant cell types and pathways and 
thus were an enabling, ex vivo tool for the rescue assay in NT4-/- mice.  We tested the 





Figure 3.1. NT4 was required for mucus overproduction following early life allergen 
exposure.  
(A) Experimental scheme of early life OVA exposure in mice.  Control mice were 
challenged with saline (PBS).  Lungs were harvested at P21. (B) Serum levels of IL-13 
measured by ELISA. (C) Differential immune cell counts in BAL. The relative 




(Lymph) was quantified as the percentage of cells in BAL. (D) Representative images of 
PAS staining in the airways of wild type (WT) and NT4-/- mice that were challenged 
with PBS or OVA.  Mucus+ cells are marked by arrows. Scale bars, 100µm. (E) Muc5ac 
mRNA expression in WT and NT4-/- mice that were challenged with PBS or OVA. 
N=14 mice for each group. (F) Muc5ac mRNA levels in lung slices of P21 WT mice 
(N=3) after 48 hrs in culture. Results were normalized to PBS-challenged controls. (G) 
Muc5ac mRNA levels in lung slices of P21 NT4-/- mice (n=6) after 48 hrs in culture with 
and without neurotransmitter treatment. Results were normalized to PBS-challenged 
slices without treatment. Neurotransmitters tested included GABA (10mg/mL), CGRP 
(10µM), substance P (SP, 10µM), dopamine (dopa, 10µM), and Mch (10µM). Data in C-










Figure S3.1. NT4 and TrkB signaling were required for early life allergen-induced 
mucus overproduction in mice.  
 
(A) Scheme of cockroach allergen (CRA) exposure in early life. Controls received saline. 
(B) Representative images of PAS staining of lung sections of wild type (WT) and NT4-/- 
mice at P21 following CRA exposure. (C) Scheme of house dust mite allergen (HDMA) 
exposure in early life. Controls received saline. (D) Representative images of PAS 
staining of lung sections of WT and NT4-/- mice following HDMA exposure. (E) Muc5ac 
gene expression in WT and NT4-/- mice following exposure to saline or HDMA were 
analyzed by qPCR. Data were normalized to 18S rRNA.  *P<0.05. (F) Scheme of 
1NMPP1 treatment of TrkBF616A/F616A mice between P10-P20 during OVA exposure. 
Controls were injected with the solvent for 1NMPP1. (G) Representative images of PAS 
staining of lung sections of TrkBF616A/F616A mice with and without 1NMPP1 





and their roles in mucus production: GABA, CGRP, substance P (SP), dopamine (Dopa), 
and methacholine (Mch, a stable mimic of acetylcholine).  Only GABA increased 
Muc5ac mRNA levels by 3-fold in NT4-/- lung slices, and the effect was evident only in 
the presence of prior OVA exposure (Figure 3.1G). 
Pulmonary neuroendocrine cells (PNECs) provided a critical source of GABA for 
allergen induced mucus overproduction in early life. 
To connect GABA with NT4-dependent nerves, we speculated that GABA may 
be released from GABAergic nerves or by cells innervated by nerves. To distinguish 
these two possibilities, we characterized the source of GABA in control and OVA-
exposed mice at P21.  We utilized a Gad1-GFP reporter line that expressed green 
fluorescent protein (GFP) under the control of the GAD1 promoter.160  Notably, the 
GAD1 gene encodes the GABA biosynthetic enzymes GAD65 and GAD67.  We found 
no GFP+ nerves in the Gad1-GFP airways (Figure 3.2A).  Instead, GFP was detected in 
a subset of airway epithelial cells that also expressed CGRP and thus were PNECs 
(Figure 3.2A).  Double staining confirmed specific Gad67 expression in ~85% of PNECs 
(Figure 3.2A). These findings were further supported by PNEC-specific expression of 
GABA vesicular transporter A1 (Slc32a1).102 No Gad65 expression was detected in lungs 
by lineage tracing using Gad2CreERT2/+;Rosa(lacZ) mice (Figure S3.3A).  Therefore, the 
only cellular source of GABA in airways is from innervated PNECs. Our finding is at 
odds with a previous report that showed ubiquitous Gad67 expression in airway 
epithelium.10  The discrepancy may be explained by technical issues of antibody staining 






Figure 3.2. GABA from PNECs was required for mucus overproduction after early 
life OVA exposure.  
 
A) PNEC expression of GAD67 assayed at P21. In lungs of GAD1-GFP mice, PNECs 
were GFP+ while TuJ1+ nerves were not. Double staining for Gad67 and PNEC marker 
CGRP also showed colocalization. Arrows indicate PNECs. Scale bars, 25 µm. B) 
Characterization of airway epithelium in ShhCre-;Slc32a1f/f control littermates and 




ciliated cells (Foxj1), and PNECs (CGRP). Negative controls were matched IgGs. 
Arrowheads indicate PNEC clusters.  Insets show enlarged images of epithelium staining. 
Scale bars, 100 µm. C) Serum levels of OVA-specific IgE in saline and OVA exposed 
littermates and ShhCre+;Slc32a1f/f mice at P21. Each mark indicates sample from 1 mouse. 
D) Differential immune cell count in BAL of PBS- and OVA-exposed control (Cre-) and 
ShhCre+;Slc32a1f/f (Cre+) mice at P21. Percentages of Macrophages (Macs), eosinophils 
(Eos), lymphocytes (Lymph), and neutrophils (Neut) are shown. E) Representative 
images of PAS staining in airways of ShhCre-;Slc32a1f/f and ShhCre+ controls and 
ShhCre+;Slc32a1f/f mutant mice at P21. Arrows indicate mucin-positive cells. Scale bars, 
100 µm. Insets show enlarged images of stained epithelium. F) Muc5ac gene expression 
in lungs of littermate controls (PBS; n = 4; OVA, n = 11) and ShhCre+;Slc32a1f/f mutant 
mice (PBS, n = 6; OVA, n = 5). Data in C, D, and F represent means 6 SEM from 3 














Figure S3.3. Gad67 expression by PNECs is required for mucus overproduction 
following early life OVA exposure.  
 
(A) Lineage tracing of Gad2-expressing lineages. Gad2CreERT2/+;Rosa(lacZ) mice received 
tamoxifen injection at P10, P14, and P18. At P21, lungs and brain tissues were processed 
for X-gal staining and histological assessment. N= 3. Arrows point to β-gal+ cells in 
mouse brains at P21. No labeling was found in lungs. (B) CGRP staining of PNECs in 
ShhCre-;Slc32a1f/f littermate controls and ShhCre+;Slc32a1f/f mutant mice at P21. Loss of 
GAD1 in airway epithelium had no effect on PNEC development. Arrowheads point to 
PNECs. (C) Representative images of PAS staining of lung sections from ShhCre-
;Slc32a1f/f littermate controls and ShhCre+;Slc32a1f/f mutant mice with and without OVA 
exposure. Arrows point to mucin+ cells. N=2 for ShhCre+;Slc32a1f/f. N=4 for ShhCre-




To establish an essential role of GABA in mucus overproduction and circumvent 
off-target effects often associated with pharmaceutical approaches in previous 
studies,10,149 we generated tissue-specific GABA deficient mice by crossing the ShhCre+ 
line into Gad1f/f and Slc32a1f/f background.  The ShhCre+ line is a widely used genetic 
tool in pulmonary research because it acts in the entire epithelium, including PNECs.161  
ShhCre+ mice had no defects in mucus overproduction after allergen exposure (Figure 
3.2E). We chose not to use neuroendocrine cell-specific Cre lines, including Ascl1CreER/+ 
and CGRPCreER/+ mice141,162, because of concerns of haploinsufficient phenotypes, as 
Ascl1 and CGRP are involved in PNEC development, inflammation, and sensory neuron 
function.116,120,163 Characterization of ShhCre+;Gad1f/f and ShhCre+;Slc32a1f/f mutant lines 
revealed normal airway epithelium and no change in baseline mucin expression (Figure 
3.2B and S3.3B). Because ShhCre+;Gad1f/f mice exhibited hydrocephalus and died when 
they were about 3 to 4 wk old, we focused on ShhCre+;Slc32a1f/f mice that were healthy 
and fertile. Loss of Slc32a1 in airway epithelium had no effect on allergic inflammation 
assayed by serum levels of OVA-specific IgE and differential BAL counts (Figure 
3.2C,D), consistent with the previous finding that GABA signaling is dispensable for 
allergen-induced inflammation.10  However, after OVA exposure, compared to Cre+ 
littermates that had excessive mucus in the airway, ShhCre+;Slc32a1f/f mice showed no 
change in baseline mucus levels (Figure 3.2E,F).Consistently, 2 ShhCre+;Gad1f/f mice 
that survived were also resistant to OVA-induced mucus overproduction (S3.3C). These 





NT4 was required for PNEC innervation and PNEC hyperinnervation following early life 
allergen exposure. 
Neuroendocrine cells that reside in multiple organs are mediators of the 
communication between the nervous system and endocrine secretion to regulate 
fundamental body functions. We speculated that a similar paradigm may apply to NT4-
dependent innervation and GABA secretion in allergic inflammation.  To test this 
hypothesis, we characterized PNEC development in postnatal mouse lungs.  We first 
assessed whether PNECs continued to form during the first 3wk after birth.164  To 
accommodate for the rapid increase in lung size during postnatal development, we 
collected all the lung slices (150 µm thick) from the entire right cranial lobe before CGRP 
staining and confocal imaging to quantify solitary PNECs, NEBs, and the total number of 
PNECs.  We found that the abundance of solitary PNECs and NEBs remained relatively 
unchanged (Figure 3.3A). However, the total number of PNECs almost tripled at P21 
from birth as a result of an increase in cell numbers within NEBs during the second week 
(Figure 3.3A). The PNEC population stabilized around P14 (Figure 3.3A).  As a second 
step, on the basis of our finding that postnatal airway innervation requires NT4,7 we 
tested whether NT4 was expressed by PNECs as a neurotrophic factor for the innervating 
nerves during postnatal development.  We assessed NT4 expression in PNECs by double 
staining for NT4 and CGRP. Compared to NT4-/- mouse as the negative control, NT4 was 
detected in all CGRP+ PNECs in WT mice (Figure 3.3B). In addition, TrkB lineage 
labeling during neonatal allergen exposure found no TrkB expression by PNECs using 





Figure 3.3. PNEC innervation during postnatal development was dependent on 
NT4.  
 
A) Quantification of solitary PNECs, clusters, and total number of PNECs at birth and at 
P7, 14, and 21 in WT mice. PNECs were quantified after CGRP staining of tissue 
sections collected from entire right cranial lobe. B) PNEC expression of NT4 by double 
staining for NT4 and CGRP.  NT4-/- lung sections were negative control for NT4 
antibody. Arrows indicate PNECs. Scale bars, 100 µm. C) Representative images of 
postnatal TrkB lineage tracing using TrkBCreERT2/+;Rosa(tmRed) mouse line. PNECs 
(arrows) were stained for CGRP indicated by arrows. Nerves (arrowheads) were labeled 
by tomato red (tmRed) fluorescence. Scale bar, 100 µm. D) Assessment of solitary 
PNECs and clusters in WT and NT4-/- lungs with and without OVA challenges at P21. 
PNECs were labeled by CGRP staining of medial lung slices from left lobe. Each mark 
indicates results from 1 lung slice; n = 3 for each group. E) Assessment of NEB 
innervation in WT and NT4-/- mice with and without OVA exposure. Lung slices were 




spatial association between NEBs and nerves. NEBs with 5 or more PNECs were 
counted. NEBs without associated nerves (none), nerves at base (basal), and nerves 
penetrating into clusters (penetrating) were grouped and presented as percentages of all 
NEBs. F) Representative images of NEBs with penetrating nerves in WT and NT4-/- mice 
with and without OVA challenges at P21. Scale bar, 50 µm. G) Quantification of NEB 
innervation density. Density of nerves was calculated by normalizing TuJ1-
immunoreactive area by number of cells within NEBs in WT and NT4-/- mice with and 
without OVA challenges. For data in E–G, total of 45–50 NEBs in lung slices from 3 







labeling identified nerves in the airway (Figure 3.3C)7 and type II pneumocytes in the 
alveoli (Figure S3.2). The discreet expression of NT4 and TrkB in PNECs and the 
innervating nerves, respectively, support NT4 as a candidate target-derived neurotrophic 
factor for PNEC innervation.  As a third step,we assessed the role of NT4 in PNEC 
innervation. Lung slices of WT and NT42/2 mice were double labeled for CGRP and 
neuron-specific b-tubulin III before confocal microscopy and 3-D rendering of the 
images. Each lung slice had an average of 2 to 3 single PNECs and 10 clusters, half of 
which contained 5 or more cells in both WT and NT4-/- mice (Figure 3.3D).  These 
findings indicated that NT4 is dispensable for PNEC development, which is consistent 
with a lack of TrkB expression by PNECs (Figure 3.3C). To assess PNEC innervation, 
we evaluated the innervation of NEBs containing 5 or more cells because a majority of 
nerves were associated with relatively large clusters. We noted 3 distinct spatial patterns 
of nerves in relationship to NEBs: no associated nerves (none), nerves only at the base 
(basal), and nerves sprouting into the NEB (penetrating). Each pattern was scored and 
presented as a percentage of all NEBs. Compared to WT mice, NT4-/- mice had more non-
innervated NEBs (none) (59 vs. 22% (WT)) but fewer basal NEBs (26 compared to 54% 
(WT)) and penetrating NEBs (15 compared to 25%, (WT)) (Figure 3.3E). Early life 
allergen exposure has been shown to elevate the levels of NT47. While it had no effect on 
the total number of PNECs and their solitary and clustered forms (Figure 3.3D), OVA 
exposure in WT mice increased the abundance of penetrating NEBs to 66% and elevated 
the density of nerves within penetrating NEBs by 4-fold compared to PBS controls 





Figure S3.2. Lineage tracing of TrkB expressing cells in postnatal lungs 
identifies selective TrkB expression by nerves in conducting airways. 
 
TrkBCreERT2/+;Rosa(tmRed) mice received 6 doses of tamoxifen between P5-P7 and P15-
P17 before lungs were harvested at P21. Frozen lung sections of tamoxifen-treated 
TrkBCreERT2/+;Rosa(tmRed) mice were collected and stained for markers of airway smooth 
muscle (α-SMA) (A-C), endothelial cells (CD31) (D-F), immune cells (CD45) (G-I), and 




directly conjugated antibodies (M) and rabbit IgG isotype for the SPC antibody (N). 
Arrows mark tmRed+ cells that also expressed individual cell markers. TmRed was 
detected only in nerves in the conducting airway. TmRed was also detected in ~5% cells 
in alveoli. Approximately 87% of these lineage labeled cells in alveoli were SPC+ type II 
pneumocytes, 10% were CD31+ endothelial cells, and 2% were CD45+ immune cells. 
Scale bars, 100µm. N=2 mice per group. Primary antibodies included: FITC-conjugated 
mouse anti-α-smooth muscle actin (SMA) (1:100; clone 1A4, Cat. #F3777, Sigma), 
FITC-conjugated rat anti-mouse CD45 (1:100, Cat. #553079, BD Pharmingen), FITC-
conjugated rat anti-mouse CD31 (1:100, Cat. #BD Pharmingen), rabbit anti-pro-SPC 




PNEC innervation and had no effect on the density of penetrating nerves in NT4-/- mice 
(Figure 3.3E–G). Together, early life allergen exposure causes aberrant increases in 
PNEC innervation by deregulating the essential neurotrophic factor NT4 during postnatal 
development. 
Early life OVA exposure deregulated sensory neuron activity by elevating NT4 levels.  
In response to injury, airway epithelium releases ATP that activates purinergic 
receptors expressed by sensory nerves.165 The nodose ganglion provides a major source 
of sensory innervation for ASM and PNECs.125,128,156 A large majority of nodose 
ganglion neurons express a purinergic P2X3 receptor that is required for ATP-induced 
activities.166 Because the development of nodose ganglion neurons during embryogenesis 
is dose-dependent on brain-derived neurotrophic factor and NT4, both of which signal 
through the TrkB receptor,167,168 we speculated that elevated levels of NT4 after early life 
OVA exposure might affect nodose sensory neuron activities.  To test this hypothesis, we 
examined the neuronal cell number and P2X3 expression in WT and NT4-/- mice at P21.  
NT4 was required for the survival of ~50% of nodose ganglion neurons (Figure 3.4A,B) 
while having no effect on the percentages of P2X3+ neurons (Figure 3.4C).168 In 
addition, OVA exposure had no effect on the number of neurons and the percentage of 
P2X3+ neurons in the nodose ganglion (Figure 3.4B, C). However, OVA exposure 
increased the P2X3 mRNA levels by 3-fold in WT mice while having no effect in NT4-/- 
mice (Figure 3.4D). These findings suggest that allergen exposure may increase the level 






Figure 3.4. NT4 was required for elevated purinergic receptor gene expression and 
increased nodose ganglion neuronal activities after early life OVA exposure.  
 
A) Representative images of double staining of medial nodose ganglions in WT 
and NT4-/- mice at P21 for pan neuronal marker Uchl1 and P2X3 receptor. Nuclei were 
labeled by DAPI. Scale bars, 250 µm. B) Quantification of neuronal numbers in medial 
sections of nodose ganglions from WT and NT4-/- mice at P21. Eighteen sections from 6 
ganglions of 3 mice were quantified.  C) Quantification of percentages of P2X3+ neurons 
in nodose ganglions from WT and NT4-/- mice at P21. D) P2X3 mRNA levels in nodose 
ganglions from WT and NT4-/- mice with and without OVA exposure.  Six ganglions 
from 3 mice were pooled as 1 sample. Three samples were analyzed for each condition.      
E) Representative images of P2X3 staining of primary nodose ganglion neurons after 72 
h in culture treated with control BSA or NT4. Arrowheads indicate P2X3+ neurons.  F) 




response to ATP stimulation. Relative fluorescence (Ft/F0) of Fluo-3 AM before and 
after ATP stimulation (arrow) was measured. To block P2X3 activities, NT4-treated 
cultures were pretreated with A-317491 (1 mM) for 20 min before ATP stimulation and 
during entire course of Ca2+ imaging. Results represent 2 independent experiments. Data 




To test whether NT4 may affect sensory neuron activity, we isolated nodose  
ganglions from P18 mice and established primary nodose sensory neuron cultures in 
defined neurobasal media. Because dissection severed the axons, neurons were allowed 
to regenerate neurites in culture for 3d before Ca2+ imaging using a fluorescent dye Fluo-
3AM for the measurement of their activities in response to ATP.  We found postnatal 
nodose sensory neurons no longer required NT4 for survival, as both BSA-treated 
controls and NT4-treated cultures (100 ng/ml) exhibited little cell death (Figure 3.4E). In 
addition, a majority of nodose sensory neurons were P2X3+ (Figure 3.4E). ATP 
stimulation (100 mM) triggered a spike of intracellular Ca2+ shown by a ~15% increase 
above the baseline fluorescence that was reduced by 40 to 50% after 15 s of stimulation 
(Figure 3.4F). Compared to control neurons, NT4-treated cultures exhibited a ~45% 
increase in fluorescence above the baseline on ATP stimulation and maintained a higher 
level of intracellular Ca2+ over time (Figure 3.4F). Therefore, NT4 treatment increases 
the activity of nodose sensory neurons to ATP.  However, neurons treated with NT4 in 
the presence of A-317491, a specific P2X3 blocker, exhibited a faster return to baseline 
fluorescence while maintaining the initial Ca2+ spike (Figure 3.4F). These findings 
provide evidence for functional involvement of P2X3 in NT4-induced nodose sensory 
neurons hyperactivity. In addition, NT4 may affect other ATP receptor expression to 





NT4 was required for GABA hypersecretion to induce mucus overproduction following 
early life allergen exposure. 
To test whether aberrant increases in PNEC innervation may deregulate GABA 
secretion from PNECs after early life allergen exposure, we measured serum levels of 
GABA in WT and NT42/2 mice by ELISA, as neuroendocrine cells secrete laterally and 
basally into the circulation.109 NT4 had no effect on baseline serum levels of GABA 
(~200 ng/ml) (Figure 3.5A).  However, OVA exposure elevated serum levels of GABA 
by ~60% in WT mice while having no effect on NT4-/- mice (Figure 3.5A). We found no 
change in Gad1 and GABA receptor mRNA expression in purified airway epithelium 
cells at P21 after early life allergen exposure (Figure 3.5B and S3.4A). These findings 
provide evidence that NT4-dependent PNEC hyperinnervation deregulates PNEC 
secretion of GABA.   
We tested whether GABA administration would restore mucus overproduction in 
NT4-/- mice. GABA (10 mg/g body weight) was installed intratracheally between P14 and 
20. Because of the relatively long half-life of GABA in vivo (5 h),169 GABA was 
provided once a day. As a control neurotransmitter, Mch (30 mg/ml) was nebulized daily. 
Mice were analyzed at P21. We found that GABA alone had no effect on baseline mucus 
levels (Figure 3.5E). In addition, GABA administration in OVA exposed WT mice had 
no effect on already high levels of mucin expression (Figure 3.5E). In contrast, 
compared to saline in NT4-/- mice, GABA fully restored mucus overproduction in OVA- 
exposed NT4-/- mice with no effect on allergic inflammation assayed by serum levels of 




3.5E). These findings indicate that NT4 is specifically required for GABA signaling 
during early life allergen-induced mucus overproduction.  To provide further evidence, 
we evaluated the epithelial expression of Foxa3, a transcriptional factor associated with 
mucus overproduction in both animal models and people with asthma.46,53,170  GABA 
partially recovered Foxa3 expression in ~13% airway epithelial cells in OVA-exposed 
NT4-/-  mice compared to WT mice, which had ~34% Foxa3+ cells in airway epithelium 
after OVA exposure (Figure 3.5G,H). Furthermore, GABA had no rescue activities in 
PBS-exposed NT42/2 mice (Figure 3.5F), similar to the results in mouse lung slice 






Figure 3.5. NT4 was required for GABA secretion and mucus overproduction after 
early life OVA exposure.  
 
A) Serum levels of GABA in WT and NT4-/- mice with and without OVA challenges 
measured by ELISA. Data represent means±SEM from 10 to 16 mice of each group. B) 
Gad1 mRNA expression in airway epithelium of WT and NT4-/- mice after PBS or OVA 
exposure at P21; n = 6. C, D) Serum levels of IgE and IL-13 levels in BAL of PBS-
exposed NT4-/- mice and OVA-exposed NT4-/- mice with and without intratracheal GABA 




staining of lungs sections of WT and NT4-/- mice with indicated treatment. Arrows 
indicate mucin+ cells. Insets show enlarged images of epithelium staining. F) Muc5ac 
gene expression in PBS- and OVA-exposed WT and NT4-/- mice with and without GABA 
treatment. Each group had minimum of 7 mice. Data represent means 6 SEM of at least 3 
independent experiments. G) Foxa3 staining of lung sections of WT and NT4-/- mice with 
and without OVA exposure and GABA treatment. Arrows indicate Foxa3+ cells. H) 
Percentages of Foxa3+ cells in airway epithelium of each experimental group. Data 
represent means 6 SEM from 15 airways of 3 mice for each experimental condition. 





Our study used a combination of lineage tracing and in vivo and ex vivo models to 
investigate the development and neural regulation of pulmonary neuroendocrine system. 
Our results revealed an orchestrating role for NT4 in PNEC innervation and 
neuroendocrine secretion of GABA. Building on these findings, we propose a model of 
NT4-dependent mucus overproduction after early life allergen exposure (Figure 3.6).  In 
the model, NT4 is expressed by PNECs and serves to attract the innervating nerves 
during postnatal development. Allergen exposure to developing lungs, which elevates the 
levels of NT4,7 causes aberrant increases in PNEC innervation and sensory neuron 
activity that feeds on efferent nerves to induce GABA hypersecretion.  Excessive GABA 
signaling and IL-13 in airway epithelium ultimately induces mucus overproduction 
(Figure 3.6).  Blockade of NT4 and TrkB receptor signaling during allergen exposure 
prevents neural deregulation GABA secretion from PNECs and therefore prevents mucus 
overproduction (Figure 3.6). Our findings, in combination with our previous work 
concerning ASM innervation and hyperreactivity, highlight the profound impact of 
allergen exposure on the pattern and degree of innervation of both ASM and PNECs in 
developing postnatal lungs. Our previous study identified mast cells as a de novo source 
of NT4 for allergen-induced ASM hyperinnervation.8 Whether mast cells play a similar 
role in aberrant PNEC innervation in the disease model warrants further investigation.         
Our findings indicate that IL-13 provides a permissive signal for the essential 





Figure 3.6. Model of NT4-PNEC axis in GABA secretion and mucus overproduction 
after early life allergen exposure.   
 
PNECs are innervated by both sensory afferents and efferent nerves. During 
development, NT4 expressed by PNECs serves as target-derived trophic factor for 
innervating nerves to establish innervation. Allergen exposure during postnatal PNEC 
development elevates levels of NT4, which in turn causes PNEC hyperinnervation and 
hyperactive nodose sensory neurons that feed on efferent nerves. Hyperactive 
neurocircuitry deregulates GABA secretion from PNECs. Aberrant levels of GABA act 
together with IL-13 to induce mucus overproduction. Loss of NT4 reduces PNEC 
innervation at baseline and prevents allergen-induced PNEC hyperinnervation. There is 
thus no induction of GABA secretion from PNECs in allergen-exposed NT4-/- mice. IL-







through the multifaceted role of IL-13 in gene activation and in epithelial cell survival 
and differentiation to enable GABA signaling.10 In addition, allergic inflammation, which 
damages the barrier function of airway epithelium,171,172 may also provide a permissive 
barrier mechanism for paracrine GABA signaling by facilitating the distribution of 
GABA after PNEC secretion in vivo. The apical–lateral distribution of a GABA receptor 
by club cells (Figure S3.4B) supports the possibility that GABA may interact with the 
receptors after basal–lateral secretion from PNECs.  Furthermore, GABA receptor 
antagonists had no worsening effect on allergen-induced airway hyperreactivity (Figure 
S3.5). Therefore, targeting NT4 along the nerve–PNEC axis to block GABA secretion 
may be a valuable treatment strategy for mucus overproduction in asthma.   
Allergen exposure to developing postnatal lungs elevates the neurogenic signal 
NT4 to disrupt the neurocircuitry that innervates PNECs.  In addition to quantitative 
increases in PNEC innervation, we also provide evidence for NT4-induced sensory 
neuron hyperactivity in response to ATP. Whether PNEC innervating efferent nerves are 
altered by early life allergen exposure warrants future work, as the efferent signal that 
induces GABA secretion from PNECs remains to be identified. However, independent of 
changes in efferent nerves, hyperactive sensory afferents are expected to feed on efferent 
nerves to deregulate the activity of the neurocircuitry, which in turn induces GABA 
hypersecretion. In contrast to neonatal mice, we showed that adult mice had no change in 
airway innervation after allergen exposure.7 Without the increase in innervation, we 
speculate that GABA secretion from PNECs may be triggered by the neurocircuitry 





Figure S3.4. NT4 deficiency has no effect on GABA receptor expression in airway 
epithelium.  
 
(A) The expression of major GABAA and GABAB receptor genes in airway epithelium 
cells isolated from PBS- and OVA-exposed, wild type and NT4-/- mice at P21. Each RNA 
sample for the array study was pooled from 4-5 mice. There are a total of 21 GABA 
receptors. To gain a comprehensive assessment of gene expression of all GABA 
receptors, we performed mRNA profiling using AffymetrixR Mouse Gene 1.0 ST Whole 
Transcript platform. Relative expression levels of major GABA receptor genes were 
shown. Data represent mean±SEM from 3 independent samples. (B) Characterization of 
GABABR2 expression in mouse airway epithelial cells by double staining.  Antibodies 
used included mouse anti-Muc5ac (1:50; Cat. #ab3649, Abcam) and rabbit anti-
GABABR2 (1:100; Cat. #AB2255, Millipore). GABABR2 had apical-lateral distribution 
in a subset of CC10+ club cells. GABABR2 was also found in a majority of Muc5ac+ 
goblet cells following OVA exposure. No GABABR2 was detected in CGRP+ PNECs. 















Figure S3.5. Blockade of GABAA receptor signaling prevented mucus 
overproduction.  
 
(A) PAS staining of lung sections from OVA-exposed mice with and without picrotoxin 
treatment between P14-P20 during OVA exposure. Picrotoxin was given intranasally 
once per day between P14-P20 (0.25µg/g body weight). Control mice received saline 
intra-nasally. Mice were analyzed at P21. Arrows point to mucin+ cells. Inserts show 
enlarged images of stained epithelium. Scale bar, 100µm. (B) qPCR assays for Muc5ac 
gene expression in OVA-exposed mice with and without picrotoxin treatment. (C) 
Picrotoxin had no worsening effect on airway reactivity. Lung slices were prepared from 
PBS- and OVA-exposed mice at P21 with and without the treatment of picrotoxin. 
Airway reactivity was measured by the percentage of reduction in the airway lumen size 
in response to increasing doses of Mch. Mid-sized airways with a baseline luminal area 
between 14,000µm2 and 20,000µm2 were selected for imaging using an inverted 
microscope (DMI6000B; Leica Microsystems, Buffalo Grove, IL, USA). From the 
acquired images, the airway luminal area was measured using NIH Image J and 
normalized to the baseline value. For all experiments, N=5 mice for each condition from 





Identification of the stimuli and investigation of their induction by injury, such as 
allergen exposure, cigarette smoke, and viral infection, may help explain why mucus 
overproduction occurs in a variety of airway diseases.   
In summary, our study provides evidence that the nerve–PNEC axis may be 
involved in the pathogenesis of asthma after early episodes of exposures. Targeting NT4-






CHAPTER FOUR  
GABA SIGNALING IS REQUIRED FOR IL-13 INDUCED MUCUS 
OVERPRODUCTION 
Abstract 
GABAα signaling is implicated in promoting mucus overproduction in asthma, 
but how the GABAβ receptor and GABA signaling overall contribute to IL-13 mediated-
mucus overproduction, is not understood.10  Using a differentiated system of human 
airway epithelium, we found that GABA signaling was required for IL-13 mediated 
mucus overproduction.  We demonstrated that pulmonary neuroendocrine cells (PNECs), 
the only innervated airway epithelial cells, were the only source of GABA in infant 
primates and humans.  We showed in an early allergen exposed primate model, similar to 
the mouse, has hyperrinnervation of PNECs and thus aberrant GABA signaling.  
Inhibition of GABA signaling, innately present in the media, significantly reduced 
MUC5AC gene expression, goblet cell percentage, and goblet cell proliferation.  
Strikingly, inhibition of GABAβ receptor signaling also reduced MUC5AC gene 
expression, however, dual combination of GABAα and GABAβ antagonists was required 
to reduce IL-13 mediated goblet cell proliferation.  In summary, our data demonstrated 
that GABA signaling was required for IL-13 mediated goblet cell proliferation, offering 







 Mucus overproduction is an obtrusive feature of asthma, chronic obstructive 
pulmonary disease (COPD), and cystic fibrosis (CF).  In asthma, increased mucus 
occlusion and numbers of mucin producing cells, goblet cells, are frequently reported and 
continually contribute to severe airway obstruction and asphyxiation. 31,45  Despite the 
burden of mucus overproduction to patient’s quality of life, treatments directly targeting 
mechanisms of mucus overproduction are lacking. 
Although the cell of origin for mucus overproduction differs between mouse and 
human, the signaling mechanisms are conserved.  In the mouse, under allergic conditions, 
mucus overproduction develops through transitioning from a secretory club cell, to a 
mucus-producing goblet cell.  This process is known as transdifferentiation.37,47  In 
human asthma, however, asthmatics have higher numbers of goblet cells compared to 
non-asthmatic controls, and these numbers highly correlate with asthma severity.31,32,45  
Airway goblet cell differentiation is highly influenced by transcription factors 
such as: SPDEF, FOXA3, and STAT6, as well as cytokine signaling through IL-
13.46,49,53,54,148  IL-13 was identified decades ago as a key type 2 inflammation mediator 
that orchestrates allergic inflammation and airway remodeling.49,148  Since then, nerves, 
neurotrophins, and their products (neurotransmitters) have also been implicated in asthma 
pathophysiology. 76,108,154,155  An aberrant GABAergic system was found to contribute to 
mucus overproduction in adult mouse models of asthma, human airway epithelium cell 
cultures, and allergen provocation in humans.10,149 GABA can interact with GABAα and 




chloride channel, they however did not address the potential role of the G protein coupled 
receptor, the GABAβ receptor, in asthma pathogenesis.10 
 In this study, we used a well-established human bronchial epithelial cell air liquid 
interface (ALI) culture system to study how GABA signaling coordinated with IL-13 to 
promote mucus overproduction.  We showed in an early life allergen exposure model of 
nonhuman primates, aberrant PNEC hyperinnervation and aberrant GABA secretion, 
which was consistent with the mouse model.13  Notably, PNEC-GABA expression was 
specific and conserved in primates and humans.  By ELISA, we detected high levels of 
GABA in ALI media.  Because our ALI culture system lacks differentiated PNECs (data 
not shown), it was an optimal system to test baseline levels of GABA and its interaction 
with IL-13.  To identify the role of the two distinct GABA receptors, α and β, we used a 
single and dual combination of pharmaceutical inhibition in conjunction with IL-13.  
Through these assays, we showed a critical role of GABAα and GABAβ signaling in 
combination with IL-13, to promote elevated MUC5AC gene expression and goblet cell 
proliferation.  In all, we hope this study highlights the role of required aberrant GABA 





Materials and Methods 
Mice 
C57BL6 mice were purchased from The Jackson Laboratories (Bar Harbor, ME, USA). 
All mouse experiments were approved by the Institutional Animal Care and Use 
Committee at Harvard Medical School. 
Nonhuman primate exposure model 
All nonhuman primate exposures were conducted by the California National Primate 
Research Center at the University of California Davis 
(http://www.cnprc.ucdavis.edu/ourscience/ respiratory-diseases/).  This infant nonhuman 
primate model of ozone (O3)  and house dust mite allergen (HDMA) exposure for 6 
months after birth, recapitulates the clinical hallmarks of asthma.  After exposures, 
primates were sacrificed and lung tissue was fixed and paraffin embedded.  25 µm 
proximal lung sections, of 6-month-old rhesus monkeys, were prepared from archived 
tissue blocks at the National Primate Research Center, UC Davis and sent to our lab for 
immunohistochemistry analysis.  
Human tissue study approval   
For immunohistological studies in humans, lungs of de-identified donors with no existing 
lung disease (0-12 years of age) were obtained from the International Institute for the 
Advancement of Medicine (IIAM) (Edison, New Jersey, USA). IRB approval was 
obtained from Brigham & Women’s Hospital.  Human lung tissue was fixed in 4% 
paraformaldehyde at 4°C overnight, paraffin embedded and sectioned.  Normal human 




donors with no pre-existing chronic lung disease under IRB approved protocol (#03-
1396, University of North Carolina, Chapel Hill, NC). 
GABABR antagonist treatment during OVA exposure 
To block GABAB receptor signaling, wild type mice were treated daily with CGP55845 
via intranasal delivery between P14-P20 (0.1µg/g body weight; Cat. # SML0594, Sigma-
Aldrich).  Control mice received saline.  Mice were sacrificed on P21 for tissue harvest. 
Antibodies  
Primary antibodies included: mouse anti-GAD67 (1:100, Cat. # MAB5406, Millipore 
Sigma), rabbit anti-CGRP (1:1000, Cat # C8198, Sigma), rabbit anti-bombesin (1:200; 
Cat. #20073, Immunostar), rabbit anti-PGP9.5 (1:100; Cat. #AB1761-I Millipore Sigma), 
rabbit anti-GABABR2 (1:100; Cat. #AB2255, Millipore Sigma), rabbit anti-Ki67 (1:200; 
Cat: ab66155, Abcam), mouse anti-MUC5AC (1:50; Cat. #ab3649, Abcam), rabbit anti-
cleaved, caspase 3 (1:100, Cat. #ab13847, Abcam), and mouse anti-neural class III b-
tubulin antibody (TuJ1) (1:50; R&DSystems, Minneapolis,MN,USA). 
Primary human bronchial epithelial (NHBE) cell culture 
 NHBE cells differentiate into all other epithelial cell types except PNECs over the course 
of 3 weeks at air-liquid interface (ALI).  ALI cultures provide a model system to study 
the effect of IL-13 on mucus overproduction. Approximately 42,000 NHBE cells were 
plated in each insert in a 12-well transwell plate (Cat. #3460, Corning Costar).  The insert 
was coated with rat-tail type 1 collagen (50µg/mL; Cat. #354236, Corning).  Cells were 
cultured in a 1:1 mixture of bronchial epithelial basal medium (BEBM, Cat. #CC-3171, 




Medium was supplemented with the SingleQuots kit (Cat. #CC-4175, Lonza) that 
included bovine pituitary extract (13mg/mL), human recombinant epidermal growth 
factor (0.5µg/mL), hydrocortisone (0.5mg/mL), epinephrine (0.5mg/mL), transferrin 
(10mg/mL), insulin (5mg/mL), triiodothyronine (6.5µg/mL), gentamicine (50mg/g), and 
amphotericin B (50µg/mL).  Medium was further supplemented with retinoic acid 
(50µM; Cat. #R-2625, Sigma), bovine serum albumin (BSA) (1.5mg/mL), and Nystatin 
(20U/mL; Cat. #N-1638, Sigma).  The GABA levels in complete culture media (1-
3mg/mL) were measured by ELISA. Medium was applied apically and basally until cells 
reached confluence after 6-7 days. After 90% confluence, apical medium was removed 
and air-liquid interface (ALI) was established.  To induce mucus overproduction, cells 
were treated with human IL-13 (10ng/mL, Peprotech) starting from day 0 of ALI.  To 
block GABA signaling, ALI cultures were treated with the antagonists of the GABAA 
receptor (picrotoxin, 50µM) and the GABAB receptor (CGP55845, 1µM) beginning at 
day 7 of ALI. The culture media was changed every other day.  Cells were maintained in 
ALI for 14 days before gene expression assays and antibody staining analysis.  Total 






Early life ozone and allergen exposure of non-human primates induced aberrant GABA 
secretion and PNEC hyperinnervation 
Our previous work demonstrated aberrant PNEC derived-GABA signaling in a 
mouse model of early life allergen exposure.13  We concluded that aberrant GABA 
secretion was due to abnormal PNEC hyperinnervation.  Consistently, we also showed 
that early airway insults in infant non-human primates contributed to significant airway 
smooth muscle (ASM) hyperinnervation.8  To assess if abnormal PNEC hyperinnervation 
and GABA secretion are conserved among species, we tested tissues from infant non-
human primates that were exposed to early life allergen.  Tissues were provided by the 
California National Primate Research Center at University of California Davis 
(http://www.cnprc.ucdavis.edu/ourscience/respiratory-diseases/).  Non-human primate 
infants were exposed to a combination of ozone (O3) and house dust mite (HDMA) 
allergen exposures beginning at postnatal day 30, continuing for 11 episodes up until six 
months of age, where tissues were collected (Figure 4.1C).  Concomitantly, filtered air 
controls (FA) were processed identically. Notably, this infant non-human primate model 
of O3 and HDMA recapitulates the clinical hallmarks of asthma and disease progression: 
increased IgE levels, increased eosinophils, and increased airway reactivity.8,173  We first 
double stained 25 µm thick paraffin sections of normal non-human primates and 6 month 
infant human for PNEC and nerve markers (Figure 4.1A).  25 µm proximal lung sections 




National Primate Research Center, UC Davis.  Infant human lung tissues were obtained 
from donated de-identified human lungs.   
PNECs express a variety of neuropeptides and bioactive amines including: 
calcitonin gene-related peptide (CGRP), PGP9.5, chromogranin A, and bombesin.  
Because neuropeptide expression differs between the mouse, human, and primate we 
used several markers of PNECs.  Critically, similar to the mouse, PGP9.5 expressing 
primate PNECs closely interacted with innervating nerves (Figure 4.1A).13  Neuron-
specific b-tubulin III (TuJ1 antibody), is a general nerve marker, which labels all nerve 
types.  Human PNECs express PNEC specific marker bombesin, and in contrast to the 
mouse, bombesin+ infant human PNECs expressed cytoplasmic TuJ1 (Figure 4.1A).   
To check for conserved GABA expression in primate and human, we stained for 
GAD67, a GABA biosynthetic enzyme, and PNEC markers for primate and human 
respectively.  Indeed, GAD67 was selectively expressed in both non-human primate and 
human infant PNECs (Figure 4.1B).  Importantly, these assays show the possibility of a 
conserved role of GABA expression between mice, primates, and humans.  Previous 
literature showed early life allergen exposure in infant non-human primates increased 
airway inflammation and innervation8,173, but whether aberrant GABA signaling and/or 
PNEC hyperinnervation contributed to the phenotype was not addressed.   
To test for aberrant GABA signaling, we analyzed GABA serum levels by ELISA 
in infant non-human primates exposed to allergen or FA.  Again, consistent with the early 
life exposed mouse model, allergen exposed infant primates had a ~59% increase in 





Figure 4.1:  Early life ozone and allergen exposure of non-human primates induced 
aberrant GABA secretion and PNEC hyperinnervation.  
 
(A) Representative images of PNECs with penetrating nerves and TuJ1 positivity in 6 
month old non-human primates and 6 month infant human. PGP9.5 is a marker of PNECs 
in the primate and bombesin is a marker of PNECs in human. 25 µm proximal lung 
sections of 6-month-old rhesus monkeys were prepared from archived tissue blocks at 
National Primate Research Center, UC Davis. 25 µm human lung sections were prepared 
from de-identified donors (0-12 years of age), N=3. Arrows denote PNECs.  Scale bar, 
50µm. (B) PNEC expression of GAD67 in 6 month old non-human primates and infant 
human. Arrows denote PNECs. GAD67 was only detected in cells that also expressed 
PGP9.5/bombesin and thus were PNECs.  Scale bar, 25 µm. (C) Schematic of ozone and 
early life allergen exposure in non-human infant primates.  Controls were exposed to 
filtered air.  (D) Serum levels of GABA (ng/mL) in primates with and without exposure 
to ozone and HDMA.  (E) Representative images of NEBs with penetrating nerves in 




Quantification of NEB innervation density. Nerve density was calculated by normalizing 
TuJ1-immunoreactive area (ImageJ) by number of cells within NEBs in infant primates 
with or without exposure to ozone and HDMA.  For data in E–F, NEB clusters from 






that early life exposure in both mice and primates lead to aberrant GABA secretion.  
Next, we sought to investigate whether aberrant GABA secretion was associated with 
PNEC hyperinnervation in non-human primates.  25 µm proximal primate lung sections 
were double stained for TuJ1 and PGP9.5 (Figure 4.1E).  Nerve density was calculated 
by normalizing TuJ1-immunoreactive area (ImageJ) by number of cells within NEBs in 
infant primates with or without exposure to ozone and HDMA. Compared with FA 
controls, O3 and HDMA exposure primates had 3.5 times higher PNEC nerve density.  In 
all, these findings provide evidence that deregulated GABA signaling is associated with 
PNEC hyperinnervation after early life exposures in non-human primates.   
GABAR is temporally expressed in human air liquid interface culture 
The GABAα receptor has been implicated previously in promoting mucus 
overproduction in an adult mouse model of asthma.10,149  However, whether the second 
GABA receptor, the GABAβ receptor, is involved in asthma pathogenesis is not known.  
The GABAβ receptor, a G protein coupled metabotropic receptor, is a dimer composed of 
R1 and R2 subunits, that is only functionally responsive as a heterodimer.174  GABAβ 
receptor expression has been reported in airway goblet cells, ciliated cells, and 
ASM.175,176  While suggestive, these studies used immortalized guinea pig and human 
cell lines to detect GABAβR expression by both mRNA and protein.  Additionally, 
antibody staining of GABAβR1 was nonspecific, where detection in airway epithelial 
cells, ASM, chondrocytes, and alveolar cells appeared equal.175  Because of this, we 
pursued a more relevant model to study GABA signaling in the context of inflammation.  




culture, has long been established to study signaling mechanisms in the lung ex 
vivo.177,178  We showed previously in the early life allergic mouse model, that GABAβR2 
expression was specific to airway epithelial cells and in some cases goblet cells, and not 
expressed in any other non-airway cell type in the lung.13  To test the possibility of 
aberrant GABAβ signaling in asthma, we first tested GABAβR2 expression in human 
ALI.  Human bronchial epithelial basal cells were obtained from de-identified patients 
maintained at the Park Lab at Harvard TH Chan School of Public Health.  First, we 
double stained 5µm thick paraffin embedded differentiated human ALI cultures with the 
GABAβR2 receptor and goblet cell marker, MUC5AC.  Like the mouse, in human ALI 
cultures, the GABAβR2 receptor was expressed apically and on MUC5AC+ cells as 
shown by arrows (Figure 4.2A).  In all, these assays affirmed the use of the ALI culture 
system to study GABA signaling in the context of inflammation.  
GABAR antagonist treatment and lineage development  
To test the individual and combined effects of the GABAα and GABAβ receptors 
on mucus overproduction, we treated differentiated hALI cultures with GABAα and 
GABAβ antagonists: picrotoxin and CGP55845, respectively.  Human ALI cultures 
naturally differentiate to mucus producing goblet cells, with up to 15% MUC5AC+ cells 
at baseline, and up to 30% MUC5AC+ cells under IL-13 conditions, providing a suitable 
system to test the effect of GABA signaling on mucociliary differentiation.179  Notably, 
through ELISA measurements, high levels of GABA were detected in the hALI media.  
To induce goblet cell proliferation, we treated human ALI cultures with IL-13, a 














                   
 
 
Figure 4.2:  GABAR is temporally expressed in human air liquid interface culture.   
 
(A)  GABABR2 immunoflurescence staining of hALI at day 14 of differentiation.  





 differentiated up to day 14, with day 0 counting as the first day of air exposure.  ALI 
cultures were treated with IL-13 at D0 of differentiation, to maximize mucus 
overproduction.  At day 7 of differentiation, we treated cultures with GABA antagonists 
to block GABA signaling and observed the effects on differentiation.  As shown 
previously, IL-13 treatment significantly impairs ciliated cell differentiation180  (Figure 
4.3A), while having no impact on CC10 gene expression (Figure 4.3B).  Interestingly, 
GABA antagonist treatment was not sufficient to rescue IL-13 mediated FOXJ1 
downregulation.  In all, these data suggest that GABA antagonists, and GABA signaling 
itself, did not significantly impact ciliated and club cell lineage differentiation. 
GABA is required for IL-13-induced mucus overproduction in NHBE cells.  
Since GABA signaling does not affect club and ciliated lineages, next we wanted 
to test if GABA signaling impacted goblet cell differentiation and proliferation. We show 
in vivo, that GABAα antagonist, picrotoxin, successfully inhibits mucus overproduction 
in an early life mouse model of allergic inflammation.13  After IL-13 treatment, MUC5AC 
gene expression increased 4.5 folds compared to untreated controls (Figure 4.4B).  Single 
and dual combination of GABA antagonists significantly reduced IL-13 mediated 
MUC5AC gene expression upregulation (up to 2.5 fold reduction) (Figure 4.4B).  
Additionally, after IL-13 treatment, goblet percentage increased from ~12% to ~30% 
(Figure 4.4C).  However, combination of GABAα and GABAβ antagonists, significantly 
reduced elevated IL-13 mediated goblet cell percentage back to control levels (Figure 
4.4C).   Notably, single GABA antagonist treatment, was not sufficient to reduce IL-13 














Figure 4.3: GABAR antagonist treatment in differentiating ALI cultures.  
 
(A) FOXJ1 and (B) CC10 expression in day 14 ALI cultures of NHBE cells under 
different conditions: with and without IL-13 and (10ng/mL) and GABA receptor 






Figure 4.4. GABA is required for IL-13-induced mucus overproduction in NHBE 
cells.   
 
(A) Representative images of double staining for Ki67 and MUC5AC in day 14 ALI 
cultures of NHBE cells with and without IL-13 and (10ng/mL) and GABA receptor 
(GABAR) blockers (50 µM picrotoxin and 1 µM CGP55845).  Arrowheads point to 
MUC5AC+Ki67+ cells.  The insert shows an enlarged image of the double positive cells 
in IL-13 treated cultures.  Scale bar, 50 µm.  (B) MUC5AC gene expression in day 14 
ALI cultures of NHBE cells under different culture conditions.  N=3 donors in triplicates 
for each experimental condition.  (C) Quantification of the percentages of MUC5AC+ 
goblet cells in day 14 ALI cultures of NHBE cells.  (D) Quantification of goblet cell 
proliferation in day 14 ALI cultures of NHBE cells. Proliferation was quantified by 
normalizing the number of MUC5AC+Ki67+ cells to the total MUC5AC+ goblet cells.  
More than 500 cells from each donor were counted for each condition.  For alpha+IL-13 
and beta+IL-13 conditions: N=2, other conditions N=5. (E) Representative images of 
staining for cleaved caspase 3 in day 14 ALI cultures of NHBE cells with and without IL-




ALI cultures of NHBE cells were shown (F).  Data in bar graph (B-F) represent 
mean±SEM from 3 donors in triplicates in 3 independent experiments.  *P<0.05. 






contributing to increases of goblet cell percentages, we examined the cell proliferation 
markers, including Ki67.  We double stained paraffin embedded ALI filters for 
MUC5AC and Ki67.  We saw a 30-fold increase of proliferating goblet cells in the IL-13 
treated conditions (Figure 4.4D).  By blocking both GABA receptors, the numbers of 
proliferating goblet cells were reduced to baseline control levels (Figure 4.4D).  In 
summary, we showed GABA signaling was essential for IL-13 induced goblet cell 
proliferation in human ALI cultures, as the inhibition of GABA signaling activated by 
GABA in the culture media, prevented IL-13-induced goblet cell proliferation and 
MUC5AC gene expression (Figure 4.4A-D).   
Next, we wanted to determine how GABA signaling modulated apoptosis.  
Normally, NHBE cells turn over at a rate of 4-5%.  Both IL-13 and GABA antagonist 
treatments, however dramatically reduce apoptosis and improve cell survival from 5% to 
less than 1% (Figure 4.4E,F).  This suggests that GABA itself is promoting apoptosis, 
possibly contradicting a previous in vitro study in BEAS2B cells, showing GABA 
promotes cell proliferation.10  Together, our findings provide solid evidence in an ex vivo 
human model of inflammation, that GABA was essential in IL-13 mediated goblet cell 






IL-13 has long been the central and sufficient driver of type 2 airway 
inflammation.  We show here, however, that GABA signaling is absolutely required for 
mucus overproduction.  Using non-human primate models of asthma and an in vitro 
system of differentiated human epithelium, we show PNECs both in human and primates 
selectively express GABA.  Concurrent with our previous mouse work, we also 
demonstrate increased PNEC innervation and enhanced GABA secretion after early life 
allergen exposure in a non-human primate model.  
To study the complexity of GABA signaling, we use a culture system of polarized 
human bronchial epithelial cells, which differentiate to club, ciliated and goblet cells.  
Notably, the media in this culture system inherently contains GABA, eliminating the 
need to add external GABA.  We show that goblet cells express the GABAR and that 
GABA antagonists have no effect on epithelial cell differentiation.  
  Finally, we show that IL-13, with the presence of GABA, induces and promotes 
goblet cell proliferation and cell survival.  However, with the addition of GABA 
antagonists, goblet cell proliferation was prevented.  We showed previously in a mouse 
model of early allergen exposure, that mice deficient in neurotrophin 4 (NT4), a nerve 
derived growth factor required for elevated PNEC innervation and aberrant GABA 
secretion, was required for mucus overproduction.  Unexpectedly, mice deficient in NT4 
maintained high levels of OVA specific IgE and elevated IL-13 serum levels.  Consistent 
with our mouse work, we show in a human bronchial epithelial culture system that IL-13 















Figure S4.1. Pharmaceutical blockade of the GABAB receptor pathway prevents 
mucus overproduction without any worsening effect on airway reactivity following 
early life allergen exposure.  
 
(A) Representative images of PAS staining of lung sections from OVA-exposed mice 
with and without CGP55845 treatment between P14-P20 during OVA exposure.  
CGP55845 was given intranasally once per day between P14-P20 (0.1µg/g body weight).  
Control mice received saline intra-nasally.  Mice were analyzed at P21.  Arrows point to 
mucus+ cells.  Scale bar, 100 µm.  (B) qPCR assays for Muc5ac gene expression in OVA-
exposed mice with and without CGP55845 treatment.  (C) The effect of CGP55845 on 
airway reactivity was assessed by contraction assays using precision cut lung slice.  Lung 
slices were prepared from PBS- and OVA-exposed mice at P21 with and without the 
treatment of CGP55845.  Airway reactivity was measured by the percentage of reduction 
in the airway lumen size in response to increasing doses of Mch.  For all experiments, 







Notably, in an in vivo model of early life allergen exposure, GABAB receptor antagonist 
treatment, had no worsening effect on allergen induced airway hyperreactivity (Figure 
S4.1).   
Mucus overproduction causes a significant burden on patients with asthma. 
Patients who suffer fatal asthmatic attacks have increased goblet cell hyperplasia and 
mucus plugs compared to mild asthmatics. Previously, it was shown that GABA 
treatment increased airway epithelial cell proliferation, so we tested whether GABA 
antagonists could impact proliferation of goblet cells.  In mice, it is believed that mucus 
cells persist through downregulation of the apoptotic pathway, Bcl2 (Bik)181.  We show 
here, that consistent with previous studies, IL-13 treatment reduces cell death,182 
however, single treatments of GABAR antagonists show decreased cell death compared 
to control, which suggests a role of GABA signaling in cell survival.  We speculate that 
this might be in part due to GABA itself participating in promoting cell death.  However, 
what cells undergo GABA signaling mediated apoptosis remains to be investigated.   
Clearly, early life allergen exposure disrupts normal PNEC innervation but as to 
what types of innervating nerves are changing within the clusters requires further study.  
We also discover a novel phenotype present in primate and human PNECs, where the 
NEBs and single PNECs express cytoplasmic TuJ1. While, intriguing, further studies are 
required to understand why PNECs are expressing neural markers and if this contributes 
to their function.  Additionally, what signal triggers aberrant GABA signaling is not 




IL-13 mediated-mucus overproduction in human.  Targeting a combination of GABA 






CHAPTER FIVE  
CONNECTIVE TISSUE MAST CELL DEPLETION IN EARLY LIFE CAUSES 
PERSISTENT AIRWAY DYSFUNCTION 
Abstract 
There are two types of mast cells in the lung: connective tissue mast cells  
(CTMCs) and mucosal mast cells (MMCs).  CTMCs are resident mast cells and localize 
in the parenchyma of the lung and surrounding blood vessels.  MMCs are recruited to the 
lung as progenitors and differentiate there under an inflammatory environment.  Mast 
cells are known to express NT4 to induce changes in airway innervation.  The goal of this 
work was to characterize the development of CTMC in postnatal lungs and identify the 
function of pulmonary CTMCs.   
Based on our previous studies on NT4, we hypothesized that CTMCs, by 
releasing neurotrophic factors and inflammatory mediators during development, 
contribute to long-term airway dysfunction.  To approach this hypothesis, we used 
Mcpt5-Cre transgenic mice where Cre was expressed selectively by CTMC.  
Mcpt5Cre+;Rosa(tmRed)+ mice were used to trace CTMC during postnatal development 
of lungs and Mcpt5Cre+;Rosa(tmRed)+; Rosa(DTA) mice to trigger apoptosis of CTMC, 
and release their intracellular contents.    
Without allergen, Mcpt5Cre+;Rosa(DTA) mice have all phenotypes reminiscent 
of allergic inflammation: mucus overproduction, increased collagen deposition, and high 
baseline cholinergic innervation.  Together, our studies uncover an unappreciated role of 




addition, our findings may provide insights into genetic predisposition to childhood 





Mast cell development  
Mast cells originate from CD34+ CD117+ hematopoietic progenitors and develop 
from the granulocyte/monocyte lineage.183,184  MC progenitors enter the bloodstream as 
undifferentiated mononuclear cells and subsequently develop into mature mast cells 
within tissue in response to the local environment.  Transcription factors that drive the 
differentiation of MCs from hematopoietic stem cells include PU.1, STAT5, and 
others.185  Mouse embryos lacking PU.1 have mast cell deficiencies as well as 
deficiencies in lymphoid and myeloid progenitors.186  STAT5 deficient mice have similar 
defects in mast cell populations in the peritoneum, skin, stomach, and spleen.  In 
addition, an essential growth factor required for human and mouse mast cell survival is 
stem cell factor (SCF).  Previous studies have shown that the ckit receptor and its ligand 
SCF are required for mast cell survival, development, adhesion, and maintenance.187,188  
Murine mast cells require an additional factor for growth, IL-3.189  Human mast cells do 
not require IL-3 for survival and growth, but it does enhance progenitor proliferation 
when added early to MC cultures.190   
 In the mouse lung, integrins and vascular cell adhesion molecule 1 (VCAM-1) are 
required for the recruitment of committed MC progenitors under inflammation, as 
antibody blocking led to significantly less MC recruitment.191  It is believed since many 
chemoattractants have been identified in the mouse and human lung, MC tissue homing is 
through active recruitment, such as in inflammation. The naïve mouse lung does not 
contain many MCs at baseline, unlike the human lung, but numbers increase dramatically 




recruitment is similar to humans, remains to be determined.  However, both human and 
mouse mature MCs have the capacity of proliferating, so mast cell increases in allergic 
diseases, such as asthma, may occur through recruitment and proliferation.193-195 Human 
mast cells are long lived and can be maintained in culture for several months while 
supplemented with SCF and IL-6196 and can also recover and replenish their granules 
after exocytosis.197  Murine MC lifespan highly depends on whether the MCs were 
recruited or are tissue resident.  Recruited mucosal mast cells (MMCs) remain in the 
trachea and main proximal airways 10-14 days189 after allergen exposure, whereas, tissue 
resident connective tissue mast cells (CTMCs) are stable and long lived.198  Human mast 
cells express different proteases if grown in serum and SCF conditions versus grown on a 
fibroblast or endothelial cell layer.  This suggests that protease expression is highly 
dependent on tissue environment and other factors other than SCF are required for MC 
maturation.193,199-201       
Types of mast cells 
Mast cells are characterized by the presence of many membrane bound dense 
granules.  Mast cells are also packed with hundreds of secretory granules which contain 
lysosomal enzymes, cytokines (TNF, IL-4, IL-33), growth factors (NGF, NT4), amines 
(histamine, dopamine), and proteases (tryptases, chymases, MMPs).202  In general, mast 
cell secretory granules serve to protect against bacteria203,204, venom205, and parasite206,207 
infection but can also contribute to asthma pathology.   
Mast cell heterogeneity exists among different species, tissues, and even the same 




serine proteases: mast cell tryptase (MCT) or mast cell tryptase/chymase (MCTC).  MCT 
subsets only express tryptase and MCTC express a higher variety of proteases including: 
tryptase, chymase, cathepsin G, and carboxypeptidase A3.208  The MCTC  subset is found 
predominantly in connective tissues, such as in skin and at subepithelial locations in the 
bronchial (ASM bundles),209 nasal, and gastrointestinal mucosa, and are most like mouse 
connective tissue mast cells (CTMCs).  The MCT subset is located predominantly in 
mucosal surfaces, such as the gastrointestinal epithelium, and in airway epithelium in 
patients with allergic disease, and are most like mouse mucosal mast cells (MMCs).210,211  
In the asthmatic lung, the MCT subset predominates whereas the MCTC subset is less than 
20% of lung MCs.212   
While different in their protease content, human mast cells also exhibit 
heterogeneity in their cytokine content.  MCTC subsets preferentially express IL-4, 
whereas IL-5 and IL-6 are almost restrictively expressed by the MCT subsets.213  The two 
distinct phenotypes within these subtypes greatly suggest differing pathophysiological 
roles.  To functionally demonstrate mast cell heterogeneity, in vitro studies show that the 
two MC types respond differently to stimuli.  Mast cell chymase inhibitors block IgE-
mediated histamine release from skin MCs (predominantly MCTC) but not from lung 
MCs (MCT) (18).214 Similar differences in response to C5a215 and corticosteroid 
treatments are seen where a specific subtype is targeted over the other.216  
In the mouse, MCs are characterized based on location.  Once mature, MCs are 
classified into two groups depending on tissue residency and location: connective tissue 




population in the lung in naïve mice and usually reside near connective tissue, blood 
vessels and nerves and are not dependent on T cells for recruitment, and as such are most 
similar to human MCTC subtype.220,221    
Pulmonary mucosal mast cells (MMCs) arise from the bone marrow (BM), are 
recruited by T-cell-dependent inflammation in organs such as the intestine and airways, 
and mainly exist intraepithelially.220,222-224  Pulmonary MMCs are most likely the human 
MCT subtype.220  With the development of antibodies against mast cell proteases and 
tissue location, investigators have been able to further define these populations.  
Specifically in the lung, through extensive immunohistochemistry staining: CTMCs are 
extensively granulated and express mast cell proteases (MCP) including mMCP-1 
(chymase), mMCP-4(chymase), mMCP-5 (chymase), mMCP-6 (tryptase), mMCP-
7(tryptase), and CPA3.  Pulmonary MMCs express mMCP1, mMCP-6, and mMCP-7.223  
As a result of mast cell heterogeneity, many mouse models have been developed to study 
mast cell function, and will be discussed below. 
Mouse models for mast cell functions 
With the variable expression of proteases, the function of different types of mast 
cells can be studied.  To better understand the role of mast cell functions in disease 
several mouse mast cell models have been developed. The most well characterized 
models involve known models are mice with mutations in the KIT receptor: WBB6F1-
KitW/W-v and C57BL/6-KitW-sh/W-sh mice, where both are deficient in mast cells.  KitW mice 
have a point mutation in Kit that produces a truncated KIT, and thus remains 




diminishes its activity.226 KitW-sh/W-sh mice have an inversion mutation, which affects the 
transcriptional regulatory elements upstream of the c-kit start site.227 As expected, mice 
with mutations in c-kit have abnormalities in other cells which express the Kit receptor, 
but this can be partially circumvented with reconstitution of WT MCs to closely monitor 
MC function, instead of secondary effects from Kit mutations.  KitW-v mice are anemic, 
have low numbers of neutrophils, basophils, and are sterile.  KitW-sh/W-sh are relatively 
stable in other immune cell numbers besides slightly higher numbers of neutrophils and 
basophils.228  
 Because of potential complications in experimental results in c-kit mutations, 
recently developed mouse models target mast cell specific proteases and chymases.  
Cpa3Cre/+ was generated independently of Kit mutations.  Cpa3Cre/+ is a knockin mouse 
that induces Cre expression under the Cpa3 promoter, carboxypeptidase A3.229  These 
mice have a complete depletion of MCs but also have reductions in other Cpa3 
expressing cell types including spleen basophils, T cell progenitors, and hematopoietic 
progenitor cells.228   
 A mast cell model that has recently generated a lot of interest is the Mcpt5Cre 
mouse line.230  This mouse model is unique because unlike the other mast cell depletion 
models, this model specifically targets CTMCs.  Other models have a complete depletion 
of both MMCs and CTMCs.  Both constitutive and inducible models of Mcpt5Cre mice 
have been generated.231  Dudeck et al. crossed Mcpt5Cre mice with R-DTAfl/fl mice to 
generate a mouse in which the diphtheria toxin a chain (DTA) is produced only in 




mating Mcpt5Cre with iDTRfl/fl mice that express a DTR transgene in the ROSA locus 
which will express DTR on Cre expressing cells.  Notably, Mcpt5 shares high amino acid 
sequence homology with human chymase-1,232 which has been identified as interacting 
with fibronectin233, angiotensin-II234, and endothelin-1.235  Both Mctp5 and human 
chymase-1 are serine proteases and are expressed in connective tissue mast cells 
including in the tongue, skin, and peritoneal cavity.219,222,236  Previous studies using 
Mcpt5Cre knockout mice, have shown Mcpt5 deficiency is protective against 
experimental arthritis, whereas in Mcpt5Cre mice (knockin loss of function) mast cell 
derived-TNF is required for dendritic cell function and CD8+ T cell priming.231,237,238   
Mast cell activation  
In order to mediate their effects, mast cells release their intracellular granules 
through a process called degranulation.  Crosslinking and receptor aggregation leads to 
the secretion of bioactive mediators that have potent effects.  Two major families of 
receptors that trigger mast cell degranulation include the Fc receptor and G protein 
coupled receptors (GPCR). All mast cells express the FcεRI receptor on their surface, 
which allow them to respond to IgE dependent allergic responses.  The FcεRI receptor 
binds to the Fc portion of B-cell derived-IgE with high affinity, which then may be 
crosslinked by allergen, leading to aggregation of FcεRI receptors.  Aggregation of FcεRI 
receptors then activates many downstream signaling cascades to induce mast cell 
degranulation.183,239      
In addition to the FcεRI receptor, GPCRs, including Mas-related G-protein-




release of mast cell granules by binding to basic cation molecules such as neuropeptide 
Y, substance P, and antimicrobial peptides.240 Notably, Mrgprb2 is specifically expressed 
on connective tissue mast cells.236  While mast cells carry a variety of secretory granules, 
the extent of their degranulation and type of granules released is highly stimulus 
dependent ie. pathogens, complement components.  Substance P activation, through 
MGRPRX2 receptor, triggers release of VEGF and mast cell protease-1, whereas, anti-
IgE triggers release of inflammatory cytokines including IL-13, VEGF, and TNF-α.241 
Mast cells in asthma 
 There is strong evidence that mast mediators cells play an important role in the 
early and late asthmatic reactions.202  Mast cell-derived mediators induce the classical 
features of the early asthmatic reaction in vivo, inducing airway inflammation, airway 
hyperreactivity, and mucus overproduction.  Further underscoring their roles in asthma, 
mast cells are consistently observed near key dysfunctional lung structures, including the 
airway epithelium242, ASM209, nerves,8 and submucosal glands.243,244  Increased numbers 
of mast cells have long been implicated in asthma.  In cases of severe and fatal asthma, 
more activated and degranulated mast cells were observed (MCTC subtype).212,243  Non-
fatal asthma patients had higher mast cell densities and mast cell degranulation which are 
both related to asthma severity and pathophysiology (MCT subtype).212,243       
 In addition to increased degranulation and increased mast cell numbers, increased 
expression of mast cell mediators have been detected in the bronchoalveolar lavage fluid 
(BALF) of asthmatic patients.  Mast cell mediators themselves contribute to and amplify 




released from degranulated mast cells are elevated in BAL of asthmatic patients after 
allergen challenge and can all contribute to airway hyperreactivity and mucus 
overproduction.245,246  Additionally, increased levels of tryptase and chymase are detected 
in severe asthmatic patients.212  Further, increased expression of mast cell survival factor, 
SCF, is seen in airways of asthmatic patients compared to controls.247  Mast cells respond 
and can also release interleukin 33 (IL-33), a major regulator of type 2 inflammation.248-
251  Mast cell derived IL-33 can then activate ILC2s– which secrete IL-5 and IL-13 in 
abundance when activated.252  In addition to IL-33, mast cell derived NT4 is increased in 
the serum of children asthmatics and expressed non-human primate and children BALF 
mast cells.8 
 Because of the role of mast cells in asthma, therapies have recently tried to target 
the mast cell receptors in asthmatic patients.  Antibodies against the FcεRI, IgE receptor, 
significantly reduce the early and late phase responses to allergen in asthmatic patients.253  
CKIT receptor inhibition in asthmatic patients by imatinib, lowers AHR, mast cell 
numbers, and tryptase levels.254  These studies highlight the diverse roles of mast cell 
mediators, however, more research is required to understand how other cells besides mast 
cells might be impacted by KIT inhibition, and thus might require more specific 
treatments toward mast cells.  
 Like human patients, after allergen exposure the numbers of mast cells increase 
substantially in sensitized mice and correlate with asthma pathophysiology.8,224,255,256  In 
mouse models of inflammation, mast cells and their mediators have many roles.  In a 




inflammation by promoting T regulatory cell population expansion through mast cell 
derived IL-2.257  In a mouse model of intestinal helminth infection, increased mast cell 
numbers promoted worm expulsion through activation of IL-13 producing ILC2s.258  
  In contrast, to these studies, we and others, have shown the detrimental effects of 
increased mast cell numbers and their mediators in mouse models of asthma.  We showed 
previously that early life neuroplasticity from mast cell derived-NT4 contributed to 
persistent AHR, after early life allergen exposure.7,8  In summary, this study highlights an 
important role of mast cells in mediating neuroplasticity following early life allergen 
exposure.   
 This project arose to understand the role of CTMCs during lung development and 
their potential role during early life allergen exposure.  The function/s of CTMCs in the 
developing lung are unknown, but these cells remain intriguing because they are stable, 
long lived, and are present as early as embryonic day 18.  In addition, they are 
extensively granulated, reside near blood vessels and nerves, but their role in disease, if 
any, is not well understood.  Based on our previous studies, increased numbers of mast 
cells elevate the levels of NT4, but the role of CTMCs in allergic inflammation is 
unknown.  Thus, we utilized the Mcpt5Cre mouse model to specifically and 
constitutively deplete CTMCs and observe and monitor whether CTMCs or MMCs were 







C57BL6, Rosa-DTA (09669), and RosatmRed/tmRed (007955) were purchased from The 
Jackson Laboratories (Bar Harbor, ME, USA).  Mcpt5Cre mouse line230 was kindly 
gifted by Axel Roers.  All mouse experiments were approved by the Institutional Animal 
Care and Use Committee at Harvard Medical School.  For macrophage depletion, mice 
were injected intraperitoneally with control and clodronate liposomes (10 uL/gram, 
FormuMax, F70101C-A) at postnatal days P5, P10, and P15.  Tissue was harvested for 
histological and flow analysis on P21.   
Toluidine Blue Staining 
Stock solution of 1% toluidine blue solution was prepared in 70% ethanol.  1% sodium 
chloride solution was prepared and pH was adjusted to 2.0-2.5.  Working 0.1% toluidine 
blue solution was prepared by diluting stock toluidine blue (1%) with freshly prepared 
1% NaCl solution.  5 µm paraffin sections were then stained with working toluidine blue 
solution (pH 2.0-2.5) for 2-3 minutes after rehydration. The sections were washed by 
dipping in water 3-5 times followed by dehydration in 100% ethanol and histoclear.  
Bronchoalveolar lavage (BAL) counts 
Mouse lungs were flushed with 0.5mL cold PBS before BAL fluid was collected. Cells 
were pelleted, resuspended in 200µl PBS, and spun onto a histology slide by using 
Cytospin (ThermoScientific). The slides stained with Hema3 Stain. 200 cells were 





Histology and immunohistochemistry 
Lungs were fixed in 4% paraformaldehyde/PBS. Paraffin sections (5µm) of right cranial 
lobes were collected for Periodic acid–Schiff (PAS) staining of mucus (Cat. #395B, 
Sigma-Aldrich) and for antibody staining.  For double staining of PNECs and nerves, 5 
µm paraffin sections were used. Primary antibodies include: mouse anti-neural class III 
β-tubulin antibody (TuJ1) (1:50; Cat. #MAB1195, R&D Systems) and rabbit anti-CGRP 
(1:1000; Sigma-Aldrich, Cat. #C8198.  All secondary antibodies were purchased from 
Life Technologies. Nuclei were stained using Hoescht dye (1:1000).  Fluorescent staining  
was imaged using Leica DFC480.  For double stained lung slices, slices were imaged by 
confocal microscopy (Carl Zeiss, LSM 710). Compressed z-stack images were quantified 
to determine the PNEC innervation density by normalizing the TuJ1 immune-reactive 
area quantified using NIH Image J to the number of cells within the cluster.  
Quantitative Real Time PCR (qRT-PCR) 
RNA was extracted from lung samples with an RNeasy kit (QIAGEN) followed by 
reverse transcription using Superscript III Reverse Transcriptase (Invitrogen). TaqMan 
primers were purchased from Applied Biosystems.  Primers used were as follows: IL-33 
(Mm00505403_m1) and IL-13 (Mm00434204_m1).   The relative gene expression was 
measured by normalizing to 18S rRNA using ΔΔCt (cycle threshold difference).   
Picro Sirius Red Staining for collagen  
Left lung lobes fixed in 4% paraformaldehyde, paraffin embedded, and tissue blocks 
were cut into 5 µm paraffin sections.  Picro Sirius red was dissolved in aqueous picric 




for 1 hour at room temperature.  Stained sections were then briefly washed with 0.5% 
glacial acetic acid and dehydrated.  Collagen fibers were imaged through polarized light, 
resulting in birefringence of the collagen fibers.  Collagen deposition was quantified by 
dividing the area of collagen by the perimeter of the area via ImageJ. 
Statistical Analysis 
Data were presented as mean ± SEM from at least 3 independent experiments.  Statistical 
significance was determined using paired, two-tailed Student’s t-test or two-way 
ANOVA of variance with appropriate post hoc tests using GraphPad Prism 5 (GraphPad 






CTMC mast cells can be labeled and monitored over the course of development and 
disease progression.   
 Mast cells have long been established as important mediators of the allergic 
response.  However, the role of resident mast cells, connective tissue mast cells 
(CTMCs), is not well understood in the context of lung disease pathology.  To study this 
phenomenon, Mcpt5Cre mice were utilized.  Mcpt5Cre mice, express Cre recombinase in 
the mast cell protease 5 promoter, and have been used before in other organs to study the 
role of connective tissue mast cells in development and disease.230  To understand where 
connective tissue mast cells reside in the lung, we crossed a Mcpt5Cre mouse line230 
(gifted by Axel Roers) with Rosa(tmRed) mice (Figure 5.1A). Mcpt5Cre+;Rosa(tmRed)+ 
mice allowed the tracing of connective tissue mast cells over development.  In frozen 
sections of postnatal day 21 mice, we saw abundant tmRed+ CTMCs.  TmRed+ cells 
denoted by arrowheads (Figure 5.1A), were present throughout the lung, including the 
parenchyma and main airways.  To test CTMC depletion efficiency through constitutive 
expression of diphtheria toxin, we crossed the Mcpt5Cre mouse, with Rosa(DTA) and 
Rosa(tmRed) mice.  Through this analysis we would be able to test the percentage of mast 
cells remaining after Cre excision of both Rosa promoters.  Notably, we noticed that 
almost 100% of tmRed+ CTMCs were ablated.  Arrowheads denoted remaining mast 
cells, and airways were outlined by white dashes (Figure 5.1A).  We and others, have 






Figure 5.1: Mcpt5Cre+;Rosa(tmRed)+ cells are present during lung development.  
 
(A)  Connective tissue mast cell (CTMC) expression assayed at postnatal day 21.  In the 
frozen sections of lungs of Mcpt5Cre+;Rosa(tmRed)+ mice, connective tissue mast cells 
are tmRed+. Mcpt5Cre+;Rosa(tmRed)+ mice were crossed with Rosa(DTA) mice, to 
generate mice deficient in connective tissue mast cells.  TmRed+ cells are marked by 
arrowheads.  Airways denoted by dotted lines.  Scale bar 100  µm.  (B)  Representative 





development.8,259  Both studies have shown a peak of mast cell numbers at postnatal day 
14 in the lung, with numbers decreasing thereafter.  While informative, both studies did 
not focus on CTMCs.  Therefore, we decided to look at CTMC abundance over the 
course of postnatal development.  We collected frozen sections from 
Mcpt5Cre+;Rosa(tmRed)+ mice at P0, P7, and P21.  TmRed+ CTMCs were present as 
early as postnatal day 0 (Figure 5.1B).   Our observations indicated that while at baseline 
conditions, mast cells were present at abundant numbers early in development and can be 
traced and studied with the Mcpt5Cre mouse line.  Given the roles of mast cells during 
lung inflammation our findings suggest that CTMCs might contribute to lung 
development or recruited mast cell function during inflammation. 
CTMC loss promotes spontaneous inflammation through IL-33 mediated inflammation 
and mast cell recruitment  
To test the function of mast cells over development, we crossed Mcpt5Cre mice 
with Rosa(DTA) mice, and assessed phenotypes at P21.  Cells that ever express Mcpt5 
gene would undergo DTA-mediated apoptosis.  We therefore investigated whether 
depletion of CTMCs would impact inflammation, as mast cells are important for 
initiating and maintaining inflammatory responses.202  Loss of CTMCs (hereafter referred 
to as Cre+) induced spontaneous neutrophilic inflammation compared to WT PBS-and-
OVA exposed mice, a common model for allergic inflammation (Figure 5.2A).7,8,13  
Additionally, the OVA mouse model had elevated levels of Il-13 mRNA, as expected, 





Figure 5.2:  CTMC depleted mice have spontaneous inflammation.  
 
Differential immune cell counts in bronchoalveolar lavage fluid (BALF) of PBS-and 
OVA-exposed WT controls and Mcpt5Cre+;Rosa(DTA)+ (Cre+) mice at P21.  
Percentages of macrophages(macs), eosinophils(eos), neutrophils(neuts), and 
lymphocytes (lymphs) are shown.  (B)  Il-13 mRNA levels in lungs of WT PBS/OVA 
exposed mice and PBS Cre- and PBS Cre+ mice.  Results were normalized to PBS 
controls.  N=3 for each group.  (C)  Il-33 mRNA levels in lungs of WT PBS/OVA 
exposed mice and PBS Cre- and PBS Cre+ mice.  Results were normalized to PBS 
controls.  N=5 for each group. (D)  Quantification of toluidine blue+ mast cells assayed at 
P21.  Average number of toluidine blue+ mast cells were quantified per each 5 µm 
section from the left lobe.  Mast cells quantified as proximal were immediately close to 
airways.  Mast cells quantified as distal were found in the lung parenchyma, in the 






inflammation, epithelial cytokines, such as IL-33 are released and promote activation of 
dendritic cells and innate lymphoid cells to mediate the sensitization response.260,261 
During lung development, increased levels of IL-33 also establish the neonatal TH2 
bias.259  Thus, we decided to test whether in this early life spontaneous inflammation 
model, IL-33 was involved.  Indeed, compared to its Cre- control, Il-33 levels were 
significantly elevated in Cre+ mice (Figure 5.2C).  Because mast cell recruitment occurs 
under allergic conditions, we stained 5 µm thick paraffin for toluidine blue, a dye for 
mast cells, which recognizes the high acidic components in granulated cells.  Mast cell 
counting in both proximal airways and distal alveolar spaces revealed significantly 
elevated levels of mast cells (likely submucosal mast cells) in Cre+ CTMC depleted mice 
(Figure 5.2D).  As expected WT OVA mice also had significantly higher mast cell 
recruitment compared to WT PBS controls.8   These results indicated that CTMCs might 
have a direct or indirect role in promoting immune homeostasis by preventing IL-33 
inflammation and recruiting inflammatory mast cell recruitment. 
CTMC mast cell depletion promotes mucus overproduction  
Given that CTMC loss promoted spontaneous lung inflammation, we assessed 
whether mucus overproduction was affected.  We detected spontaneous mucus 
overproduction in P21 Cre+ mice compared to its Cre- control (Figure 5.3A). To rule out 
the possibility that general immune cell death caused the CTMC depletion phenotype, we 
treated P5 mice with control liposomes and clodronate liposomes.  Clodronate liposomes 
themselves are not toxic and can only be taken up by phagocytes, which includes 





Figure 5.3:  CTMC depleted mice have mucus overproduction at baseline.   
 
(A) Representative images of PAS staining in airways of Cre- and Cre+ PBS mice at 
P21.  Both Cre- and Cre+ mice were harvested at baseline without allergen exposure.  
Representative image of adult Cre+ PAS stained lung.  Mucin+ cells are marked by 
arrows.  (B)  Representative images of WT mice treated with control liposomes and 
clodronate liposomes.  Scale bar 100 µm.  (C)  CD45+ immune cells were gated for 
SiglecF+ and CD11C+ macrophages.  Macrophage populations compared between control 





accumulation promotes toxicity-mediated apoptosis.  The mechanism of cell death is 
similar to that of diphtheria toxin.  For this experiment, we adjusted clodronate treatment 
to ensure a majority of macrophages survived, as CTMCs account for less than 1% of the 
total lung cell population.  After clodronate macrophage depletion, we observed no 
spontaneous inflammation and lack of mucus overproduction (Figure 5.3B).  To quantify 
clodronate efficiency, we performed flow cytometry on digested lung tissue and observed 
a minimal reduction in macrophage numbers, relative to CTMC proportions (Figure 
5.3C).  Thus, our data suggest that loss of CTMCs promote mucus overproduction and 
was specific to mast cell loss and no other major immune cell types.  
CTMC loss promotes aberrant collagen deposition  
Another aspect of allergic inflammation and asthma, is collagen deposition and 
airway remodeling.  We next evaluated whether spontaneous inflammation in the Cre+ 
mouse also reflected increased levels collagen deposition.  To detect collagen deposition, 
we stained paraffin sections of P21 WT PBS-and-OVA exposed mice and Cre- PBS and 
Cre+ PBS mice with picro Sirius red, a stain that can detect different types of collagen 
through polarized light.  After quantification with ImageJ, we observed significantly 
elevated collagen deposition in WT OVA and Cre+ PBS mice (Figure 5.4A,B).  This 














Figure 5.4:  CTMC depleted mice have increased collagen deposition around 
airways.   
 
(A) Quantification of collagen deposition in PBS-and OVA-exposed WT mice and Cre- 
and Cre+ PBS mice.  Slides were stained with picro Sirius red and imaged via polarized 
light resulting in birefringence of the collagen fibers.  Collagen deposition was quantified 
by dividing the area of collagen by the perimeter of the area via ImageJ.  (B)  
Representative images of Picro Sirius Red staining in PBS-and OVA-exposed WT mice 
and Cre- and Cre+ PBS mice.  Positive collagen is bright orange.  Scale bar 100 µm.  






Spontaneous inflammation from CTMC loss promotes aberrant airway smooth muscle 
(ASM) innervation 
We showed previously, in an early life allergen exposure mouse model, that 
elevated levels of mast cell derived-neurotrophin 4 (NT4), induced ASM and PNEC 
hyperinnervation to cause airway hyperreactivity and mucus overproduction, 
respectively.7,13  Hence, we tested whether IL-33 inflammation, mucus overproduction, 
and collagen deposition, were linked.  Immunostaining of paraffin sections with the 
general nerve marker, β tubulin III using the TuJ1 antibody, of Cre- PBS, Cre- OVA and 
Cre+ PBS revealed increased nerve bundles (marked by arrows) in Cre+ PBS mice 
compared to Cre- PBS control (Figure 5.5A).  Western blot analysis of right caudal lobes 
also revealed increased TUJ1 labeling (Figure 5.5B,C).   
Loss of CTMCs promotes cholinergic airway hyperinnervation   
To determine what type of innervation was changing in the spontaneous mouse 
model of inflammation we tested several nerve markers.  We tested markers of sensory 
and sympathetic innervation including neuropeptide CGRP and tyrosine hydroxylase 
(TH), a marker of sympathetic innervation.  We did not see any significant differences in 
these two nerve markers between Cre- PBS and Cre+ PBS (Figure 5.6A,B).  We have 
shown previously in early life allergen exposure, ASM is hyperrinnervated by cholinergic 
nerves.262  We immunoblotted for VAChT, vesicular acetylcholine transporter, a marker 
of cholinergic nerves.  Compared to Cre- PBS controls, Cre+ mice had significantly 
elevated VAChT levels (Figure 5.6C).  In all, our data suggests that depletion of mast 










Figure 5.5:  CTMC depleted mice have aberrant airway innervation.  
  
(A)  Representative images of immunofluorescence staining of P21 Cre- PBS, Cre- 
OVA, and Cre+ PBS mice for β tubulin III (TuJ1), a pan neuronal marker (red).  Nerve 
bundles are marked by arrows.  Enlarged nerve staining is shown in inserts.  (B)  Right 
caudal lobes were collected for protein extraction and were examined by western blot for 
TuJ1.  GAPDH was loading control. Data were normalized to GAPDH levels for each 






                  
Figure 5.6:  CTMC depleted mice have upregulated cholinergic innervation.   
 
(A)  Right caudal lobes from P21 Cre- PBS, Cre- OVA, and Cre+ PBS mice were 
collected for protein extraction and were examined by Western blot for tyrosine 




sympathetic innervation.   Quantification of western blot data in (A).  (B) 
Immunofluorescence staining of  P21 Cre- PBS and Cre+ PBS mouse lung sections for 
TuJ1(red) and CGRP(green), a marker of sensory innervation.  Double staining is 
displayed in yellow marked by arrowheads.  (C) Western blot for VaCHT, vesicular 
acetylcholine transporter, a marker of cholinergic nerves.  β-actin and GAPDH was 
loading control.  Quantification of western blot data in (C).  Brain was used as a positive 








Loss of NT4 restores immune homeostasis in CTMC depletion model 
Since we showed previously that NT4 depletion rescues ASM and PNEC 
neuroplasticity7 and mucus overproduction13, we wanted to test if NT4 deficiency could 
rescue the Cre+ spontaneous inflammation phenotype.  To test this, we crossed the NT4-/- 
mouse with the Cre+ mouse. Strikingly, NT4-/-;Cre+ mice were completely deficient 
from mucus overproduction, and Il-33 levels returned to baseline (Figure 5.7A-C) .  In 
all, this suggests NT4 has a novel unknown regulation of IL-33 mediated inflammation.   
Spontaneous inflammation in CTMC depletion model induces PNEC hyperinnervation. 
We showed previously early life allergen exposure induced PNEC 
hyperinnervation.13  Therefore, we immunostained thick paraffin sections for TuJ1 and 
CGRP, a PNEC marker.  We showed that the CTMC depleted mast cell mice have 
significantly higher PNEC penetrating nerves compared to the control (Figure 5.8A).  
Shockingly, loss of NT4 not only reversed the spontaneous inflammation phenotype but 
PNEC hyperinnervation was also dramatically reduced (Figure 5.8B).  Collectively, these 
data show the important regulatory function of CTMCs in maintaining lung immune 










Figure 5.7:  Mice with CTMCs depleted of NT4 (NT4-/-;Mcpt5Cre+;Rosa(DTA)+) 
are protected from spontaneous mucus overproduction and IL-33 inflammation.   
 
(A)  Representative images of PAS staining in airways of Cre-, Cre+, NT4-/-;Cre-, and 
NT4-/-;Cre+ PBS mice at P21. All mice were harvested at baseline without allergen 
exposure.  Mucin+ cells are marked by arrows.  (B)  Il-13 mRNA levels in lungs of Cre-, 
Cre+, NT4-/-;Cre-, and NT4-/-;Cre+ PBS mice at P21.  Results were normalized to PBS 
controls.  N=4 for each group.  (C)  Il-33 mRNA levels in lungs of Cre-, Cre+, NT4-/-
;Cre-, and NT4-/-;Cre+ PBS mice at P21.  Results were normalized to PBS controls.  N=5 












Figure 5.8:  CTMC depletion contributes to PNEC hyperinnervation.  Loss of NT4 
diminishes  
 
(A) Representative images of NEBs with penetrating nerves in Cre-, Mcpt5Cre+; 
Rosa(DTA)+, and NT4-/-; Mcpt5Cre+; Rosa(DTA)+ mice at P21 baseline. Scale bar, 
25µm. (B) Quantification of NEB innervation density. Density of nerves was calculated 
by normalizing TuJ1-immunoreactive area by number of cells within NEBs in Cre-, 
Mcpt5Cre+; Rosa(DTA)+, and NT4-/-; Mcpt5Cre+; Rosa(DTA)+ mice at P21 baseline.  
For data in A-B, total of 50+ NEBs in thick 25 µm paraffin sections from 3 mice were 






The findings presented here show a possible role of connective tissue mast cells in 
maintaining pulmonary immunity homeostasis.  We propose that loss of CTMCs promote 
spontaneous IL-33 mediated inflammation to induce collagen deposition, aberrant ASM 
and PNEC innervation, and mucus overproduction (Figure 5.9).   Additionally, we show 
that NT4 orchestrates this process, as with the loss of NT4, the spontaneous inflammation 
phenotype is reversed.   
 Over time, we see dynamic mast cell development that we can efficiently trace.  
To study the function of these resident CTMCs, we depleted the mast cells with 
constitutive diphtheria toxin expression.  Depletion of mast cells induce spontaneous 
neutrophilic inflammation which is mediated by IL-33.  Allergen exposure in an early life 
mouse model of asthma elevates the levels of NT4 through the recruitment of mast cells.8  
Notably in this CTMC depletion model, we also observe significant increases of 
pulmonary mast cell numbers.  The elevated levels of NT4 cause the aberrant increases of 
ASM and PNEC innervation.  Our findings, combined with our previous work on early 
life allergen exposure promotion of ASM and PNEC hyperinnervation, highlight a new 
role for CTMCs in maintaining orderly lung innervation and an orchestrating role of NT4 
in promoting IL-33 mediated inflammation in this context. In addition, whether the 
CTMC depletion phenotype is age specific remains to be investigated.  Future 
experiments include depleting CTMC in adult life by crossing Mcpt5Cre+ mice to 











Figure 5.9:  Model of CTMC depletion in early life.  CTMCs normally reside in the 
lung at baseline conditions.  
 
Mucosal mast cells,  (MCMCs) however, are recruited under inflammatory conditions.  
Without CTMCs, mice develop spontaneous neutrophilic inflammation, increased IL-33 
inflammation, aberrant cholinergic airway innervation, and finally mucus overproduction.  
The depletion of CTMCs in the lung, prompt recruitment of MCMCs, which amplify the 
inflammation response.  Recruited mast cells bring in elevated levels of Neurotrophin 4 
(NT4), a neurotrophin required for airway hyperinnervation and airway hyperreactivity.  





 Here, spontaneous inflammation and thus mast cell recruitment cause aberrant 
innervation of ASM and PNECs.  This might occur through the multifaceted roles of IL-
33.  Mast cells have been shown to secrete and respond to IL-33, and others have shown 
that mast cell tryptase has the ability to cleave IL-33 to its most pathogenic form.263,264  It 
is possible that the recruited mast cells might be contributing to the elevated levels as the 
numbers of mast cells are significantly increased in the Cre+ mice compared to the Cre-  
mice.  It is also possible that resident CTMCs contribute to elevated IL-2 levels, which 
has been shown to be critical for regulatory T cell expansion, which then inhibit innate 
lymphoid cell 2 (ILC2) expansion and IL-13 production.257  
 Elevated levels of IL-33 might also be coming from damaged epithelial cells due 
to the resulting inflammation in the CTMC mouse model.252  As to what other cell types 
and if their numbers are changing, remains to be explored.  It is possible that the loss of 
this specific niche is also affecting the development and numbers of these other cells.  
While IL-33 inflammation is upregulated in this model, it is unclear whether IL-33 is 
promoting this phenotype or is a result of the spontaneous inflammation.  Notably, loss of 
NT4 completely ablates spontaneous inflammation in the CTMC loss model.  However, 
whether or how NT4 regulates IL-33 or inflammation is not known.  We postulate that 
NT4 might be required for processing or maturation of elevated IL-33, as both IL-33 and 
NT4 are found in mast cells.  We also showed previously, in an early life mouse model of 
allergen exposure, that PNEC hyperinnervation contributes to elevated GABA signaling 




that mucus overproduction in this model is derived from aberrant GABA signaling, but 
this remains to be confirmed.   
  In summary, our study provides evidence that the CTMC are important for 
regulating baseline immunity early in development. We show that NT4 is critical for 
establishing this phenotype as the spontaneous inflammation can be reversed.  Thus, 








The work presented here illustrates a novel role of PNEC function and secretion 
through neural regulation (Figure 3.6).  Our studies delineate the roles of NT4-regulation 
of PNEC function over the course of lung development and disease.  Initially, we showed 
that elevated levels of mast cell derived-NT4 contributed to neonatal lung neuroplasticity 
and AHR.7,8  Next, we observed with genetic disruption of NT4, mice lacked mucus 
overproduction after early life allergen exposure (Figure 3.1).  We tested a series of 
neurotransmitters and identified GABA as a candidate that could induce mucus 
overproduction in OVA-exposed mouse lung slices (Figure 3.1G).  We next identified 
PNECs as the sole source of GABA in the airways and that GABA was required for 
mucus overproduction (Figure 3.2A,E).  We next sought out to determine what 
established PNEC innervation.  We discovered that PNECs expressed NT4, and 
depended on the trophic factor for PNEC innervation during postnatal development 
(Figure 3.3).  Further we showed aberrant PNEC innervation after early life allergen 
exposure required elevated levels of NT4 (Figure 3.3F).  Most of PNEC innervating 
nerves come from the nodose ganglion and express ATP responsive P2X receptors.  
Since elevated levels of NT4 contributed to PNEC hyperinnervation we next looked if 
NT4 had any effects on sensory neuron hyperactivity.  Treatment with NT4 indeed 
increased the activity of sensory neurons to ATP (Figure 3.4F).  As a result of 
hyperinnervation and hyperactivity, PNECs secreted abnormal levels of GABA to induce 




innervation, the efferent signal that triggers GABA secretion from PNECs requires future 
studies. We further investigated the GABAergic mechanism in human ALI, and 
discovered that in addition to IL-13 signaling, GABA was required for goblet cell 
proliferation (Figure 4.4B).  We show for the first time, that IL-13 mediated goblet cell 
proliferation requires GABA signaling as IL-13 alone is not sufficient.  We are the first to 
demonstrate that IL-13 requires GABA signaling to induce goblet cell proliferation.   Our 
work also highlights important conserved mechanisms between mice, non-human 
primates, and humans, and emphasizes the importance these studies might have on 
neuroendocrine disorders in humans such as neuroendocrine cell hyperplasia (NEHI) and 
small cell lung cancer (SCLC).  These exciting new data open new avenues to study the 
nervous system and its role in regulating inflammation.   
We showed previously that mast cells are an essential source of elevated NT4 
levels after early life allergen exposure.8  To investigate the role of non-recruited resident 
mast cells during lung development and allergic disease, we utilized Mcpt5-Cre 
transgenic mice where Cre was expressed selectively by connective tissue mast cells.  We 
find that depletion of resident mast cells induces spontaneous inflammation (Figure 5.2) 
and neuroplasticity (Figure 5.5).  We find here that NT4 deficiency completely reverses 
these phenotypes (Figure 5.7).  Future studies are required to better understand the role of 
NTs in asthma pathophysiology and to evaluate whether NTs and their receptors may 
serve as new drug targets. Together, these studies suggest a novel role of neurotrophins in 




Overall, the data presented here highlight a fundamental role of the nervous 
system in regulating PNEC function and mucus secretion in allergic disease.  Finally, 
with this discovery of neural regulation of mucus overproduction, there are new avenues 









1. Cardoso, W.V. & Lu, J. Regulation of early lung morphogenesis: questions, facts and 
controversies. Development 133, 1611-1624 (2006). 
2. Aven, L. & Ai, X. Mechanisms of respiratory innervation during embryonic 
development. Organogenesis 9, 194-198 (2013). 
3. Dakhama, A., et al. Alteration of airway neuropeptide expression and development of 
airway hyperresponsiveness following respiratory syncytial virus infection. American 
Journal Physiology Lung Cellular Molecular Physiology 288, L761-770 (2005). 
4. Jackson, D.J., et al. Wheezing rhinovirus illnesses in early life predict asthma 
development in high-risk children. American Journal of Respiratory and Critical 
Care Medicine 178, 667-672 (2008). 
5. Tortorolo, L., et al. Neurotrophin overexpression in lower airways of infants with 
respiratory syncytial virus infection. American Journal of Respiratory and Critical 
Care Medicine 172, 233-237 (2005). 
6. Barrios, J. & Ai, X. Neurotrophins in Asthma. Current Allergy and Asthma Reports 
18, 10 (2018). 
7. Aven, L., et al. An NT4/TrkB-dependent increase in innervation links early-life 
allergen exposure to persistent airway hyperreactivity. FASEB Journal 28, 897-907 
(2014). 
8. Patel, K.R., et al. Mast cell-derived neurotrophin 4 mediates allergen-induced airway 
hyperinnervation in early life. Mucosal Immunology 9, 1466-1476 (2016). 
9. Fahy, J.V. & Dickey, B.F. Airway mucus function and dysfunction. New England 
Journal of Medicine 363, 2233-2247 (2010). 
10. Xiang, Y.Y., et al. A GABAergic system in airway epithelium is essential for mucus 
overproduction in asthma. Nature Medicine 13, 862-867 (2007). 
11. Herriges, M. & Morrisey, E.E. Lung development: orchestrating the generation and 
regeneration of a complex organ. Development 141, 502-513 (2014). 
12. Langsdorf, A., Radzikinas, K., Kroten, A., Jain, S. & Ai, X. Neural crest cell origin 
and signals for intrinsic neurogenesis in the mammalian respiratory tract. American 




13. Barrios, J., et al. Early life allergen-induced mucus overproduction requires 
augmented neural stimulation of pulmonary neuroendocrine cell secretion. FASEB 
Journal 31, 4117-4128 (2017). 
14. Patel, K.R., Bai, Y., Trieu, K.G., Barrios, J. & Ai, X. Targeting acetylcholine receptor 
M3 prevents the progression of airway hyperreactivity in a mouse model of childhood 
asthma. FASEB J (2017). 
15. Wenzel, S.E. Asthma phenotypes: the evolution from clinical to molecular 
approaches. Nature Medicine 18, 716-725 (2012). 
16. Wills-Karp, M., et al. Interleukin-13: central mediator of allergic asthma. Science 
282, 2258-2261 (1998). 
17. Chavan, S.S., Pavlov, V.A. & Tracey, K.J. Mechanisms and Therapeutic Relevance 
of Neuro-immune Communication. Immunity 46, 927-942 (2017). 
18. Stern, D.A., Morgan, W.J., Halonen, M., Wright, A.L. & Martinez, F.D. Wheezing 
and bronchial hyper-responsiveness in early childhood as predictors of newly 
diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 372, 
1058-1064 (2008). 
19. Guilbert, T.W., et al. Decreased lung function after preschool wheezing rhinovirus 
illnesses in children at risk to develop asthma. Journal of Allergy and Clinical 
Immunology 128, 532-538.e531-510 (2011). 
20. Young, S., et al. The influence of a family history of asthma and parental smoking on 
airway responsiveness in early infancy. New England Journal of Medicine 324, 1168-
1173 (1991). 
21. Latzin, P., Roosli, M., Huss, A., Kuehni, C.E. & Frey, U. Air pollution during 
pregnancy and lung function in newborns: a birth cohort study. European Respiratory 
Journal 33, 594-603 (2009). 
22. Turner, S., et al. A longitudinal study of lung function from 1 month to 18 years of 
age. Thorax 69, 1015-1020 (2014). 
23. Szefler, S.J., et al. Characterization of within-subject responses to fluticasone and 
montelukast in childhood asthma. Journal of Allergy and Clinical Immunology 115, 
233-242 (2005). 
24. van Asperen Peter, P., Mellis, C.M. & Sly, P.D. The role of corticosteroids in the 




25. Van Asperen, P.P., Mellis, C.M., Sly, P.D. & Robertson, C.F. Evidence-based asthma 
management in children--what's new? Medical Journal of Australia 194, 383-384 
(2011). 
26. Gauthier, M., Ray, A. & Wenzel, S.E. Evolving Concepts of Asthma. American 
Journal of Respiratory and Critical Care Medicine 192, 660-668 (2015). 
27. Corren, J., et al. A randomized, controlled, phase 2 study of AMG 317, an IL-
4Ralpha antagonist, in patients with asthma. American Journal of Respiratory and 
Critical Care Medicine 181, 788-796 (2010). 
28. Flood-Page, P., et al. A study to evaluate safety and efficacy of mepolizumab in 
patients with moderate persistent asthma. American Journal of Respiratory and 
Critical Care Medicine 176, 1062-1071 (2007). 
29. Sheehan, J.K., Richardson, P.S., Fung, D.C., Howard, M. & Thornton, D.J. Analysis 
of respiratory mucus glycoproteins in asthma: a detailed study from a patient who 
died in status asthmaticus. American Journal of Respiratory Cell and Molecular 
Biology 13, 748-756 (1995). 
30. Innes, A.L., et al. Ex vivo sputum analysis reveals impairment of protease-dependent 
mucus degradation by plasma proteins in acute asthma. American Journal of 
Respiratory and Critical Care Medicine 180, 203-210 (2009). 
31. Kuyper, L.M., et al. Characterization of airway plugging in fatal asthma. The 
American Journal of Medicine 115, 6-11 (2003). 
32. Aikawa, T., Shimura, S., Sasaki, H., Ebina, M. & Takishima, T. Marked Goblet Cell 
Hyperplasia with Mucus Accumulation in the Airways of Patients Who Died of 
Severe Acute Asthma Attack. Chest 101, 916-921 (1992). 
33. Evans, C.M., Kim, K., Tuvim, M.J. & Dickey, B.F. Mucus hypersecretion in asthma: 
causes and effects. Current Opinion in Pulmonary Medicine 15, 4-11 (2009). 
34. Evans, C.M. & Koo, J.S. Airway mucus: the good, the bad, the sticky. Pharmacology 
and Therapeutics 121, 332-348 (2009). 
35. Curran, D.R. & Cohn, L. Advances in mucous cell metaplasia: a plug for mucus as a 
therapeutic focus in chronic airway disease. American Journal of Respiratory Cell 
and Molecular Biology 42, 268-275 (2010). 
36. Chen, Y., Zhao, Y.H., Di, Y.P. & Wu, R. Characterization of human mucin 5B gene 
expression in airway epithelium and the genomic clone of the amino-terminal and 5'-





37. Evans, C.M., et al. Mucin is produced by clara cells in the proximal airways of 
antigen-challenged mice. American Journal of Respiratory Cell and Molecular 
Biology 31, 382-394 (2004). 
38. Reader, J.R., et al. Pathogenesis of mucous cell metaplasia in a murine asthma model. 
American Journal of Pathology 162, 2069-2078 (2003). 
39. Young, H.W., et al. Central role of Muc5ac expression in mucous metaplasia and its 
regulation by conserved 5' elements. American Journal of Respiratory Cell and 
Molecular Biology 37, 273-290 (2007). 
40. Roy, M.G., et al. Muc5b is required for airway defence. Nature 505, 412-416 (2014). 
41. Kirkham, S., Sheehan, J.K., Knight, D., Richardson, P.S. & Thornton, D.J. 
Heterogeneity of airways mucus: variations in the amounts and glycoforms of the 
major oligomeric mucins MUC5AC and MUC5B. Biochemical Journal 361, 537-546 
(2002). 
42. Zuhdi Alimam, M., et al. Muc-5/5ac mucin messenger RNA and protein expression is 
a marker of goblet cell metaplasia in murine airways. American Journal of 
Respiratory Cell and Molecular Biology 22, 253-260 (2000). 
43. Evans, C.M., et al. The polymeric mucin Muc5ac is required for allergic airway 
hyperreactivity. Nat Commun 6, 6281 (2015). 
44. Shimura, S., Andoh, Y., Haraguchi, M. & Shirato, K. Continuity of airway goblet 
cells and intraluminal mucus in the airways of patients with bronchial asthma. 
European Respiratory Journal 9, 1395-1401 (1996). 
45. Ordonez, C.L., et al. Mild and moderate asthma is associated with airway goblet cell 
hyperplasia and abnormalities in mucin gene expression. American Journal of 
Respiratory and Critical Care Medicine 163, 517-523 (2001). 
46. Chen, G., et al. SPDEF is required for mouse pulmonary goblet cell differentiation 
and regulates a network of genes associated with mucus production. Journal of 
Clinical Investigation 119, 2914-2924 (2009). 
47. Pardo-Saganta, A., Law, B.M., Gonzalez-Celeiro, M., Vinarsky, V. & Rajagopal, J. 
Ciliated cells of pseudostratified airway epithelium do not become mucous cells after 
ovalbumin challenge. American Journal of Respiratory Cell and Molecular Biology 
48, 364-373 (2013). 
48. Grunig, G., et al. Requirement for IL-13 independently of IL-4 in experimental 




49. Kuperman, D.A., et al. Direct effects of interleukin-13 on epithelial cells cause 
airway hyperreactivity and mucus overproduction in asthma. Nature Medicine 8, 885-
889 (2002). 
50. Atherton, H.C., Jones, G. & Danahay, H. IL-13-induced changes in the goblet cell 
density of human bronchial epithelial cell cultures: MAP kinase and 
phosphatidylinositol 3-kinase regulation. American Journal of Physiology: Lung 
Cellular and Molecular Physiology 285, L730-739 (2003). 
51. Mathew, A., et al. Signal transducer and activator of transcription 6 controls 
chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary 
inflammation. Journal of Experimental Medicine 193, 1087-1096 (2001). 
52. Whitsett, J.A. & Alenghat, T. Respiratory epithelial cells orchestrate pulmonary 
innate immunity. Nature Immunology 16, 27-35 (2015). 
53. Rajavelu, P., et al. Airway epithelial SPDEF integrates goblet cell differentiation and 
pulmonary Th2 inflammation. Journal of Clinical Investigation 125, 2021-2031 
(2015). 
54. Chen, G., et al. Foxa3 induces goblet cell metaplasia and inhibits innate antiviral 
immunity. American Journal of Respiratory and Critical Care Medicine 189, 301-
313 (2014). 
55. Bu, D.F., et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa 
GAD, are each encoded by a single gene. Proceedings of the National Academy of 
Sciences of the United States of America 89, 2115-2119 (1992). 
56. Wojcik, S.M., et al. A shared vesicular carrier allows synaptic corelease of GABA 
and glycine. Neuron 50, 575-587 (2006). 
57. Bibel, M. & Barde, Y.A. Neurotrophins: key regulators of cell fate and cell shape in 
the vertebrate nervous system. Genes and Development 14, 2919-2937 (2000). 
58. Chao, M.V. Neurotrophins and their receptors: a convergence point for many 
signalling pathways. Nature Reviews: Neuroscience 4, 299-309 (2003). 
59. Barbacid, M. The Trk family of neurotrophin receptors. Journal of Neurobiology 25, 
1386-1403 (1994). 
60. Bibel, M., Hoppe, E. & Barde, Y.A. Biochemical and functional interactions between 




61. Braun, A., et al. Cellular sources of enhanced brain-derived neurotrophic factor 
production in a mouse model of allergic inflammation. American Journal of 
Respiratory Cell and Molecular Biology 21, 537-546 (1999). 
62. Prakash, Y.S., Iyanoye, A., Ay, B., Mantilla, C.B. & Pabelick, C.M. Neurotrophin 
effects on intracellular Ca2+ and force in airway smooth muscle. American Journal of 
Physiology: Lung Cellular and Molecular Physiology 291, L447-456 (2006). 
63. Levi-Montalcini, R. The nerve growth factor 35 years later. Science 237, 1154-1162 
(1987). 
64. Ehrhard, P.B., Erb, P., Graumann, U. & Otten, U. Expression of nerve growth factor 
and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell 
clones. Proceedings of the National Academy of Sciences of the United States of 
America 90, 10984-10988 (1993). 
65. Nilsson, G., et al. Human mast cells express functional TrkA and are a source of 
nerve growth factor. European Journal of Immunology 27, 2295-2301 (1997). 
66. Ehrhard, P.B., Ganter, U., Stalder, A., Bauer, J. & Otten, U. Expression of functional 
trk protooncogene in human monocytes. Proceedings of the National Academy of 
Sciences of the United States of America 90, 5423-5427 (1993). 
67. Noga, O., et al. Activation of the specific neurotrophin receptors TrkA, TrkB and 
TrkC influences the function of eosinophils. Clinical and Experimental Allergy 32, 
1348-1354 (2002). 
68. Hahn, C., Islamian, A.P., Renz, H. & Nockher, W.A. Airway epithelial cells produce 
neurotrophins and promote the survival of eosinophils during allergic airway 
inflammation. Journal of Allergy and Clinical Immunology 117, 787-794 (2006). 
69. Ogawa, H., et al. Nerve growth factor derived from bronchial epithelium after chronic 
mite antigen exposure contributes to airway hyperresponsiveness by inducing 
hyperinnervation, and is inhibited by in vivo siRNA. Clinical and Experimental 
Allergy 42, 460-470 (2012). 
70. Hamada, A., Watanabe, N., Ohtomo, H. & Matsuda, H. Nerve growth factor enhances 
survival and cytotoxic activity of human eosinophils. British Journal of Haematology 
93, 299-302 (1996). 
71. Horigome, K., Pryor, J.C., Bullock, E.D. & Johnson, E.M., Jr. Mediator release from 
mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. 




72. Bischoff, S.C. & Dahinden, C.A. Effect of nerve growth factor on the release of 
inflammatory mediators by mature human basophils. Blood 79, 2662-2669 (1992). 
73. Torcia, M., et al. Nerve growth factor is an autocrine survival factor for memory B 
lymphocytes. Cell 85, 345-356 (1996). 
74. Kawamoto, K., et al. Nerve growth factor prevents apoptosis of rat peritoneal mast 
cells through the trk proto-oncogene receptor. Blood 86, 4638-4644 (1995). 
75. Hu, C., Wedde-Beer, K., Auais, A., Rodriguez, M.M. & Piedimonte, G. Nerve growth 
factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. 
American Journal of Physiology: Lung Cellular and Molecular Physiology 283, 
L494-502 (2002). 
76. Wu, Z.X., Hunter, D.D., Batchelor, T.P. & Dey, R.D. Side-stream tobacco smoke-
induced airway hyperresponsiveness in early postnatal period is involved nerve 
growth factor. Respiratory Physiology & Neurobiology 223, 1-8 (2016). 
77. Path, G., et al. Augmentation of allergic early-phase reaction by nerve growth factor. 
American Journal of Respiratory and Critical Care Medicine 166, 818-826 (2002). 
78. Hoyle, G.W., et al. Hyperinnervation of the airways in transgenic mice 
overexpressing nerve growth factor. American Journal of Respiratory Cell and 
Molecular Biology 18, 149-157 (1998). 
79. Chen, Y.L., Huang, H.Y., Lee, C.C. & Chiang, B.L. Small interfering RNA targeting 
nerve growth factor alleviates allergic airway hyperresponsiveness. Mol Ther Nucleic 
Acids 3, e158 (2014). 
80. Piedimonte, G., Rodriguez, M.M., King, K.A., McLean, S. & Jiang, X. Respiratory 
syncytial virus upregulates expression of the substance P receptor in rat lungs. 
American Journal of Physiology 277, L831-840 (1999). 
81. Piedimonte, G. Neural mechanisms of respiratory syncytial virus-induced 
inflammation and prevention of respiratory syncytial virus sequelae. American 
Journal of Respiratory and Critical Care Medicine 163, S18-21 (2001). 
82. Graham, R.M., Friedman, M. & Hoyle, G.W. Sensory nerves promote ozone-induced 
lung inflammation in mice. American Journal of Respiratory and Critical Care 
Medicine 164, 307-313 (2001). 
83. Bonini, S., et al. Circulating nerve growth factor levels are increased in humans with 
allergic diseases and asthma. Proceedings of the National Academy of Sciences of the 




84. Szczepankiewicz, A., et al. Neurotrophin serum concentrations and polymorphisms 
of neurotrophins and their receptors in children with asthma. Respiratory Medicine 
107, 30-36 (2013). 
85. Radzikinas, K., et al. A Shh/miR-206/BDNF cascade coordinates innervation and 
formation of airway smooth muscle. Journal of Neuroscience 31, 15407-15415 
(2011). 
86. Tam, S.Y., et al. Expression of functional TrkA receptor tyrosine kinase in the HMC-
1 human mast cell line and in human mast cells. Blood 90, 1807-1820 (1997). 
87. Pruunsild, P., Kazantseva, A., Aid, T., Palm, K. & Timmusk, T. Dissecting the human 
BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. 
Genomics 90, 397-406 (2007). 
88. Prakash, Y.S. & Martin, R.J. Brain-derived neurotrophic factor in the airways. 
Pharmacology and Therapeutics 143, 74-86 (2014). 
89. Pang, P.T., et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term 
hippocampal plasticity. Science 306, 487-491 (2004). 
90. Lee, F.S. & Chao, M.V. Activation of Trk neurotrophin receptors in the absence of 
neurotrophins. Proceedings of the National Academy of Sciences of the United States 
of America 98, 3555-3560 (2001). 
91. Vohra, P.K., et al. TRPC3 regulates release of brain-derived neurotrophic factor from 
human airway smooth muscle. Biochimica et Biophysica Acta 1833, 2953-2960 
(2013). 
92. Aravamudan, B., Thompson, M.A., Pabelick, C.M. & Prakash, Y.S. Mechanisms of 
BDNF regulation in asthmatic airway smooth muscle. American Journal of 
Physiology: Lung Cellular and Molecular Physiology 311, L270-279 (2016). 
93. Watanabe, T., et al. Brain-Derived Neurotrophic Factor Expression in Asthma. 
Association with Severity and Type 2 Inflammatory Processes. American Journal of 
Respiratory Cell and Molecular Biology 53, 844-852 (2015). 
94. Virchow, J.C., et al. Neurotrophins are increased in bronchoalveolar lavage fluid after 
segmental allergen provocation. American Journal of Respiratory and Critical Care 
Medicine 158, 2002-2005 (1998). 
95. Jesenak, M., Babusikova, E., Evinova, A., Banovcin, P. & Dobrota, D. Val66Met 
polymorphism in the BDNF gene in children with bronchial asthma. Pediatric 




96. Egan, M.F., et al. The BDNF val66met polymorphism affects activity-dependent 
secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269 
(2003). 
97. Szczepankiewicz, A., et al. Multilocus analysis of candidate genes involved in 
neurogenic inflammation in pediatric asthma and related phenotypes: a case-control 
study. Journal of Asthma 49, 329-335 (2012). 
98. Ernfors, P., Lee, K.F. & Jaenisch, R. Mice lacking brain-derived neurotrophic factor 
develop with sensory deficits. Nature 368, 147-150 (1994). 
99. Ernfors, P., Lee, K.F., Kucera, J. & Jaenisch, R. Lack of neurotrophin-3 leads to 
deficiencies in the peripheral nervous system and loss of limb proprioceptive 
afferents. Cell 77, 503-512 (1994). 
100. Pan, J., Rhode, H.K., Undem, B.J. & Myers, A.C. Neurotransmitters in airway 
parasympathetic neurons altered by neurotrophin-3 and repeated allergen challenge. 
American Journal of Respiratory Cell and Molecular Biology 43, 452-457 (2010). 
101. Szczepankiewicz, A., et al. Serum neurotrophin-3 and neurotrophin-4 levels are 
associated with asthma severity in children. European Respiratory Journal 39, 1035-
1037 (2012). 
102. Schnorbusch, K., et al. GABAergic signaling in the pulmonary neuroepithelial body 
microenvironment: functional imaging in GAD67-GFP mice. Histochemistry and 
Cell Biology 140, 549-566 (2013). 
103. Kerzel, S., et al. Pan-neurotrophin receptor p75 contributes to neuronal 
hyperreactivity and airway inflammation in a murine model of experimental asthma. 
American Journal of Respiratory Cell and Molecular Biology 28, 170-178 (2003). 
104. Tollet, J., Everett, A.W. & Sparrow, M.P. Spatial and temporal distribution of nerves, 
ganglia, and smooth muscle during the early pseudoglandular stage of fetal mouse 
lung development. Developmental Dynamics 221, 48-60 (2001). 
105. Burgi, B., et al. Basophil priming by neurotrophic factors. Activation through the trk 
receptor. Journal of Immunology 157, 5582-5588 (1996). 
106. Nassenstein, C., et al. Neuroimmune crosstalk in asthma: dual role of the 
neurotrophin receptor p75NTR. Journal of Allergy and Clinical Immunology 120, 
1089-1096 (2007). 
107. Dobrowsky, R.T. & Carter, B.D. Coupling of the p75 neurotrophin receptor to 





108. Larson, S.D., et al. Postnatal remodeling of the neural components of the epithelial-
mesenchymal trophic unit in the proximal airways of infant rhesus monkeys exposed 
to ozone and allergen. Toxicology and Applied Pharmacology 194, 211-220 (2004). 
109. Linnoila, R.I. Functional facets of the pulmonary neuroendocrine system. Laboratory 
Investigation 86, 425-444 (2006). 
110. Sommer, L., Shah, N., Rao, M. & Anderson, D.J. The cellular function of MASH1 in 
autonomic neurogenesis. Neuron 15, 1245-1258 (1995). 
111. Borges, M., et al. An achaete-scute homologue essential for neuroendocrine 
differentiation in the lung. Nature 386, 852-855 (1997). 
112. Linnoila, R.I., et al. Constitutive achaete-scute homologue-1 promotes airway 
dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Research 60, 
4005-4009 (2000). 
113. Tsao, P.N., et al. Notch signaling controls the balance of ciliated and secretory cell 
fates in developing airways. Development 136, 2297-2307 (2009). 
114. Kotton, D.N. & Morrisey, E.E. Lung regeneration: mechanisms, applications and 
emerging stem cell populations. Nature Medicine 20, 822-832 (2014). 
115. Artavanis-Tsakonas, S. & Simpson, P. Choosing a cell fate: a view from the Notch 
locus. Trends in Genetics 7, 403-408 (1991). 
116. Ito, T., et al. Basic helix-loop-helix transcription factors regulate the neuroendocrine 
differentiation of fetal mouse pulmonary epithelium. Development 127, 3913-3921 
(2000). 
117. Boers, J.E., Ambergen, A.W. & Thunnissen, F.B. Number and proliferation of clara 
cells in normal human airway epithelium. American Journal of Respiratory and 
Critical Care Medicine 159, 1585-1591 (1999). 
118. Li, K., Nagalla, S.R. & Spindel, E.R. A rhesus monkey model to characterize the role 
of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of 
airway growth. Journal of Clinical Investigation 94, 1605-1615 (1994). 
119. Emanuel, R.L., et al. Bombesin-like peptides and receptors in normal fetal baboon 
lung: roles in lung growth and maturation. American Journal of Physiology 277, 
L1003-1017 (1999). 
120. Branchfield, K., et al. Pulmonary neuroendocrine cells function as airway sensors to 




121. Kuo, C.S. & Krasnow, M.A. Formation of a Neurosensory Organ by Epithelial Cell 
Slithering. Cell 163, 394-405 (2015). 
122. Cutz, E., Pan, J., Yeger, H., Domnik, N.J. & Fisher, J.T. Recent advances and 
contraversies on the role of pulmonary neuroepithelial bodies as airway sensors. 
Seminars in Cell and Developmental Biology 24, 40-50 (2013). 
123. De Proost, I., et al. Purinergic signaling in the pulmonary neuroepithelial body 
microenvironment unraveled by live cell imaging. FASEB Journal 23, 1153-1160 
(2009). 
124. Cutz, E. Neuroendocrine cells of the lung. An overview of morphologic 
characteristics and development. Experimental Lung Research 3, 185-208 (1982). 
125. Brouns, I., et al. Neurochemical pattern of the complex innervation of neuroepithelial 
bodies in mouse lungs. Histochemistry and Cell Biology 131, 55-74 (2009). 
126. Van Lommel, A., Lauweryns, J.M. & Berthoud, H.R. Pulmonary neuroepithelial 
bodies are innervated by vagal afferent nerves: an investigation with in vivo 
anterograde DiI tracing and confocal microscopy. Anatomy and Embryology 197, 
325-330 (1998). 
127. Adriaensen, D., et al. Pulmonary intraepithelial vagal nodose afferent nerve terminals 
are confined to neuroepithelial bodies: an anterograde tracing and confocal 
microscopy study in adult rats. Cell and Tissue Research 293, 395-405 (1998). 
128. Adriaensen, D., Brouns, I. & Timmermans, J.P. Sensory input to the central nervous 
system from the lungs and airways: A prominent role for purinergic signalling via 
P2X2/3 receptors. Autonomic Neuroscience 191, 39-47 (2015). 
129. Lembrechts, R., et al. Neuroepithelial bodies as mechanotransducers in the 
intrapulmonary airway epithelium: involvement of TRPC5. American Journal of 
Respiratory Cell and Molecular Biology 47, 315-323 (2012). 
130. Brouns, I., Van Genechten, J., Scheuermann, D.W., Timmermans, J.P. & Adriaensen, 
D. Neuroepithelial bodies: a morphologic substrate for the link between neuronal 
nitric oxide and sensitivity to airway hypoxia? Journal of Comparative Neurology 
449, 343-354 (2002). 
131. Cutz, E. & Jackson, A. Neuroepithelial bodies as airway oxygen sensors. Respiration 
Physiology 115, 201-214 (1999). 




133. Gonzalez, C., Almaraz, L., Obeso, A. & Rigual, R. Oxygen and acid chemoreception 
in the carotid body chemoreceptors. Trends in Neurosciences 15, 146-153 (1992). 
134. Van Lommel, A. & Lauweryns, J.M. Postnatal development of the pulmonary 
neuroepithelial bodies in various animal species. Journal of the Autonomic Nervous 
System 65, 17-24 (1997). 
135. Fu, X.W., Nurse, C.A., Wang, Y.T. & Cutz, E. Selective modulation of membrane 
currents by hypoxia in intact airway chemoreceptors from neonatal rabbit. Journal of 
Physiology 514 ( Pt 1), 139-150 (1999). 
136. Fu, X.W., Nurse, C.A., Wong, V. & Cutz, E. Hypoxia-induced secretion of serotonin 
from intact pulmonary neuroepithelial bodies in neonatal rabbit. Journal of 
Physiology 539, 503-510 (2002). 
137. Fu, X.W., et al. Neuroepithelial bodies in mammalian lung express functional 
serotonin type 3 receptor. American Journal of Physiology: Lung Cellular and 
Molecular Physiology 281, L931-940 (2001). 
138. Pan, J., Copland, I., Post, M., Yeger, H. & Cutz, E. Mechanical stretch-induced 
serotonin release from pulmonary neuroendocrine cells: implications for lung 
development. American Journal of Physiology: Lung Cellular and Molecular 
Physiology 290, L185-193 (2006). 
139. van Meerbeeck, J.P., Fennell, D.A. & De Ruysscher, D.K. Small-cell lung cancer. 
Lancet 378, 1741-1755 (2011). 
140. Park, K.S., et al. Characterization of the cell of origin for small cell lung cancer. Cell 
Cycle 10, 2806-2815 (2011). 
141. Song, H., et al. Functional characterization of pulmonary neuroendocrine cells in lung 
development, injury, and tumorigenesis. Proceedings of the National Academy of 
Sciences of the United States of America 109, 17531-17536 (2012). 
142. Young, L.R., et al. Neuroendocrine cell distribution and frequency distinguish 
neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest 
139, 1060-1071 (2011). 
143. Johnson, D.E., Anderson, W.R. & Burke, B.A. Pulmonary neuroendocrine cells in 
pediatric lung disease: alterations in airway structure in infants with 





144. Sunday, M.E., Kaplan, L.M., Motoyama, E., Chin, W.W. & Spindel, E.R. Gastrin-
releasing peptide (mammalian bombesin) gene expression in health and disease. 
Laboratory Investigation 59, 5-24 (1988). 
145. Popler, J., et al. Familial neuroendocrine cell hyperplasia of infancy. Pediatric 
Pulmonology 45, 749-755 (2010). 
146. Davies, S.J., et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an 
under-recognised spectrum of disease. Thorax 62, 248-252 (2007). 
147. Kantarci, S. & Donahoe, P.K. Congenital diaphragmatic hernia (CDH) etiology as 
revealed by pathway genetics. American Journal of Medical Genetics. Part C: 
Seminars in Medical Genetics 145c, 217-226 (2007). 
148. Wills-Karp, M., et al. Interleukin-13: Central Mediator of Allergic Asthma. Science 
282, 2258-2261 (1998). 
149. Fu, X.W., Wood, K. & Spindel, E.R. Prenatal nicotine exposure increases GABA 
signaling and mucin expression in airway epithelium. American Journal of 
Respiratory Cell and Molecular Biology 44, 222-229 (2011). 
150. Maddox, L. & Schwartz, D.A. The pathophysiology of asthma. Annual Review of 
Medicine 53, 477-498 (2002). 
151. Stern, D.A., Morgan, W.J., Halonen, M., Wright, A.L. & Martinez, F.D. Wheezing 
and bronchial hyper-responsiveness in early childhood as predictors of newly 
diagnosed asthma in early adulthood: a longitudinal birth-cohort study. The Lancet 
372, 1058-1064 (2008). 
152. Guilbert, T.W., et al. Long-term inhaled corticosteroids in preschool children at high 
risk for asthma. New England Journal of Medicine 354, 1985-1997 (2006). 
153. Dakhama, A., et al. Alteration of airway neuropeptide expression and development of 
airway hyperresponsiveness following respiratory syncytial virus infection. American 
Journal of Physiology: Lung Cellular and Molecular Physiology 288, L761-770 
(2005). 
154. Yu, M., Zheng, X., Peake, J., Joad, J.P. & Pinkerton, K.E. Perinatal environmental 
tobacco smoke exposure alters the immune response and airway innervation in infant 
primates. Journal of Allergy and Clinical Immunology 122, 640-647 e641 (2008). 
155. Wu, Z.X., et al. Prenatal and early, but not late, postnatal exposure of mice to 
sidestream tobacco smoke increases airway hyperresponsiveness later in life. 




156. Chang, R.B., Strochlic, D.E., Williams, E.K., Umans, B.D. & Liberles, S.D. Vagal 
Sensory Neuron Subtypes that Differentially Control Breathing. Cell 161, 622-633 
(2015). 
157. Oswald, D.J., et al. Communication between corneal epithelial cells and trigeminal 
neurons is facilitated by purinergic (P2) and glutamatergic receptors. PloS One 7, 
e44574 (2012). 
158. Jarvis, M.F., et al. A-317491, a novel potent and selective non-nucleotide antagonist 
of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in 
the rat. Proceedings of the National Academy of Sciences of the United States of 
America 99, 17179-17184 (2002). 
159. Chen, X., et al. A chemical-genetic approach to studying neurotrophin signaling. 
Neuron 46, 13-21 (2005). 
160. Chattopadhyaya, B., et al. Experience and activity-dependent maturation of 
perisomatic GABAergic innervation in primary visual cortex during a postnatal 
critical period. Journal of Neuroscience 24, 9598-9611 (2004). 
161. Harris, K.S., Zhang, Z., McManus, M.T., Harfe, B.D. & Sun, X. Dicer function is 
essential for lung epithelium morphogenesis. Proceedings of the National Academy of 
Sciences of the United States of America 103, 2208-2213 (2006). 
162. Kim, E.J., Ables, J.L., Dickel, L.K., Eisch, A.J. & Johnson, J.E. Ascl1 (Mash1) 
defines cells with long-term neurogenic potential in subgranular and subventricular 
zones in adult mouse brain. PloS One 6, e18472 (2011). 
163. van Rossum, D., Hanisch, U.K. & Quirion, R. Neuroanatomical localization, 
pharmacological characterization and functions of CGRP, related peptides and their 
receptors. Neuroscience and Biobehavioral Reviews 21, 649-678 (1997). 
164. Hung, K.S. Development of neuroepithelial bodies in pre- and postnatal mouse lungs: 
scanning electron microscopic study. Anatomical Record 203, 285-291 (1982). 
165. Lazarowski, E.R., Sesma, J.I., Seminario, L., Esther, C.R., Jr. & Kreda, S.M. 
Nucleotide release by airway epithelia. Sub-Cellular Biochemistry 55, 1-15 (2011). 
166. Cockayne, D.A., et al. P2X2 knockout mice and P2X2/P2X3 double knockout mice 
reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of 
ATP. Journal of Physiology 567, 621-639 (2005). 
167. Liu, X., Ernfors, P., Wu, H. & Jaenisch, R. Sensory but not motor neuron deficits in 




168. Erickson, J.T., et al. Mice lacking brain-derived neurotrophic factor exhibit visceral 
sensory neuron losses distinct from mice lacking NT4 and display a severe 
developmental deficit in control of breathing. Journal of Neuroscience 16, 5361-5371 
(1996). 
169. Li, J., et al. Study of GABA in Healthy Volunteers: Pharmacokinetics and 
Pharmacodynamics. Frontiers in Pharmacology 6, 260 (2015). 
170. Park, S.W., et al. Distinct roles of FOXA2 and FOXA3 in allergic airway disease and 
asthma. American Journal of Respiratory and Critical Care Medicine 180, 603-610 
(2009). 
171. Stevens, P.T., Kicic, A., Sutanto, E.N., Knight, D.A. & Stick, S.M. Dysregulated 
repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator 
inhibitor-1. Clinical and Experimental Allergy 38, 1901-1910 (2008). 
172. Saatian, B., et al. Interleukin-4 and interleukin-13 cause barrier dysfunction in human 
airway epithelial cells. Tissue Barriers 1, e24333 (2013). 
173. Schelegle, E.S., et al. Repeated episodes of ozone inhalation amplifies the effects of 
allergen sensitization and inhalation on airway immune and structural development in 
Rhesus monkeys. Toxicology and Applied Pharmacology 191, 74-85 (2003). 
174. White, J.H., et al. Heterodimerization is required for the formation of a functional 
GABA(B) receptor. Nature 396, 679-682 (1998). 
175. Mizuta, K., Osawa, Y., Mizuta, F., Xu, D. & Emala, C.W. Functional expression of 
GABAB receptors in airway epithelium. American Journal of Respiratory Cell and 
Molecular Biology 39, 296-304 (2008). 
176. Osawa, Y., et al. Functional expression of the GABAB receptor in human airway 
smooth muscle. American Journal of Physiology: Lung Cellular and Molecular 
Physiology 291, L923-931 (2006). 
177. Fulcher, M.L. & Randell, S.H. Human nasal and tracheo-bronchial respiratory 
epithelial cell culture. Methods in Molecular Biology 945, 109-121 (2013). 
178. Stewart, C.E., Torr, E.E., Mohd Jamili, N.H., Bosquillon, C. & Sayers, I. Evaluation 
of differentiated human bronchial epithelial cell culture systems for asthma research. 
J Allergy (Cairo) 2012, 943982 (2012). 
179. Ross, A.J., Dailey, L.A., Brighton, L.E. & Devlin, R.B. Transcriptional profiling of 
mucociliary differentiation in human airway epithelial cells. American Journal of 




180. Gomperts, B.N., Kim, L.J., Flaherty, S.A. & Hackett, B.P. IL-13 regulates cilia loss 
and foxj1 expression in human airway epithelium. American Journal of Respiratory 
Cell and Molecular Biology 37, 339-346 (2007). 
181. Tesfaigzi, Y., et al. Bax is Crucial for IFN- -Induced Resolution of Allergen- Induced 
Mucus Cell Metaplasia. The Journal of Immunology 169, 5919-5925 (2002). 
182. Zhen, G., et al. IL-13 and epidermal growth factor receptor have critical but distinct 
roles in epithelial cell mucin production. American Journal of Respiratory Cell and 
Molecular Biology 36, 244-253 (2007). 
183. Virk, H., Arthur, G. & Bradding, P. Mast cells and their activation in lung disease. 
Translational Research: The Journal of Laboratory and Clinical Medicine 174, 60-76 
(2016). 
184. Arinobu, Y., et al. Developmental checkpoints of the basophil/mast cell lineages in 
adult murine hematopoiesis. Proceedings of the National Academy of Sciences of the 
United States of America 102, 18105-18110 (2005). 
185. Dahlin, J.S. & Hallgren, J. Mast cell progenitors: origin, development and migration 
to tissues. Molecular Immunology 63, 9-17 (2015). 
186. Scott, E.W., Simon, M.C., Anastasi, J. & Singh, H. Requirement of transcription 
factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 
1573-1577 (1994). 
187. Williams, D.E., et al. Identification of a ligand for the c-kit proto-oncogene. Cell 63, 
167-174 (1990). 
188. Bradding, P. & Arthur, G. Mast cells in asthma--state of the art. Clinical and 
Experimental Allergy 46, 194-263 (2016). 
189. Gurish, M.F. & Austen, K.F. Developmental origin and functional specialization of 
mast cell subsets. Immunity 37, 25-33 (2012). 
190. Valent, P., et al. Failure to detect IL-3-binding sites on human mast cells. Journal of 
Immunology 145, 3432-3437 (1990). 
191. Abonia, J.P., et al. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are 
essential for recruitment of mast cell progenitors to the inflamed lung. Blood 108, 
1588-1594 (2006). 
192. Ikeda, R.K., et al. Accumulation of peribronchial mast cells in a mouse model of 
ovalbumin allergen induced chronic airway inflammation: modulation by 




193. Mierke, C.T., et al. Human endothelial cells regulate survival and proliferation of 
human mast cells. Journal of Experimental Medicine 192, 801-811 (2000). 
194. Kambe, N., Kambe, M., Kochan, J.P. & Schwartz, L.B. Human skin-derived mast 
cells can proliferate while retaining their characteristic functional and protease 
phenotypes. Blood 97, 2045-2052 (2001). 
195. Tsai, M., et al. Induction of mast cell proliferation, maturation, and heparin synthesis 
by the rat c-kit ligand, stem cell factor. Proceedings of the National Academy of 
Sciences of the United States of America 88, 6382-6386 (1991). 
196. Duffy, S.M., Lawley, W.J., Kaur, D., Yang, W. & Bradding, P. Inhibition of human 
mast cell proliferation and survival by tamoxifen in association with ion channel 
modulation. Journal of Allergy and Clinical Immunology 112, 965-972 (2003). 
197. Dvorak, A.M., Schleimer, R.P. & Lichtenstein, L.M. Human mast cells synthesize 
new granules during recovery from degranulation. In vitro studies with mast cells 
purified from human lungs. Blood 71, 76-85 (1988). 
198. Fukuzumi, T., et al. Differences in irradiation susceptibility and turnover between 
mucosal and connective tissue-type mast cells of mice. Experimental Hematology 18, 
843-847 (1990). 
199. Levi-Schaffer, F., et al. Co-culture of human lung-derived mast cells with mouse 3T3 
fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, 
and leukotrienes. Journal of Immunology 139, 494-500 (1987). 
200. Saito, H., et al. Characterization of cord-blood-derived human mast cells cultured in 
the presence of Steel factor and interleukin-6. International Archives of Allergy and 
Immunology 107, 63-65 (1995). 
201. Saito, H., et al. Selective growth of human mast cells induced by Steel factor, IL-6, 
and prostaglandin E2 from cord blood mononuclear cells. Journal of Immunology 
157, 343-350 (1996). 
202. Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nature 
Reviews: Immunology 14, 478-494 (2014). 
203. Orinska, Z., et al. IL-15 constrains mast cell-dependent antibacterial defenses by 
suppressing chymase activities. Nature Medicine 13, 927-934 (2007). 
204. Thakurdas, S.M., et al. The mast cell-restricted tryptase mMCP-6 has a critical 





205. Metz, M., et al. Mast cells can enhance resistance to snake and honeybee venoms. 
Science 313, 526-530 (2006). 
206. Shin, K., et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive 
and innate immunity in the chronic phase of Trichinella spiralis infection. Journal of 
Immunology 180, 4885-4891 (2008). 
207. Knight, P.A., Wright, S.H., Lawrence, C.E., Paterson, Y.Y. & Miller, H.R. Delayed 
expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-
specific granule chymase, mouse mast cell protease-1. Journal of Experimental 
Medicine 192, 1849-1856 (2000). 
208. Irani, A.A., Schechter, N.M., Craig, S.S., DeBlois, G. & Schwartz, L.B. Two types of 
human mast cells that have distinct neutral protease compositions. Proceedings of the 
National Academy of Sciences of the United States of America 83, 4464-4468 (1986). 
209. Brightling, C.E., et al. Mast-cell infiltration of airway smooth muscle in asthma. New 
England Journal of Medicine 346, 1699-1705 (2002). 
210. Benyon, R.C., Lowman, M.A. & Church, M.K. Human skin mast cells: their 
dispersion, purification, and secretory characterization. Journal of Immunology 138, 
861-867 (1987). 
211. Church, M.K., Pao, G.J. & Holgate, S.T. Characterization of histamine secretion from 
mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore 
A23187, compound 48/80, and basic polypeptides. Journal of Immunology 129, 
2116-2121 (1982). 
212. Balzar, S., et al. Mast cell phenotype, location, and activation in severe asthma. Data 
from the Severe Asthma Research Program. American Journal of Respiratory and 
Critical Care Medicine 183, 299-309 (2011). 
213. Bradding, P., Okayama, Y., Howarth, P.H., Church, M.K. & Holgate, S.T. 
Heterogeneity of human mast cells based on cytokine content. Journal of Immunology 
155, 297-307 (1995). 
214. He, S., Gaca, M.D., McEuen, A.R. & Walls, A.F. Inhibitors of chymase as mast cell-
stabilizing agents: contribution of chymase in the activation of human mast cells. 
Journal of Pharmacology and Experimental Therapeutics 291, 517-523 (1999). 
215. Schulman, E.S., Post, T.J., Henson, P.M. & Giclas, P.C. Differential effects of the 
complement peptides, C5a and C5a des Arg on human basophil and lung mast cell 




216. Bentley, A.M., et al. Prednisolone treatment in asthma. Reduction in the numbers of 
eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, 
and interferon-gamma cytokine gene expression within the bronchial mucosa. 
American Journal of Respiratory and Critical Care Medicine 153, 551-556 (1996). 
217. Dwyer, D.F., Barrett, N.A., Austen, K.F. & Immunological Genome Project, C. 
Expression profiling of constitutive mast cells reveals a unique identity within the 
immune system. Nature Immunology 17, 878-887 (2016). 
218. Enerback, L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and 
metachromatic properties. Acta Pathologica et Microbiologica Scandinavica 66, 303-
312 (1966). 
219. Stevens, R.L., et al. Strain-specific and tissue-specific expression of mouse mast cell 
secretory granule proteases. Proceedings of the National Academy of Sciences of the 
United States of America 91, 128-132 (1994). 
220. Irani, A.M., et al. Deficiency of the tryptase-positive, chymase-negative mast cell 
type in gastrointestinal mucosa of patients with defective T lymphocyte function. 
Journal of Immunology 138, 4381-4386 (1987). 
221. Ruitenberg, E.J. & Elgersma, A. Absence of intestinal mast cell response in 
congenitally athymic mice during Trichinella spiralis infection. Nature 264, 258-260 
(1976). 
222. Friend, D.S., et al. Mast cells that reside at different locations in the jejunum of mice 
infected with Trichinella spiralis exhibit sequential changes in their granule 
ultrastructure and chymase phenotype. Journal of Cell Biology 135, 279-290 (1996). 
223. Xing, W., Austen, K.F., Gurish, M.F. & Jones, T.G. Protease phenotype of 
constitutive connective tissue and of induced mucosal mast cells in mice is regulated 
by the tissue. Proceedings of the National Academy of Sciences of the United States 
of America 108, 14210-14215 (2011). 
224. Bankova, L.G., Dwyer, D.F., Liu, A.Y., Austen, K.F. & Gurish, M.F. Maturation of 
mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation 
in mice. Mucosal Immunology 8, 596-606 (2015). 
225. Hayashi, S., Kunisada, T., Ogawa, M., Yamaguchi, K. & Nishikawa, S. Exon 
skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic 




226. Nocka, K., et al. Molecular bases of dominant negative and loss of function mutations 
at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO Journal 9, 
1805-1813 (1990). 
227. Nagle, D.L., Kozak, C.A., Mano, H., Chapman, V.M. & Bucan, M. Physical mapping 
of the Tec and Gabrb1 loci reveals that the Wsh mutation on mouse chromosome 5 is 
associated with an inversion. Human Molecular Genetics 4, 2073-2079 (1995). 
228. Reber, L.L., Marichal, T. & Galli, S.J. New models for analyzing mast cell functions 
in vivo. Trends in Immunology 33, 613-625 (2012). 
229. Feyerabend, T.B., et al. Cre-mediated cell ablation contests mast cell contribution in 
models of antibody- and T cell-mediated autoimmunity. Immunity 35, 832-844 
(2011). 
230. Scholten, J., et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. 
Transgenic Research 17, 307-315 (2008). 
231. Dudeck, A., et al. Mast cells are key promoters of contact allergy that mediate the 
adjuvant effects of haptens. Immunity 34, 973-984 (2011). 
232. Caughey, G.H., Zerweck, E.H. & Vanderslice, P. Structure, chromosomal 
assignment, and deduced amino acid sequence of a human gene for mast cell 
chymase. Journal of Biological Chemistry 266, 12956-12963 (1991). 
233. Okumura, K., et al. Human chymase degrades human fibronectin. Clinica Chimica 
Acta 347, 223-225 (2004). 
234. Urata, H., Kinoshita, A., Misono, K.S., Bumpus, F.M. & Husain, A. Identification of 
a highly specific chymase as the major angiotensin II-forming enzyme in the human 
heart. Journal of Biological Chemistry 265, 22348-22357 (1990). 
235. Semaan, W., et al. Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by 
recombinant mouse mast cell protease 4 and human chymase. Biochemical 
Pharmacology 94, 91-100 (2015). 
236. McNeil, B.D., et al. Identification of a mast-cell-specific receptor crucial for pseudo-
allergic drug reactions. Nature 519, 237-241 (2015). 
237. Stevens, R.L., et al. Experimental Arthritis Is Dependent on Mouse Mast Cell 
Protease-5. Journal of Biological Chemistry 292, 5392-5404 (2017). 
238. Dudeck, J., et al. Mast-Cell-Derived TNF Amplifies CD8(+) Dendritic Cell 




239. Turner, H. & Kinet, J.P. Signalling through the high-affinity IgE receptor Fc 
epsilonRI. Nature 402, B24-30 (1999). 
240. Tatemoto, K., et al. Immunoglobulin E-independent activation of mast cell is 
mediated by Mrg receptors. Biochemical and Biophysical Research Communications 
349, 1322-1328 (2006). 
241. Gaudenzio, N., et al. Different activation signals induce distinct mast cell 
degranulation strategies. Journal of Clinical Investigation 126, 3981-3998 (2016). 
242. Bradding, P., et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal 
and asthmatic airways: evidence for the human mast cell as a source of these 
cytokines. American Journal of Respiratory Cell and Molecular Biology 10, 471-480 
(1994). 
243. Carroll, N.G., Mutavdzic, S. & James, A.L. Distribution and degranulation of airway 
mast cells in normal and asthmatic subjects. European Respiratory Journal 19, 879-
885 (2002). 
244. Carroll, N.G., Mutavdzic, S. & James, A.L. Increased mast cells and neutrophils in 
submucosal mucous glands and mucus plugging in patients with asthma. Thorax 57, 
677-682 (2002). 
245. Cruse, G. & Bradding, P. Mast cells in airway diseases and interstitial lung disease. 
European Journal of Pharmacology 778, 125-138 (2016). 
246. Sedgwick, J.B., et al. Immediate and late airway response of allergic rhinitis patients 
to segmental antigen challenge. Characterization of eosinophil and mast cell 
mediators. American Review of Respiratory Disease 144, 1274-1281 (1991). 
247. Al-Muhsen, S.Z., Shablovsky, G., Olivenstein, R., Mazer, B. & Hamid, Q. The 
expression of stem cell factor and c-kit receptor in human asthmatic airways. Clinical 
and Experimental Allergy 34, 911-916 (2004). 
248. Schmitz, J., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 
receptor-related protein ST2 and induces T helper type 2-associated cytokines. 
Immunity 23, 479-490 (2005). 
249. Chang, Y.J., et al. Innate lymphoid cells mediate influenza-induced airway hyper-
reactivity independently of adaptive immunity. Nature Immunology 12, 631-638 
(2011). 
250. Bartemes, K.R., et al. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells 
mediate innate type 2 immunity and allergic inflammation in the lungs. Journal of 




251. Halim, T.Y., et al. Group 2 innate lymphoid cells are critical for the initiation of 
adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425-435 
(2014). 
252. Liew, F.Y., Girard, J.P. & Turnquist, H.R. Interleukin-33 in health and disease. 
Nature Reviews: Immunology 16, 676-689 (2016). 
253. Fahy, J.V., et al. The effect of an anti-IgE monoclonal antibody on the early- and late-
phase responses to allergen inhalation in asthmatic subjects. American Journal of 
Respiratory and Critical Care Medicine 155, 1828-1834 (1997). 
254. Cahill, K.N., et al. KIT Inhibition by Imatinib in Patients with Severe Refractory 
Asthma. New England Journal of Medicine 376, 1911-1920 (2017). 
255. Yu, C.K. & Chen, C.L. Activation of Mast Cells Is Essential for Development of 
House Dust Mite Dermatophagoides farinae-Induced Allergic Airway Inflammation 
in Mice. The Journal of Immunology 171, 3808-3815 (2003). 
256. Yu, M., et al. Identification of an IFN-gamma/mast cell axis in a mouse model of 
chronic asthma. Journal of Clinical Investigation 121, 3133-3143 (2011). 
257. Morita, H., et al. An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-
Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. Immunity 
43, 175-186 (2015). 
258. Shimokawa, C., et al. Mast Cells Are Crucial for Induction of Group 2 Innate 
Lymphoid Cells and Clearance of Helminth Infections. Immunity 46, 863-874 e864 
(2017). 
259. de Kleer, I.M., et al. Perinatal Activation of the Interleukin-33 Pathway Promotes 
Type 2 Immunity in the Developing Lung. Immunity 45, 1285-1298 (2016). 
260. Hammad, H., et al. House dust mite allergen induces asthma via Toll-like receptor 4 
triggering of airway structural cells. Nature Medicine 15, 410-416 (2009). 
261. Willart, M.A., et al. Interleukin-1alpha controls allergic sensitization to inhaled house 
dust mite via the epithelial release of GM-CSF and IL-33. Journal of Experimental 
Medicine 209, 1505-1517 (2012). 
262. Patel, K.R., Bai, Y., Trieu, K.G., Barrios, J. & Ai, X. Targeting acetylcholine receptor 
M3 prevents the progression of airway hyperreactivity in a mouse model of childhood 




263. Lefrancais, E., et al. Central domain of IL-33 is cleaved by mast cell proteases for 
potent activation of group-2 innate lymphoid cells. Proceedings of the National 
Academy of Sciences of the United States of America 111, 15502-15507 (2014). 
264. Gordon, E.D., et al. Alternative splicing of interleukin-33 and type 2 inflammation in 
asthma. Proceedings of the National Academy of Sciences of the United States of 
America 113, 8765-8770 (2016). 
 154 
CURRICULUM VITAE 
 155 
 
 
156 
